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Su m m a r y
This thesis describes the development and utilisation of a transgenic system, a 
technology that was not established at Glasgow Veterinary School prior to the 
commencement of these studies. Satisfactory embryo culture is essential for the 
production of transgenic mice and Chapter 2 describes this aspect of the work. In this 
chapter different media were compared and protocols for culturing mouse embryos 
were established. Various aspects of the system were tested to ensure that conditions 
were optimal for embryo culture.
Chapter 3 describes the generation of transgenic mice using pronuclear microinjection 
and those aspects of the system that influence the efficacy of this procedure were 
examined. Pronuclear microinjection is associated with immediate and delayed 
mortality of the embryos, this chapter concentrates on the timing of the embryo loss 
and discusses the causes of post-injection embryo and foetal death.
The experience gained from the work described in Chapter 2 and 3 was adapted to 
investigate transient transgene expression in the murine preimplantation embryos using 
the bacterial lac Z reporter gene, the results of which are presented in Chapter 4. As 
preimplantation development proceeded there was an observed decline in the activity 
of the lac Z product - jS-galactosidase. The chapter concludes with an investigation 
into the effects of DNA méthylation on the expression of the introduced construct.
Chapter 5 describes an experiment designed to investigate the potential of retroviruses 
to act as vectors for exogenous gene transfer in the ovine species. Wild type Feline 
Leukaemia Virus (FeLV) was used to infect early ovine embryos and subsequent 
analysis of foetuses was used to assess the efficacy of introducing viral gene sequences 
into the mammalian genome. Two out of the 17 foetuses examined contained FeLV 
proviral sequences.
The transgenic system was utilised to investigate the role of the human myc proto­
oncogene in the induction of murine T-cell leukaemia, this work is presented in 
Chapter 6. This is the first study to exclusively target murine T-cells with the c-myc 
oncogene and these transgenic mice developed thymic lymphoma at low frequency 
despite the apparent absence of transgene expression in healthy pre-lymphomatous 
mice. However the presence of the oncogene accelerates Murine Leukaemia Virus 
(MuLV) induced lymphoma development. The results presented in Chapter 6 indicate 
that the exogenous myc oncogene can co-operate in the tumourigenic process but that 
subsequent events are required for the development of the fully malignant phenotype.
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CHAPTER 1 - GENERAL MATERIAL AND METHODS
1.1. Mice Stocks
Different breeding groups were maintained to supply the animals used in this 
work. Original stocks of inbred strains, C57B1/6J and CBA/Ca, were purchased from 
Harlan Olac (Blackthorn, Oxford.) as were the M Fl outbred mice. Balb/c mice were 
purchased from Bantin and Kingman (Grimston, Hull).
Inbred colonies of C57B1/6J and CBA/Ca mice were kept to produce female 
C57B1/6J stock and male CBA/Ca stock. Small groups of C57BL/6J females (4-5) 
were housed with single CBA/Ca males, the resultant FI hybrid (B6/CBA) offspring 
were weaned at between three and four weeks of age. Weaned females were pooled 
and used as embryo donors, some of the male offspring were retained and used for 
mating with the superovulated embryo donors, the remainder were culled.
In addition, a breeding colony of outbred M Fl mice was maintained. The 
female offspring from this group were weaned at three to six weeks of age, pooled 
and used as recipient females in the embryo transfer programme. A small proportion 
of male offspring from this breeding group was retained and later vasectomised, the 
remainder being culled.
1.2. Preparation Of Superovulated Females
Freeze-dried aliquots of Pregnant Mare Serum Gonadotrophin (PMSG, FoUigon 
- Intervet) and Human Choronic Gonadotrophin (hCG, Chorulon - Intervet) were each 
made up to a final concentration of 50 international units (i.u.) in each millilitre of 
sterile water. These were then divided into 1 ml aliquots and frozen until required.
B6/CBA FI females aged between three to six weeks of age were superovulated 
and used as embryo donors. The animals were maintained on a light/dark cycle with 
lights on from 6 am to 8 pm daily. Superovulation was accomplished by an 
intraperitoneal injection (i/p) of 5 i.u. of PMSG between the hours of 2 and 4 pm. 
Five i.u. of hCG was injected i/p 46-48 hours later. Immediately after injection each 
female mouse was placed with a single male mouse (B6/CBA FI) of proven fertility. 
The following morning (designated day 0.5 of gestation) the female mice were 
inspected for the presence of a copulation plug and used for embryo collection.
1.3. Preparation Of M urine Embryo Culture Media
a) Materials
Water - millipore Q filter sterilised
Media Ingredients NaCl (Sigma Chemical Co.)
KH2PO4 (Sigma Chemical Co.)
KCl (BDH - Analar)
CaC1.2H20 (BDH - Analar)
MgC1.6H20 (BDH - Analar)
NaH2P04.2H20 (BDH - Analar)
Na2HP04.12H20 (BDH - Analar)
NaHCOs (Formachem)
MgS04.7H20 (Sigma Chemical Co.)
Sodium Pyruvate (Sigma Chemical Co.)
Sodium Lactate
(DL lactic acid, 60% solution)
(Sigma Chemical Co.)
Glucose (BDH - analar)
Penicillin G (Sigma Chemical Co.)
Streptomycin Sulphate (Sigma Chemical Co.)
Phenol Red (Sigma Chemical Co.)
HEPES (Sigma Chemical Co.)
Bovine Serum Albumin 
(Fraction V)
(Sigma Chemical Co.)
Liquid Paraffin Liquid Paraffin (Boots Pic)
Light Paraffin Oil (BDH)
Glassware 250ml glass beakers. 
250ml volumetric flasks.
Tissue Culture 35mm petri dishes (Gibco)
50ml tissue culture centrifuge tubes. (Flow)
50ml sterile syringes (Plastipak)
0.22um dish filters. (Millipore)
b) Method
Millipore Q water was used for all batches of embryo culture or embryo 
handling media used in these experiments. Details of the embryo culture media and 
embryo handling media are given in Table 1.1. Embryos were either cultured in T6 - 
a modified Tyrodes solution (Howlett et ah, 1987), or M16 - a modified Krebs- 
Ringer solution (Whittingham, 1971). Embryos were handled or stored outside the 
C02 incubator either in PBl - a phosphate buffered medium (Whittingham and Wales, 
1969) or M2 - a HEPES buffered medium (Fulton and Whittingham, 1978).
The medium was prepared by weighing out the relevant salts separately and 
dissolving each in a small volume of water, which was transferred to a 250ml 
volumetric flask and made up to 250ml with water. The medium was filter sterilised 
using 0.22^m millipore filters and stored at 0-4®C in 50ml tissue culture centrifuge 
tubes until required.
M l6 and M2 were prepared following the protocol outlined by Hogan et al. 
(1986). The various salts except CaCl were weighed out into a volumetric flask and 
dissolved in millipore Q water. CaCl was weighed out and dissolved in water 
separately before being added to the main salt solution as was the 
penicillin/streptomycin mixture. Finally, lactate syrup was weighed out and mixed 
with a small volume of water and then added to the salt solution. Additional water 
was then added to the volumetric flask to achieve the correct concentration. The 
preparation of M2 was similar to that of M16 except HEPES was weighed out and 
dissolved separately before being added to the salt solution. The authors recommend 
that the final Ix  concentration should be used within a week of preparation.
1.4. Collection Of Mouse Embryos
Embryos were collected on the day of plugging (day 0.5). The superovulated 
mice were killed by cervical dislocation, their oviducts dissected out and placed in 
35mm petri dishes (Nunc) containing 2ml of holding medium. The oviducts were 
then transferred to petri dishes containing 1(X) /xl drops of holding medium and under 
the dissecting microscope the ampulla of each oviduct was tom to release the cumulus 
mass containing the one-cell embryos. After removal of the oviducts, hyaluronidase 
(Sigma - type II from sheep testes at a concentration of 300 /-tg/ml in holding medium) 
was added to the drop containing the embryos in order to remove the attached 
cumulus cells. When the embryos were free of cumulus cells they were removed and 
transferred through two washes (each containing approximately 2mls of holding 
medium) before being held in another petri dish also containing holding medium.
Table 1.1. Murine Embryo Culture Media.
(mg/100 ml)
T6 PBl M16 M2
NaCl 472 597 553 553
KCl 11 20 35.6 35.6
NaH2PO4.2H20 6 - - -
Na2HPO4.12H20 - 288^ - -
NaHC03 2 # - 210 35
KH2P04 - 19 16.2 16.2
MgCl2.6H20 10 10 - -
CaCl2.2H20 26 14 25.2 25.2
MgS04.7H20 - - 29.3 29.3
HEPES - - - 497
Sodium Pyruvate 3 4 3.6 3.6
Glucose 100 100 100 100
Sodium Lactate 0.305ml (60% soln.) - 261 261
Penicillin 6 6 6 6
Streptomycin 5 5 5 5
Phenol red 0.1 0.1 1.0 1.0
Bovine Serum Albumin 
(BSA)
400 400 400 400
a. Na2HP04.12H20 was added to the final solution last when PBl was being prepared.
b. NaHC03 was added to the final solution last when T6 was being prepared.
1.5. M urine Embryo Culture
Two main types of media - T6 and M16 - were used to culture murine embryos. 
Embryos were cultured in 5% C02, the pH of the medium being buffered by the 
C02. When embryos were handled outside the incubator, the medium used was either 
buffered by HEPES in the case of M2 or phosphate buffered in the case of PBl. 
Microdrops of culture medium were placed on 35mm tissue culture petri dishes 
(Gibco) and overlaid with liquid paraffin (Boots) or light paraffin oil (BDH) and
allowed to equilibrate in the CO2 incubator for at least two hours before the embryos 
were added. This method was first described by Brinster in 1963.
Embryos were washed twice before being cultured in 30 /xl microdrops in 
groups of between 20 to 30 per drop and were examined daily using an invert 
microscope (Willovert - Leitz), the proportion of embryos proceeding to the next 
stage of development being noted. In order to replicate the results described by 
Lavitrano et al. (1989), in vitro fertilisation was carried out as described by this 
group.
1.6. Preparation O f Foster Mothers
M Fl female mice aged between two to six months of age were used as 
pseudopregnant recipients. A state of pseudopregnancy was induced by mating a 
female mouse in natural oestrus with a vasectomised male mouse. Three females 
were placed with each vasectomised M Fl male, those females which were plugged 
usually entered a state of pseudopregnancy which lasted between ten to fourteen days.
1.7. Preparation O f Vasectomised Mice
Young adult (older than 2 months of age) male mice were selected for 
vasectomy and were anaesthetised using a combination of Hypnorm/Hypnovel and 
sterile water in a 1:1:4 ratio, the dosage used in the final solution being 0.5-1.0 
ml/lOOg body weight (Hypnorm is supplied by Janssen Animal Health, each millilitre 
contains 0.315 mg fentanyl citrate and 10 mg of flunisone. Hypnovel is supplied by 
Roche Pharmaceuticals Ltd and each millilitre contains 5mg of midazolam 
hydrochloride). This anaesthetic was administered by the intraperitoneal route. The 
operating site was prepared by clipping the hair and swabbing the area with 70% 
ethanol. A horizontal incision was made through the skin and body wall on the 
ventral abdomen at the level of the tuber coxae. The testes were exteriorised and a 
section of the vas deferens was removed, each end being ligated with 5/0 silk (Mersilk 
- Ethicon). The procedure was repeated on the other side, the body wall and skin 
incisions were each closed with a single suture of 5/0 silk.
1.8. Microinjection
One-cell embryos were placed under a diavert microscope (Leitz) fitted with 
differential interference contrast optics (DIG) and flanked with Leitz 
micromanipulators. A coverslip holding a 15 /xl drop of handling medium covered 
with liquid paraffin (Boots) was placed on a 60mm petri dish which in turn was placed 
on the microscope stage. A square hole was cut in the base of the petri dish which the 
coverslip spanned - this allowed the embryos to be viewed directly through the 
coverslip and gave good visualisation of the pronuclei.
A flame polished glass pipette, attached to the left hand manipulator, was used 
to hold the embryos. These holding pipettes were fashioned by flame pulling a length 
of glass capillary tubing (GC 100-10 Clarks electromedical instruments). Using a 
microforge (Research Instruments Ltd.) two 90° angles were introduced into the glass 
pipette and the pipette was broken just beyond the second angle. The broken end of 
the pipette was heated over the microforge's filament resulting in a smooth polished 
end with a very small opening (5-10 micrometers). This pipette was then inserted in 
the pipette holder and Fluorinert (FC 77 Sigma) was used to fill the air spaces of the 
pipette, holder and tubing so that fine adjustments of pressure could be applied.
Injection pipettes were also fashioned from the glass capillary tubing (GCKXTTf- 
15, Clarks Electromedical instruments). Injection pipettes were pulled using a 
moving-coil microelectrode puller (model 753, Camden Instruments) and were filled 
with approximately 1 /xl of DNA solution, the remainder of the pipette being filled 
with Fluorinert. The right hand manipulator held the injection pipette. Pressure on 
the injection needle was exerted using a 100ml air filled syringe with tubing 
connecting the syringe to the right hand pipette holder.
The embryos were injected in groups of 15-25. An embryo was picked up, held 
by the holding pipette and the fine focus adjusted until the outline of the pronuclear 
membrane was in focus. The injection pipette was brought into the same plane as the 
pronuclei which was then injected - swelling of the pronucleus usually indicated a 
successful injection.
After injection the embryos were washed once in 2 ml of the culturing medium 
and those embryos which had not been lysed were transferred to a 30 /xl culture drop 
under oil and placed in the C02 incubator.
1.9. Embryo Transfer
Embryos were normally transferred at the two-cell stage to a foster mother 
which had been plugged on the morning of transfer. For experimental reasons, other 
embryonic stages were sometimes transferred - four-cells and early morulae were also 
transferred into the oviduct of foster mothers at day 0.5 of pseudopregnancy but late 
morulae and blastocysts were transferred into the uteri of foster mothers at day 2.5 of 
pseudopregnancy.
The recipient mouse was anaesthetised and the operating site prepared as 
described in section 1.7. Embryos were loaded into a glass transfer pipette which had 
an internal diameter of approximately 120 /xm and a flame polished end. Plastic 
tubing (Portex Ltd., Kent), filled with light paraffin oil (BDH Ltd.), is attached to the 
other end of the glass capillary tubing and fine movements in the pipette are 
controlled by mouth pipetting.
Embryo transfers were performed using a dissecting microscope, the operating 
site being illuminated with a fibre optic light source. A small skin and body wall 
incision was made over the dorsal-lateral aspect of the abdominal wall and the ovary, 
oviduct and proximal part of the uterus were exteriorised.
The oviduct opening was located, the transfer pipette inserted into the 
infundibulum and the embryos delivered by gently blowing down the attached tubing. 
The body wall and skin were closed separately with a single horizontal mattress suture 
using 5/0 silk. The procedure was then repeated on the other side. Each recipient 
received between 15-30 embryos.
The mice were allowed to recover in an incubator to minimise hypothermia and 
recovery was usually complete within 1-2 hours.
1.10. Fragment And Plasmid Construction
With the exception of the CD2-myc construct, which was made by Dr. M. 
Stewart, all DNA constructs used in this work were prepared by Dr. S. Hettle who 
kindly provided the following information. The various gene constructs are shown in 
Figures 1.1. - 1.5. Preparation of the CD2-myc construct is described in Chapter 6. 
The DNA was isolated and purified for microinjection following the protocol 
described by Hogan et al. , 1986.
Tk-ENV
The entire coding sequence of the env gene of Moloney Murine Leukaemia 
Virus (MoMuLV) was cloned into an expression vector. The site chosen resulted in 
the env gene being flanked on its 5 prime side with the Herpes Simplex Virus Type 1 
Thymidine Kinase (HSVl-Tk) promoter (Wagner et al., 1981b) and on its 3 prime 
side by the HSVl-Tk polyadenylation signal. A 2.78 kb Hind III restriction fragment 
containing the HSVl-Tk promoter, the env coding region and the HSVl-Tk 
polyadenylation signal was isolated from this plasmid and used for microinjection.
Tk-lac Z
The Tk-lac Z gene construct was made by fusing the E coli gpt-trpS-lac Z fusion 
gene derived from plasmid CHI 10 (Hall et al, 1983) to the Human Simplex Virus 
Type 1 Thymidine Kinase promoter (HSVl-Tk). This fragment was excised from its 
vector sequences by restriction with BamHl and consists of 240 base pairs of the 
HSV-Tk promoter region, ligated to the lac Z coding region at the Hind III site. The 
polyadenylation signal is derived from simian virus 40 (SV40).
CMV-lac Z
The CMV-lac Z gene construct was made by fusing the E coli gpt-trpS-lac Z 
fusion gene derived from plasmid CHI 10 (Hall et al, 1983) to the Human 
Cytomegalovirus Immediate Early promoter (HCMV-IEP) sequences (-302 to 4-72 
relative to the start of transcription). A 4.38 kb fragment containing the HCMV-IEP 
promoter, the lac Z coding region, the SV40 polyadenylation signal and the HCMV- 
IEP terminator (4-2757-3052) region was isolated by partial digestion of the plasmid 
with EcoRl. The resulting linear fragment was termed CMV-lac Z and used for 
microinjection experiments.
Tk-BGB and CMV-BGB
The 3.95 kb Tk-lac Z BamHl restriction fragment consisting of the coding 
region of the E coli lac Z gene fused to the Herpes Simplex Virus Type 1 Thymidine 
Kinase promoter was cloned into the BamHl site of pARS65 to produce Tk-BGB. 
The 4.38 EcoRl partial restriction fragment CMV-lac Z comprised of the E coli lac Z 
coding region fused to the immediate early promoter of the Human Cytomegalovirus 
was also cloned into the BamHl site of the ARS65 plasmid to produce CMV-BGB.
Plasmid pARS65 contained putative mouse autonomous replicating sequences 
(ARS) and has been described previously (Ariga et al, 1987). This plasmid was
supplied by H. Ariga, to whom I am most grateful.
1.11. Transgenic Screening
Those animals born to foster mothers which had received manipulated embryos 
were screened as follows. After weaning, the offspring were anaesthetised as
described in section 1.7. and approximately 2 cm of the tail tip was removed, the
wound was cauterised and the animals were assigned an identification number using 
an ear punch. Tail biopsies were then analysed for the presence of the transgene by 
Southern blotting after extracting DNA from the tissue.
DNA Extraction
This work was carried out by Dr. Hettle who kindly provided the following 
information, the protocol used for DNA isolation was outlined by Hogan et al (1986).
Tail tissue was placed in 1.5 ml microforge tubes to which was added 0 .7  ml of 
50 mM EDTA, 0.5% SDS and 35 /xl of a 10 mg/ml solution of proteinase K. The 
tissue was incubated overnight at 55°C using a waterbath with a moving arm 
(Gallenkamp Ltd.). The following day 0.7 ml of phenol was added and the tubes 
shaken. After shaking the tubes were centrifuged for 3 minutes before the aqueous 
phase was removed and transferred to a fresh microfuge tube. To the aqueous phase 
was added 0.7 ml phenol:chloroform (1:1) and again the samples were shaken, 
centrifuged and the aqueous phase transferred. The DNA was precipitated by adding 
70 /xl of 3M sodium acetate and 0.7 ml of 100% ethanol to the aqueous phase, the 
precipitate was pelleted by centrifugation, the ethanol poured off and the DNA dried 
by leaving the tubes in a warmed room with the lids open. The DNA was dissolved 
by adding 0.1 ml of 10 mM Tris (pH8) 1 mM EDTA to the pellet. DNA was 
digested by adding the appropriate restriction enzyme and incubating for the 
recommended period of time, to each sample was added 5 /xg of DNase free RNase A 
to remove contaminating RNA.
A similar procedure was used for both foetal sheep and mouse tissues. The 
procedures used for Southern blotting, nick translation, hybridisation and 
autoradiography were those described by Sambrook et al (1989). DNA extraction and 
Southern blotting for the c-myc studies was carried out by Dr. M. Stewart and Dr. M. 
Campbell.
a.
N.
C\j
at
■a
O)
O)
Figure 1.1.
Diagram of the Linear Construct Tk-env
Showing Relevant Restriction Enzyme Sites,
10
2
>  0 O) 
m  "O ' t n
o»
a
en
(/) 2 
%  CL
Figure 1.2.
Diagram of the Linear Construct Tk-lac Z
Showing Relevant Restriction Enzyme Sites.
11
0 O)
0 D)
Figure 1.3.
Diagram of the Linear Construct CMV-lac Z
Showing Relevant Restriction Enzyme Sites.
12
c  CO 
0  C  
D ) O )
c
(0 c  
0
II
■O 0Û
E
(f)
0
CD
1CO
Û . 1 -
0
C
0O)
N
Ü0
_l
oÜ
LiJ
0Ü
c
03CJ
0W
CO
oc
<
0C
V—
3
E
Figure 1.4.
Diagram of Plasmid Tk-BGB Showing Relevant Restriction Enzyme Sites.
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Diagram of Plasmid CMV-BGB Showing Relevant Restriction Enzyme Sites.
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1.12. Statistical Analysis
Where appropriate the results were analysed by standard deviation, students t- 
distribution or chi-square using a minitab programme (Minitab Statistical Software, 
Minitab Inc.). All chi-squares are based on a 2x2 contingency table with 1 degree of 
freedom (d.f.), except where specified in the text. The Yates correction factor was 
not applied but no significant result had an expected value of 5 or below (Campbell, 
1967).
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CHAPTER 2 - MURINE EMBRYO CULTURE 
SECTION 2. 1. - INTRODUCTION
There are a number of different methods used to produce transgenic mice but 
murine embryo culture is an important component of each approach. The quality of 
the media and the suitability of the protocol employed are important in order to 
maximise the overall efficiency of transgenic animal production. Although murine 
embryo research extends over the past three decades it is still an area of active 
research as workers continue to endeavour to improve culture conditions. As a part of 
transgenic research it is important to optimise culture conditions as it not only affects 
the number of embryos suitable for transfer but can also affect subsequent in vivo 
development. The following brief literature review highlights the important findings 
in the development of murine embryo cuture media and culture conditions.
Early Work
In 1949 Hammond reported the successful development of preimplantation 
mouse embryos in vitro. The culture system designed by Hammond consisted of a 
simple salt solution supplemented with glucose and egg extract and with this media he 
was able to culture embryos from the four-cell stage to the blastocyst stage. However, 
he found that this system could not support the development of two-cell embryos 
beyond the four-cell stage.
Whitten (1956) extended these studies and showed it was possible to culture 
eight-cell embryos to the blastocyst stage in Krebs-Ringer bicarbonate solution 
supplemented with glucose and bovine albumin. The following year Whitten (1957) 
made a number of observations concerning the factors which affected the in vitro 
development of murine preimplantation embryos. This work showed that egg albumin 
or a mixture of amino acids and peptides could replace bovine serum albumin (BSA) 
as the nitrogen source but that the removal of a macromolecule made handling mouse 
embryos difficult. Further, he showed that embryo culture was successful when 5% 
C02 in air or 5% C02 in nitrogen was used but that embryos failed to develop in 
oxygen. In addition, Whitten identified those sugars which could support embryo 
development and those which could not. It was observed that development was 
superior when lactate was used and when CaCl was replaced with Ca lactate it was 
possible to culture a proportion of two-cell embryos to the blastocyst stage.
McLaren and Michie (1956) perfected the technique of embryo transfer in the 
mouse and by 1958 McLaren and Diggers were able to show that embryos cultured
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using Whitten's technique were capable of developing into normal healthy adult mice 
after transfer to foster mothers.
In 1965 Brinster (Brinster 1965a, 1965b and 1965c) produced a series of reports 
which investigated and expanded upon many of Whitten's original observations. 
Brinster (1965a) examined the capacity of murine embryos to develop at different 
osmolarities and found that the range over which embryos could be cultured was from 
216-339 milliosmoles with an optimum of 276. However, as NaCl made up such a 
large proportion of the salts present in the medium it was difficult to distinguish 
between the effects of varying the NaCl concentration and varying the osmolarity.
The hydrogen ion concentration is also a critical factor influencing the success 
of in vitro embryo culture. Whitten (1956) observed that eight-cell embryos only 
developed between pH 6.9-7.7. For two-cell embryo development, Brinster (1965a) 
found the optimum range to lie between 6.4-7.2 and reported that the greatest number 
of embryos developed at around a pH of 6.8. However, he noted that complex 
interactions between the effects of pH and energy source made it difficult to establish 
a response curve to pH alone.
Brinster (1965b) also examined the energy sources which could support 
development and the optimum concentrations of these compounds. He found that 
lactate, phosphoenolpyruvate, oxaloacetate and pyruvate could all support embryonic 
growth. However, glucose and malate which will support development of the eight­
cell mouse embryo (Whitten, 1956) would not support that of the two-cell mouse 
embryo. Brinster (1965c) also established that murine embryos would not develop in 
the absence of a fixed nitrogen source but that serum. Bovine Serum Albumin (BSA) 
and free amino acids could all be used as a source of fixed nitrogen.
BSA appeared to have other beneficial effects. In addition to that of supplying a 
source of nitrogen, its absence from embryo culture media made the embryos sticky 
and difficult to handle (Brinster, 1965c). It has also been suggested that it may 
remove toxic factors as BSA is known to be a potent binder of small molecules (Kane, 
1985 and references therein).
In 1968 Whitten and Diggers reported that it was possible to culture murine 
preimplantation embryos from the one-cell stage to the blastocyst stage, but found that 
this could only be done with certain hybrid strains and was not possible with 
randomly bred mice. Therefore, these workers were able to show, at least for the 
hybrid strain used, that a specific maternal factor was not required at this stage of 
development. A number of modifications were made to the media used in these 
experiments and it was, therefore, not easy to assess the importance of each. 
However, two changes which may have contributed to the improvement were the 
reduction in osmolarity and the increase of BSA concentration from Img/ml to 
4mg/ml.
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Factors Affecting The Successful Culture Of Murine Embryos
Since the time of these innovative experiments, numerous modifications have 
been made to the media originally formulated by Whitten and Brinster. The inability 
to culture certain hybrid strains and randomly bred mice, together, with the 
observation that the rate of cell division is slower in vitro than in vivo (Harlow and 
Quinn, 1982) has stimulated a large number of groups to explore the limitations of 
this technique. In addition, the growth of human I VF and embryo culture has 
expanded the use of murine embryos both as a quality control assay and as a model 
for assessing modifications to either the media or the protocol used in culturing 
embryos.
Murine embryo culture media are relatively simple solutions and all contain 
water, inorganic salts, an energy source and a source of fixed nitrogen. However, 
different modifications vary in the relative concentrations of these constituents.
In an attempt to optimise in vitro culture conditions Quinn and Harlow (1978) 
investigated the gaseous environment used for culturing mouse embryos. These 
workers noted that the greatest number of embryos developed when the oxygen 
concentration was between 2.5% and 5%, the balance consisting of C02 (5%) and 
nitrogen. In addition, blastocysts grown in 5% 02 had a greater number of cells at 
the blastocyst stage than those grown in 20%.
In 1971 Whittingham reported that for embryo culture the use of triple distilled 
water was superior to that of water distilled once or twice. The importance of water 
quality was further emphasised by Fukuda et al. (1987) who compared five different 
classes of water quality and showed that optimum culturing results were achieved with 
water subjected to purification using the millipore system and that this was superior to 
deionised water or triple distilled water.
Quinn et al. (1985) compared modified Tyrodes solution (T6) with a media 
formulated on the composition of human tubal fluid (HTF) and found that HTF was 
better able to support murine embryo development. The main difference between the 
two media was the potassium concentration, the potassium concentration of HTF and 
T6 being 4.9 mM and 1.4 mM respectively. Reducing the potassium concentration of 
HTF to that of T6 resulted in a reduced capacity to support development causing these 
workers to suggest that higher potassium concentrations improved embryo culture 
rates. Conversely, Wiley et al. (1986) found that reducing the potassium 
concentration from 6 mM to 1.4 mM improved the capacity of T6 media to support 
the development of murine embryos. These authors also found that increasing the 
number of embryos cultured in each microdrop increased the rate of embryo
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development, suggesting that embryos have the capacity to positively condition the 
media.
Those researchers primarily interested in mouse embryo culture have mainly 
used bovine serum albumin as a source of fixed nitrogen and most have found it 
satisfactory for the purpose. However, workers interested in human embryo culture 
and the culture of the embryos of domestic animals have been interested in assessing 
various serum supplements. A number of reports concerning the use of serum in 
embryo culture have been produced but it is difficult to establish a clear picture as 
some of the results are contradictory. Menino et al. (1985) found that, at certain 
concentrations, heat treated bovine serum gave better results than BSA and Bates et 
al. (1985) found that human foetal cord serum was superior to foetal calf serum. 
However, Shirley et al. (1985) reported that culturing in Hams F-10 with foetal cord 
serum did not improve culture results compared to Hams F-10 alone whilst Ogawa et 
al. (1987) found that embryo culture rates were markedly reduced by the use of foetal 
cord serum compared to using BSA. Kane (1987), in a review of embryo culture, 
emphasised the difficulties associated with comparing different types of serum or 
protein supplements pointing out that these are undefined substances which can vary 
widely from batch to batch. Kane's group has investigated these variations and has 
found a low molecular weight contaminant in a batch of BSA which is embryotrophic 
(Kane, 1985).
An additional problem in using the preimplantation embryo culture rate to assess 
culture media was outlined by Amy et al. (1987). These workers compared murine 
embryo culture rates using T6 with and without serum supplementation. The two 
groups of embryos cultured to the blastocyst stage at similar rates but post­
implantation development of those embryos cultured with FCS was significantly 
poorer than those embryos cultured in T6 alone.
The inability of certain strains and randomly bred mouse embryos to develop in 
vitro beyond the two-cell stage was originally noted by Whitten and Biggers (1968) 
and these observations were extended by Shire and Whitten in 1980. Muggleton- 
Harris et al. (1982) demonstrated that substances present in the two-cell cytoplasm of 
certain non-blocking strains were responsible for the embryos ability to overcome the 
two-cell block. These workers transferred small quantities of cytoplasm from non- 
blocking to blocking embryos and found that embryos treated in this manner could 
continue development beyond the two-cell stage. Cytoplasm from the two-cell 
embryo was better able to support development than that of the one-cell embryo. 
Work by Goddard and Pratt (1983) revealed that it was the maternal genotype of the 
embryo which was the important factor in determining whether the embryo blocks or 
not and suggested that maternally inherited information played an important role in 
controlling early cleavage in the mouse embryo.
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Recently, workers have reported that the two-cell block observed in certain 
strains of mice and in randomly bred mice could be overcome. In 1977 Abramczuk et 
al. found that the inclusion of small quantities of ethylenediamine tetraacetate (EDTA) 
could result in a proportion of embryos from outbred mice culturing from the one-cell 
stage through to the blastocyst stage but Poueymirou et al. (1989) found that the 
results achieved using EDTA were very variable. In 1989, Chatot et al. developed a 
medium (CZB) which could consistently support the development of one-cell mouse 
embryos, including those embryos which originated from strains of mice that 
normally exhibit the 2-cell block. This medium contained EDTA but three other 
modifications were also made. These authors found that the presence of glucose had a 
detrimental effect during early cleavage stages but was required for development from 
the eight-cell stage. In addition, they found that increasing the lactate to pyruvate 
ratio improved embryo culture results as did adding glutamine to the medium. 
Poueymirou et al. (1989) compared Whittens medium with CZB medium and found 
that embryos grown in CZB had a significantly higher rate of protein synthesis and 
that the synthesis of embryonic proteins was delayed when embryos were grown in 
Whittens medium. Chatot et al. (1990) extended their studies to other strains of mice 
which normally exhibit the two-cell block and showed that this media supported the 
development of embryos in all strains tested.
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MURINE EMBRYO CULTURE 
SECTION 2. 2. - RESULTS
2.2.1. Introduction
In the following experiments two different culture media, T6 (Hewlett et al., 
1987) and M16 (Whittingham, 1971), were examined for their ability to support 
embryo development. In addition the effect of two different types of handling media, 
M2 (Fulton and Whittingham, 1978) and FBI (Whittingham and Wales, 1969), on the 
embryos' subsequent ability to culture was examined. It was considered important to 
discover the optimal combination of handling and culturing media as a number of 
experiments necessitated holding the embryos outside the CO2 incubator for extended 
periods of time. In this section the technical aspects of murine embryo culture were 
also examined. These included the effect of the length of media storage time on 
embryo development, the embryo toxicity of liquid paraffin and the batch variation of 
embryo culture medium. These results allowed an "in-house" protocol to be 
established for this aspect of transgenic mouse production.
Only those one-cell embryos which appeared healthy were incubated in the 
culture group. Those zygotes which were fragmented, shrunken or otherwise 
abnormal in appearance were excluded. However, the embryos were not examined 
closely to distinguish between fertilised one-cell embryos and unfertilised oocytes. 
For this reason, any given collection of embryos probably contains a proportion of 
unfertilised oocytes. Therefore, although all embryos were cultured from the one-cell 
stage, the success of the groups were evaluated by recording the number of two-cell 
embryos that developed to the expanded blastocyst stage. There are two potential 
sources of error in this approach 1) it assumes that all fertilised one-cell embryos will 
develop to the two-cell stage, obviously this is not the case. However, when 
assessing media or conditions of culture, the first cleavage division is not a 
particularly sensitive stage of development. 2) Activation of unfertilised oocytes or 
fragmentation of the oocytes may cause a number of oocytes to be mistakenly scored 
as two-cell embryos. Despite these problems most experiments involving embryo 
culture were of a comparative nature. Embryos were randomly distributed to the 
different groups and were examined at least once daily.
2.2.2. Comparison Of Two Different Embryo Culturing Media
M16, a modified Krebs-Ringers solution, and T6, a media originally based on 
Tyrodes solution, were compared for their ability to support the development of
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mouse preimplantation embryos. When embryos were cultured in T6, 72.0% of two­
cell embryos developed to the blastocyst stage whereas 74.2% of two-cell embryos 
developed when cultured in M l6. The results of pooled experiments are shown in 
Table 2.2.1., there was no significant difference between the two media in their 
ability to support embryo development (x^ =  0.3: P >  0.05).
Table 2.2.1. Preimplantation Embryo Development in M16 and T6.
Media 1-cell 2-cell Blastocyst 2-cell/Blastocyst*
(%)
T6 255 246 177 (72.0)
M16 269 252 187 (74.2)
a. refers to the proportion of two-cell embryos culturing to the blastocyst stage.
2.2.3. Effects Of Holding Embryos In M2 And Culturing In M16
The effect of holding embryos outside the CO2 incubator in M2 medium for 
periods ranging from 4 to 6 hours was examined. In group A, embryos were 
collected, washed in M2 and cultured in M l6 shortly after collection. In group B the 
embryos were held in M2 at 37°C for between 4 to 6 hours before being placed in 
culture. The results are pooled and presented in Table 2.2.2. Although the embryos 
in group A appear to have greater viability as assessed by their ability to develop from 
the two-cell stage, this difference is not significant (x^ =  3.6: P >  0.05).
Table 2.2.2. Effect of Holding Embryos in Handling Media Before Culture
Group 1-cell 2-cell Blastocyst 2-cell/Blastocyst*
(%)
A 269 252 187 (74)
B 140 116 75 (65)
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Measuring the viability of two-cell embryos may not be the best test for 
assessing an "insult" to one-cell embryos. It may be that those embryos which 
survive to the two-cell stage have fully recovered from the effect of extended holding 
in M2. A comparison of the cleavage rate from the one-cell to the two-cell stage 
reveals that significantly more embryos cleaved through to the two-cell stage when 
incubated shortly after collection than when held in handling media for 2-4 hours (x^ 
=  12.0: P <  0.01).
2.2.4. Effect Of Holding Embryos In PBl Or M2 And Culturing In T6
The effect of holding embryos in M2 or PBl before culturing in T6 was 
examined by either placing the embryos directly in culture shortly after collection or 
storing the embryos for 4-6 hours in one of the two holding media before placing 
them in the culture media. The cleavage rate from the one to the two-cell stage 
differs significantly between those embryos which were held in handling media for a 
time before being cultured or those embryos that were cultured immediately. Of 
those embryos incubated immediately in T6, 96% cleaved to the two-cell stage. This 
is a significantly greater cleavage rate than those embryos held for 4-6 hours in either 
PBl (x^ =  9.6: P <  0.01) or M2 (x^ =  27.4: P <  0.01), in these groups the 
percentage of embryos cleaving to the two-cell stage was 89% and 82% respectively. 
A greater number of embryos cleaved to the two-cell stage after being held in PBl 
than in M2 (x^ = 4.7: P <  0.05). However, there was no significant difference in 
the culturing rate from the two-cell to the blastocyst stage between those cultured 
immediately and those held in handling media (x^ =  0.3: P >  0.05). In addition 
there was no difference in the culture rate to the blastocyst stage between the different 
holding media, PBl and M2 (x^ =  0.4: P >  0.05). These results are shown in Table
2.2.3.
Table 2.2.3. Effect of Holding Embryos in Different Types of Media.
Group 1-cell 2-cell Blastocyst l-cell/2-cell*
(%)
2-cell/Blastocyst**
(%)
T6 only 255 246 177 (96) (72.0)
T6 + PBl 214 191 144 (89) (75.4)
T6 + M2 308 254 185 (82) (72.8)
a. refers to the proportion of one-cell embryos cleaving to the two-cell stage.
b. refers to the proportion of two-cell embryos culturing to the blastocyst stage.
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2.2.5. Effect Of T6 Batch Variations On Embryo Development
In order to assess if there was significant variation between different batches of 
T6 media each batch of T6 was assessed shortly after preparation. The results, shown 
in Table 2.2.4., show that there were small differences between different batches of 
media. However, none of these differences were significant when the results were 
analysed using a 9x2 contingency table with 8 d.f. (x^: =  11.5: P >  0.05). On 
average 84% of two-cell embryos developed to the blastocyst stage.
Table 2.2.4. Embryo Culture Results for Different Batches of T6.
Batch 1-cell 2-cell Blastocyst 2-cell/Blastocyst
(%)
1 34 33 29 (87.9)
2 48 37 34 (91.9)
3 74 61 46 (75.4)
4 58 56 50 (89.3)
5 141 103 88 (85.4)
6 45 41 30 (73.1)
7 130 69 55 (79.6)
8 41 34 28 (82.3)
9 141 121 104 (86.0)
Total 712 555 464 (84)
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2.2.6. Effect Of Different Batches Of Liquid Paraffin On Embryo Culture
It has been reported (Fleming et al. , 1987) that liquid paraffin which is used to 
cover the media can occasionally contain impurities or toxic substances which can 
retard embryo development. For this reason two different liquid paraffin products, 
Boots liquid paraffin and BDH light paraffin oil were tested (Table 2.2.5.). Two 
different batches were examined for each product. No consistent difference was 
detected between the different products but analysing the results using a 4x2 
contingency table with 3 d.f. showed that different batches could differ significantly 
(x2 =  11.7: P <  0.01).
Table 2.2.5. Effect of Different Batches of Liquid Paraffin on Embryo 
Culture.
Batch 1-cell 2-cell Total Blastocyst 2-cell/Blastocyst
(%)
Batch A (Boots) 54 41 30 73.2
Batch B (BDH) 91 75 49 65.3
Batch C (Boots) 71 60 51 85.0
Batch D (BDH) 70 61 53 86.8
2.2.7. Effect Of In Vitro Fertilisation On Embryo Culture
On some occasions it is considered desirable to fertilise oocytes in vitro instead 
of in vivo. Usually this is done to obtain a more synchronous population of embryos, 
an important prerequiste in many studies concerned with temporal aspects of embryo 
development. In this study, however, in vitro fertilisation (IVF) was carried out as 
Lavitrano et al. (1989) had reported that it was possible to produce transgenic mice by 
incubating DNA with sperm and then using this solution to fertilise freshly collected 
oocytes. Experiments were carried out in an attempt to verify this work, the results 
of which are presented in Chapter 3. As a result of these experiments it was possible
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to compare the embryo fertilisation and culture rates between those embryos which 
had been fertilised in vivo and those that had been fertilised in vitro.
A total of 641 oocytes were collected and fertilised in vitro and of these 395 
cleaved through to the two-cell stage giving a cleavage rate of 62%. This is 
significantly lower than the cleavage rate obtained after in vivo fertilisation (x^ =  7.5: 
P <  0.01). It is also significantly lower than the 1st cleavage rate of control embryos 
used throughout this study (x^ =  166.0: P <  0.01).
A lower percentage of two-cell embryos developed to the four-cell stage or the 
blastocyst stage in the IVF group compared to the control group, however, in neither 
case was the difference between the two groups significant. This may be because the 
control group is small. If the culture rate to the four-cell and blastocyst stages of the 
IVF group is compared against in vivo fertilised control embryos (group B) cultured 
throughout the entire period of this study then the difference from the two-cell to the 
four-cell and from the two-cell to the blastocyst stages is significant (x^ =  8.5 and 5.2 
respectively: P <  0.01 and P <  0.05). These results are shown in Table 2.2.6.
Table 2.2.6. Embryo Development After In Vitro Fertilisation.
Group 1-cell 2-cell 4-cell Blastocyst l-cell/2-celP
(%)
2-cell/Blastocyst^
(%)
A 41 34 28 28 (83) (82.4)
B 3712 3101 2833 2353 (84) (75.8)
C 183 93 68 61 (51) (66.0)
D 458 302 260 - (66) -
C + D 641 395 328 - (62) -
A) - In vivo fertilised group run in parallel with IVF group.
B) - overall controls pooled throughout study.
C) - IVF embryos cultured to the blastocyst stage.
D) - IVF embryos cultured to the four-cell stage.
C+D) - Total number of IVF embryos cultured to the four-cell stage.
1. Proportion of one-cell embryos cleaving to the two-cell stage.
2. Proportion of blastocysts developing from the two-cell stage.
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2.2.8. Media Storage
The T6 embryo culture media was made up at Ix  concentration, divided into 50 
ml aliquots and stored at between 0 - 4° C. BSA was not added to the medium until 
the aliquot was required. The effects of storing media were examined in two different 
batches of T6 media, see Table 2.2.7. Batch A was used over a 5 month period and 
Batch B was used for 3 months, no significant decrease in the capacity of this media 
to support development was observed in either Batch A (x^ =  8.3: P >  0.05, using a 
2x5 contingency table with 4 d.f.) or Batch B (x^ =  5.1: P >  0.05, using a 2x3 
contingency table with 2 d.f.). The quality appeared to decline after 4 months storage 
in Batch A, but this result is not significant, perhaps due to the relatively small sample 
size in this group. Therefore, it appears that this media can be stored for at least 4 
months without any significant reduction in its ability to support embryo culture.
Table 2.2.7. Effect of Storage Time on Media Quality.
1-cell 2-cell Blastocyst 2 cell/Blastocyst 
(%)
Batch A
0-1 month old 84 76 61 (80)
1-2 months old 171 170 117 (69)
2-3 months old 278 252 183 (73)
3-4 months old 134 124 94 (76)
4-5 months old 40 32 18 (56)
Batch B
0-1 month old 213 121 92 (76)
1-2 months old 189 146 117 (80)
2-3 months old 289 210 180 (86)
It has been reported (Fleming et ah, 1987) that culturing embryos after the zona 
pellucida has been removed is a more critical test of media quality and more readily
27
identifies the presence of toxic substances in the media. To check that low level 
contaminants were not present in the media the zonae were removed from one-cell 
embryos. In this experiment 20 blastocysts developed from 23 two-cell embryos 
suggesting that toxic factors were not present in the media or the liquid paraffin.
In addition, Wiley et al. (1986) have reported that embryos cultured in groups 
have a faster rate of development than embryos cultured singly. Table 2.2.8. shows 
that a greater percentage of two-cell embryos cultured in groups reached the blastocyst 
stage than when they were cultured singly. However, the difference between the two 
results was not significant (x^ =  3.2: P >  0.05).
Table 2.2.8. Group Size and Zona Removal - Effect on Development.
2-cell stage Blastocyst 2-cell/Blastocyst
(%)
Singly, Without Zona. 23 20 (87)
Singly, With Zona 49 37 (76)
Groups (20-30), With Zona 86 76 (88)
2.2.9. Overall Culture Rate Using T6
Table 2.2.9. shows the overall culturing rate achieved with a number of batches 
of T6. Examination of embryo loss throughout preimplantation development reveals 
that 16.5% of one-cell embryos failed to cleave to the two-cell stage and there is 
significantly greater embryonic loss at this point than between any other two stages. 
Although obviously abnormal embryos were excluded from the culture group, a 
proportion of these one-cell embryos would have been unfertilised oocytes as a 
detailed examination of every embryo placed in culture was not carried out.
Excepting the loss incurred between the one and the two-cell stage, the greatest 
loss of embryos occurred between the morula and blastocyst stage. The loss at this 
stage was significantly greater than that between the four-cell and the morula stage (x^ 
=  20.9: P <  0.01) and was greater than the loss incurred between the two-cell and 
the four-cell stage, the difference being significant at the 5 % level but not at the 1 %
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level (x^ =  6.3: P <  0.05). A greater proportion of two-cell embryos failed to 
develop to the four-cell stage compared to the proportion of four-cell embryos that 
failed to form morulae, the difference being significant at the 5% level (x^ =  4.9: P 
<  0.05).
The morula and blastocyst stages are easily recognisable but the development 
from the morula stage to the expanded blastocyst requires two cleavage divisions, all 
other stages counted being separated by only one cleavage division. This may explain 
why apparently greater embryonic loss occurs at this point than at other stages of 
preimplantation development.
Table 2.2.9. Overall Culturing Rate Using T6.
1-cell 2-cell 4-cell Morula Blastocyst
3712 3101 2833 2632 2353
(119.7%) (100%) (91.4%) (84.9%) (75.9%)
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MURINE EMBRYO CULTURE.
SECTION 2.3. - DISCUSSION
The major objective of this study was to examine those aspects of murine 
embryo culture which were relevant to transgenic mouse production.
Although a number of different procedures have been developed for producing 
transgenic mice each necessitates the in vitro holding and usually the in vitro culture 
of preimplantation embryos. It was considered important, therefore, to optimise the 
culture conditions in an attempt to maximise the number of manipulated embryos 
suitable for transfer. It has been shown (Amy et al., 1987; Ryan et al., 1990) that 
culture conditions can affect the subsequent development of transferred embryos and 
ultimately influence the number of offspring bom.
There is no generally accepted optimal formula for murine embryo culture 
media and a number of different media have been used in different laboratories. 
These media are similar in that they all contain a chemically defined salt solution, 
bicarbonate, lactate, pymvate and a macromolecule usually bovine semm albumin. 
Some workers, especially those primarily involved in human embryo culture, 
regularly use a semm component in the media.
In all of the culturing experiments described the embryos were cultured from the 
one-cell stage rather than the two-cell stage as it has been reported that culturing from 
the one-cell stage is a better indicator of culture conditions (Davidson et al., 1988). 
However, the results are based on the number of two-cell embryos reaching the 
expanded blastocyst stage as it was not possible to accurately define the fertilisation 
status of the one-cell stage.
Two different culture media routinely used to culture mouse embryos were 
compared: M16 - a modified Krebs-Ringers solution very similar to Whitten's 
medium (Whitten, 1971; Whittingham, 1971) and T6 - a modification of tyrodes 
medium (Hewlett et al., 1987). Within the experimental design described there was 
no significant difference between these two media in their ability to support murine 
embryo development. There are a number of differences between these two media. 
The concentration of both sodium chloride and potassium is higher in M l6 than in T6 
but these differences do not appear to have significant effects on embryo culture.
T6 was adopted for general use and all subsequent culturing experiments were 
carried out using this media. During the course of this work a total of 3101 two-cell 
embryos were placed in culture and 2353 developed through to the expanded 
blastocyst stage. This gave a culturing rate of 76% which was deemed satisfactory.
It is extremely difficult to make direct comparisons between the culturing rates 
reported by different workers as a number of different genetic strains of mice are used
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and small variations in procedure, water quality and ingredients are inevitable. For 
example, batch to batch variations in the quality of bovine serum albumin have been 
reported (Kane, 1987), some of this variation being ascribed to the presence of 
embryotrophic contaminant (Kane, 1985). However, Quinn et al. (1984) reported 
that up to 80% of one-cell embryos cultured through to the expanded blastocyst stage 
when T6 was used and Pomp et al. (1988) achieved a culturing rate of 98.5% using a 
low lactate modification of Whitten's medium. Whitten's medium itself supported a 
culturing rate of 89% using FI hybrid females ICR x C57B1/6J. It would appear, 
therefore, that given certain mouse strains and a high standard of media quality high 
rates of development can be achieved with mouse embryos.
Embryos were collected into handling media and held in this media outside the 
C02 incubator until they were microinjected. Microinjection usually took a number 
of hours to perform and this necessitated the holding of embryos outside the C02 
incubator for extended periods of time. The effect of incubating one-cell embryos in 
handling media outside the C02 incubator for 4-6 hours was examined. Holding 
embryos outside the CO2 incubator significantly reduced the number of one-cell 
embryos cleaving to the two-cell stage. This was observed both when embryos were 
held in M2 before being cultured in M l6 and when embryos were held in M2 or PBl 
before being cultured in T6. Fewer embryos cultured to the two-cell stage in T6 after 
being held in M2 than those held in PBl. Although embryos were randomly 
distributed to the different groups, an unequal allocation of unfertilised embryos to 
any one of the test groups could have affected the significance of the results. The 
intrinsic differences between the embryos from different donor females could be 
excluded from the experiment by culturing embryos within donor groups. It has been 
argued that an experimental design of this type would be a statistically more powerful 
approach (Pomp et a l ,  1988). When the subsequent culture rate of two-cell embryos 
to the blastocyst stage was examined no significant difference was observed between 
the different groups.
There are three major reasons for culturing embryos in a controlled gaseous 
environment such as exists within a CO2 incubator: (1) embryos require a source of 
CO2/HCO3 for normal development (Quinn and Wales, 1973), (2) a 5% level of CO2 
is required to interact with the bicarbonate in the medium to maintain an optimum pH 
- the importance of buffering and adequate equilibration of the media has been 
stressed by a number of authors (John and Kiessling, 1988) and (3) it has been shown 
that decreasing the oxygen concentration from 20% to 5% significantly improved 
culture conditions for preimplantation embryos (Quinn et a l ,  1978). In this study, 
however, embryos were cultured in the presence of 20% oxygen.
The handling media is already buffered in atmospheric conditions, PBl is a 
phosphate buffered medium and M2 is a HEPES buffered medium. Therefore, the
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reduction in the cleavage rate in those embryos incubated outside the CO2 incubator 
appears to be due either to the absence of an appropriate CO2 concentration exerting a 
direct effect on the zygote stage or because the handling media is suboptimal for 
embryo culture.
Lactate is present in murine embryo culture but absent from the handling media 
PBl and M2. The absence of lactate should not be detrimental to the one-cell stage as 
it has been reported that reducing the lactate concentration (and/or the osmolarity) 
improves the developmental capacity of one-cell embryos (Pomp et al. , 1988) and that 
lactate is actually detrimental to normal first cleavage (Cross and Brinster, 1973). 
However, in contrast to these findings, studies in recent years (Chatot et al., 1989, 
1990) have found that a high lactate:pyruvate ratio was beneficial for the development 
of early stages.
The effect of prolonged incubation of mouse embryos in HEPES containing 
medium has not been reported but Quinn et al. (1984) have reported that holding in 
HEPES buffered T6 for 30-60 minutes had no significant effect on subsequent 
development.
Batch Variations
After each batch of medium had been prepared its ability to support embryo 
development was tested. There were only small differences in media quality between 
different batches with only small variations in embryo culture rates being recorded. 
As the same batches of reagents were used throughout, this experiment was designed 
to test the repeatability of media preparation. It would appear that inevitable small 
variations in the preparation of media do not affect the quality of the media to any 
great extent. Batch variations in embryo culture media have been widely reported but 
these have usually been attributed to variations in the quality of the individual reagents 
such as liquid paraffin (Fleming et al., 1987), BSA (Kane, 1987), serum (Shirley et 
al., 1985) and water (Fukuda et al., 1987). A significant difference in the success of 
human IVF has been attributed to different batches of T6 (Gianaroli et al., 1986) but 
these authors did not identify the reasons for these differences. Batch variations based 
on inherent variations in procedure have not been reported and these results suggest 
that either small variations in protocol do not affect the final product greatly or that 
the procedure was repeated fairly accurately.
In this study different products and batches of liquid paraffin were examined for 
their ability to support embryo development. Two batches of liquid paraffin (Boots) 
and two batches of light paraffin oil (BDH) were tested and although there were no 
consistent differences between the products there was a significant difference between 
batches. It has been reported that toxicity effects associated with liquid paraffin can
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be subtie (Fleming et al., 1987 ) and the experimental design reported here may not 
be the most sensitive method for detecting less obvious toxic effects.
In vitro Fertilisation
Embryo fertilisation and culture rates were compared between those embryos which 
had been fertilised in vivo and those that had been fertilised in vitro. A difference 
might arise between these two groups for at least two reasons. Firstly, the oocytes 
were collected from the donors between 12 and 14 hours after hCG injection whereas 
the embryos were collected between 22 and 24 hours after hCG injection and 
therefore were cultured for twelve hours longer than the in vivo group. Secondly, the 
embryos fertilised in vitro would be exposed not only to T6 and PBl but also to 
fertilising media for 6-8 hours.
In this study the fertilisation and/or one-cell cleavage rates of oocytes fertilised 
in vitro was significantly lower than those embryos fertilised in vivo. A report by 
Brinister et al. (1989) summarises the results of similar experiments undertaken by 
their group and a number of other workers in which fertilisation rates ranged from 
49% to 86%. The average fertilisation rate quoted in Brinster's report was 64% 
which is similar to the fertilisation rate of 62% reported here.
Although the difference was not significant, fewer in vitro fertilised embryos 
cleaved through to the four-cell stage and developed to the blastocyst than in the small 
control group run in parallel. If, however, the two to the four-cell and the two to the 
blastocyst cleavage rates of the in vitro fertilised embryos are compared against the 
overall culture rate achieved during the course of this work, then the difference in 
subsequent development is significant. A direct comparison between the development 
rate of the in vitro group and this composite control group of in vivo fertilised 
embryos cannot be made as the experiments were carried out at different times using 
different batches of media. It is possible that if more embryos had been included in 
the control group run in parallel with these experiments the difference may have been 
significant.
If the proportion of embryos developing from the two-cell stage is reduced, this 
may be due to either a direct effect of in vitro fertilisation (eg polyspermy) or may 
reflect the extended period of time these embryos spent in vitro at a sensitive stage of 
development.
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Storage Times
Due to the short half-life and instability of certain reagents used in embryo 
culture media, namely penicillin and pyruvate (Wiley et al., 1986), it has been 
variously recommended that medium made up at 1 x concentration and stored at 0- 
4®C should be used within 2 days (Wiley et al., 1986), 1 week (Hogan et al., 1986) 
or 2 weeks (Pratt, 1987) of preparation. Pyruvate is important because it is used as 
an energy substrate for the first cleavage (Whittingham and Biggers, 1967).
In this study, the length of time that two different batches of T6, made up at Ix 
concentration, could be stored at 0-4® C was examined. There was no significant 
difference in the ability of Batch A to support embryo development until after 4 
months storage at which time the culture rate declined. Similarly there was no 
significant decrease in the quality of Batch B with up to 3 months storage.
Therefore, it was found, in contrast to the above recommendations, that murine 
embryo culture could be stored for extended periods without any loss of culturing 
capacity. It may be that this experimental design was not sufficiently sensitive to 
detect a reduction in media quality and that other more sensitive tests of media quality 
would be required.
Wiley et al. (1986) reported that culturing embryos in large groups improved 
the rate of development, it being suggested that a large group of embryos conditions 
the media and that factors produced by the embryo improve the quality of the media. 
Although these authors noted that the rate of development improved, the total number 
of embryos reaching the blastocyst stage was unaffected. As a result of this work, 
many labs have followed this protocol by culturing embryos in groups of 20-30 per 
microdrop, a microdrop usually having a volume of 30-50 fil. In this study it was 
found that a greater proportion of embryos cultured through to the blastocyst stage 
when in groups of 20-30 than when cultured singly although the difference was not 
significant.
The success of producing transgenic mice is dependent upon the success of a 
number of different experimental procedures. Embryo culture is central to transgenic 
production for, if the handling or culturing media is substandard, it will limit the 
number of manipulated embryos suitable for transfer at the appropriate stage. Sub- 
optimal embryo media can also affect subsequent development in utero (Amy et al., 
1987). Therefore, to maximise the number of manipulated embryos resulting in 
viable offspring it is essential that media be of the highest quality.
In these experiments, assessment of different conditions was made by examining 
the number of embryos developing to the expanded blastocyst stage. There is 
evidence from a number of sources that the culture of embryos from the one-cell to 
the blastocyst stage is not the best available assessment of embryo viability/potential
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or of the culture conditions. Fleming et al. (1987) has suggested that the sensitivity 
of this assay could be increased by removing the embryos' zonae pellucidae. They 
showed that embryos cultured after removal of the zona pellucida, were sensitive to a 
toxic batch of liquid paraffin. This protocol was followed to assay one batch of media 
and liquid paraffin but there was no significant difference between the group cultured 
after removal of the zona pellucida and the control group.
Therefore, removing the zonae pellucidae of cultured embryos or examining 
foetal development of embryos grown in culture have both highlighted deficiencies in 
culture medium not detected by the embryo culture results. Other workers (Harlow 
and Quinn, 1982) have preferred to measure the rate of development or the embryo 
cell number at a given stage rather than the total number reaching the expanded 
blastocyst stage. Ryan et al., (1990) showed that the addition of Platelet Activating 
Factor (PAF) to embryo culture media did not result in a greater proportion of 
embryos reaching the blastocyst stage but blastocyst cell number was enhanced in the 
treated group and more of these embryos implanted than in the control group. More 
sophisticated techniques, such as measuring the glucose uptake of embryos, have also 
been applied in order to assess viability more accurately (Butler et al., 1988).
In this study the conclusions were drawn after comparing the proportion of 
embryos that developed to a defined stage between two or more groups of embryos. 
Although this method is not the most sensitive assay of culture conditions available, it 
was possible, using this approach, to assess media quality and to develop a 
standardised approach to murine embryo culture. As shown in the next chapter, 
embryos cultured for varying periods of time using the system described here were 
capable of developing into viable offspring after transfer to pseudopregnant recipients.
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CHAPTER 3. - TRANSGENIC PRODUCTION 
SECTION 3.1. - INTRODUCTION
Early Work
The ability to transfer genetic material into the mammalian germline has only 
been achieved during the last decade and resulted from the pioneering work of 
Brinster, Gordon, Ruddle and others (Gordon et a l ,  1980; Brinster et ah, 1981c; 
Costantini and Lacy, 1981; Wagner et ah , 1981a; Wagner et ah , 1981c). During this 
time, this technology has been used to address fundamental questions in many aspects 
of biomedical science including the areas of genetics, development, immunology and 
oncology (for reviews see: Palmiter and Brinster 1986; Jaenisch, 1988; Cuthbertson 
and Klintworth, 1988; Hanahan, 1989).
The first successful attempt to transfer genetic material into the mouse genome 
was reported in 1974 by Jaenisch and Mintz. These workers microinjected SV40 
DNA sequences into the blastocoel cavity of mouse embryos and the subsequent 
analysis of adult offspring revealed the presence of SV40 sequences in at least a 
proportion of the adult tissues.
During the 1970s, researchers made increasing use of amphibian oocytes and 
eggs to investigate the expression of a wide variety of cloned genes (for review see 
Gurdon and Melton, 1981). It was shown that DNA could be transcribed into 
functional message (Mertz and Gurdon, 1977) and in some cases this message could 
be translated to produce the protein product (De Robertis and Mertz, 1977). Many of 
the features which characterise the introduction of genetic material into mammalian 
embryos were first observed in amphibian oocytes and embryos. These included the 
observation that circular DNA has greater stability in biological systems than linear 
DNA and that efficient ligase activity is present in the amphibian oocyte nucleus 
(Gurdon and Melton, 1981). In 1981 Rusconi and Schaffner produced adult frogs 
carrying rabbit globin sequences introduced into fertilised eggs. Analysis of these 
frogs revealed that the introduced sequences were present in the form of head to tail 
tandem arrays - a feature also observed after the injection of DNA in mammalian 
embryos (Brinster et ah, 1981c).
The technique of DNA microinjection in amphibian oocytes and eggs was 
adapted to investigate the regulation of both mRNA (Brinster et ah, 1980, 1981b) and 
DNA within mammalian embryos (Brinster et ah, 1981a). These studies laid the 
foundation and developed the techniques subsequently used for the production of 
transgenic mice. In 1980, Gordon et ah successfully introduced cloned DNA into the 
mouse genome using the technique of pronuclear microinjection. The following year
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four other groups reported the successful production of transgenic mice using this 
approach (Brinster et ah, 1981c; Costantini and Lacy, 1981; Wagner et a l ,  1981a; 
Wagner et al., 1981c). It was apparent from these reports that the integrated 
transgene could be transmitted to subsequent generations and that expression was 
possible both in the founder mice and their transgenic progeny. It appeared that the 
introduced DNA integrated into the host chromosomes at a very early stage in 
development, usually in head to tail tandem arrays. After these initial innovative 
reports the use of transgenic mice increased rapidly and data quickly accumulated 
concerning both the expression of the introduced genes and the efficacy of producing 
transgenic mice.
In 1982, Palmiter et al. introduced rat growth hormone sequences into the germ 
line of mice and demonstrated the dramatic affect transgenes could exert on the 
phenotype of the animal. These workers fused the promoter of the mouse 
metallothionein-I (MT-I) gene to the rat growth hormone gene. Some of the resultant 
transgenic mice showed high levels of rat growth hormone and produced double the 
normal growth rate in a proportion of offspring. Such alterations in normal 
physiology dramatically demonstrated the potency of this technique and gave 
researchers an insight into the many biochemical interactions that control important 
characteristics such as growth.
Gene Expression in Transgenic Animals
It is possible to direct transgene expression to particular tissues by fusing tissue 
specific promoters to the gene of interest. Gene expression has been targeted to the 
pancreas using both the insulin gene (Bucchini et al., 1986) and an elastase - human 
growth hormone gene (Omitz et al., 1985). Tissue specific expression was also 
recorded in the lens of the eye using the murine a-A - crystalline promoter (Overbeek 
et al., 1985) and muscle using the rat myosin light-chain 2 gene (Shani, 1986).
Examples of temporal control of expression have also been reported with the a- 
foetoprotein gene being expressed in a manner analogous to the endogenous gene 
(Krumlauf et al., 1985). Human foetal globin transgenes introduced into mice were 
also regulated in a temporal manner (Chada et al., 1986).
As information accumulated, it became apparent that transgene expression could 
be unpredictable. Different lines of mice produced with the same DNA construct 
showed different levels of expression and although the transgene copy number was 
different for each line the level of expression did not necessarily correlate with the 
copy number (Palmiter and Brinster, 1986). In some cases transgenes carrying tissue 
specific regulatory signals were expressed in inappropriate tissues. Stewart et al. 
(1984) reported that the c-myc oncogene, targeted to the mammary gland using the
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Murine Mammary Virus (MMTV) promoter, produced mammary adenocarcinomas in 
the transgenic lines created. In one line, however, transgene expression was present 
in a number of organs resulting in spontaneous tumour development in a wide range 
of different tissues (Leder et al. , 1986).
Most researchers ascribed the variable and unpredictable nature of transgene 
expression to the influence of the surrounding chromatin at the site of integration and 
this was demonstrated by Allen et al. in 1988 when they produced transgenic mice 
expressing the reporter gene lac Z under the influence of the Herpes Simplex Virus 
Thymidine Kinase (Tk HSV) promoter. Different lines of mice differed considerably 
in both spatial and temporal patterns of expression. Palmiter and Brinster (1986) had 
previously suggested that some promoters were much more sensitive to their site of 
integration. Cumulative data using the MT-I promoter, a promoter active in a number 
of different cell types, revealed that tissue expression varied widely between different 
transgenic lines. In 1990 Al-Shawi et al. confirmed that the site of chromosomal 
integration can have a major influence on transgene expression. These workers 
produced a transgenic line of mice in which aberrant transgene expression was 
detected, reisolated the transgene from its chromosomal position and reintroduced this 
construct to create a new transgenic line. The different chromosomal position in the 
new line altered the pattern of expression in the secondary transgenic mice.
It now appears that variable gene expression is a combination of both 
chromosomal site and the absence of sufficient regulatory signals within the transgene 
construct. In 1987 Grosveld et al. reported that elements, now termed dominant 
control regions (DCR), situated between 65 and 44 kilobases upstream of the j8- 
haemoglobin gene could exert a high degree of control upon transgene expression. 
When these elements were included in the transgene construct, expression in the 
resulting transgenic mice was highly tissue specific, of a high level, copy number 
dependent and independent of the site of integration. Similar elements have now been 
found associated with the human «-haemoglobin gene (Ryan et al., 1989) and the 
CD2 gene (Lang et al., 1988).
In 1986 Palmiter and Brinster noted that levels of expression could vary within a 
transgenic line, both between siblings and between generations. In some cases animals 
with low levels of expression gave rise to offspring with high levels of expression and 
vice versa. Allen et al. (1990) showed that levels of expression, although not the 
general pattern of expression, can vary within a transgenic line depending on the 
genetic background of the transgenic mice. This observation may explain why 
expression can vary within a line as most founder animals are initially hybrids and 
subsequent breeding will result in gene segregation - possibly including those genes 
which modify transgene expression.
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Significant differences in transgene expression between generations are a feature 
of a phenomenon known as imprinting described by Reik et al. (1987), Sapienza et al. 
(1987) and Swain et al. (1987). These workers independently identified transgenic 
lines in which the paternal genetic contribution differed in expression potential from 
that of the maternal contribution. The consequence of this was that certain transgenes 
(and presumably certain endogenous genes) have a different level of expression 
depending upon whether the individual receives the transgene from the sire or the 
dam.
Factors Affecting The Production Of Transgenic Mice By Pronuclear 
Microinjection
The application of pronuclear microinjection is associated with high levels of 
embryonic mortality. The number of offspring carrying integrants varies widely both 
between experiments conducted by the same group and by different groups, but 
usually ranges between 15-30% (Gordon and Ruddle, 1983). In 1985 Brinster et al. 
investigated the factors which affected the successful production of transgenic mice 
using pronuclear microinjection. These workers demonstrated that the efficiency of 
integration increased with increasing DNA concentration in the injection solution. 
Above 2 /xg/ml no further increase in integration efficiency occurred and embryo 
mortality increased when concentrations of 10 /xg/ml were injected. Obviously at a 
given DNA concentration the number of copies injected will depend on the size of the 
plasmid or linear construct. It is not clear from Brinster's work whether the toxic 
effect on embryos results directly from a high concentration or high copy number. 
The form of injected DNA was also important, linear molecules with 'sticky ends' 
integrating at a much higher efficiency than either supercoiled circular plasmid or 
blunt ended linear molecules. This group also showed that by using hybrid mice the 
efficiency was eight fold greater than when an inbred strain of mice was used. This 
difference was due to a number of factors, namely, a greater number of fertilised eggs 
was recovered from the hybrid mice, a greater proportion of hybrid embryos survived 
injection and developed to term, and a greater percentage of hybrid offspring carried 
the transgene in the hybrid group compared to the inbred group.
The mechanism of DNA integration following pronuclear microinjection is not 
fully understood. It was established at an early stage that a variable number of gene 
copies are found in the resulting transgenic animals, usually in long head to tail 
tandem arrays (Brinster et al., 1981c). It is believed that DNA integrates at random 
chromosomal breaks, the number of breaks limiting the number of integration sites 
per cell (Brinster et ah, 1985). Microinjection into tissue culture cells has also been 
developed (Capecchi, 1980). The previously established and most commonly used
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method of introducing DNA into tissue culture cells is by transfection, this method 
utilises the cell's ability to take up DNA when it is precipitated with calcium 
phosphate (CaP04). However, the proportion of cells taking up DNA after 
microinjection was reported as being 1(P to 10® greater than after transfection. As 
there are a number of differences between the two techniques it is difficult to identify 
the factors which affect the proportion of cells taking up DNA. The difference 
probably reflects the fact that microinjection results in the DNA being deposited in the 
nucleus of the cell (Capecchi, 1980). However, it is possible that with microinjection 
of both cells and embryos, the physical trauma sustained by the nucleus (or 
pronucleus) assists the integration of DNA.
Pronuclear microinjection is associated with embryonic mortality which can be 
divided into two types, those embryos dying shortly after microinjection due to severe 
and usually obvious damage and those dying later in development. Wilmut pointed 
out that in sheep this deferred loss continues throughout foetal development (Wilmut 
etal., 1990).
The efficiency of producing transgenic mice varies between groups and between 
experiments with the same group. The optimal rate for embryo survival is roughly 
25 % and a similar figure is considered optimal for DNA integration (Brinster et al. ,
1985). This means that even with the most efficient operators and the most optimal 
conditions, the number of transgenic animals is unlikely to exceed 6% of all 
successfully injected embryos transferred to recipients.
This chapter describes various aspects of transgenic mouse production, 
concentrating on the detrimental effect of pronuclear injection which is examined at 
various stages of development. The efficiency of the various component parts which 
make up the protocol for producing transgenic mice is examined in an attempt to 
optimise this procedure.
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TRANSGENIC PRODUCTION 
SECTION 3.2. - RESULTS
3.2.1. Introduction
During the course of this work transgenic mice were produced using three 
different gene constructs. Two different methods of gene insertion were used in an 
attempt to produce transgenic mice - pronuclear microinjection (Hogan et al. , 1986) 
and sperm mediated transfer of DNA (Lavitrano et al. , 1989).
The production of transgenic mice is dependent upon the success of a number of 
different techniques and procedures which include: the superovulation and mating of 
young female embryo donors; the collection of embryos and subsequent pronuclear 
microinjection of these embryos; overnight culture to the two-cell stage and transfer 
into the oviducts of pseudopregnant recipients. Finally, the resultant offspring are 
screened for the presence of the introduced DNA by Southern blotting.
The primary purpose of these experiments was to produce transgenic mice. 
Information pertaining to the efficacy of the procedure was recorded, however, as this 
was a secondary consideration the sample sizes in some of the results presented are 
not always well balanced.
3.2.2. Embryo Collection
In a series of experiments in which the collection rates were recorded, a total of 
5802 embryos were collected from 214 three to six week old superovulated females, 
the average number of embryos collected per mouse being 27.1. A number of 
embryos collected were rejected because they appeared lysed, fragmented or 
otherwise morphologically abnormal but overall 85.3% were judged as having a good 
appearance and on average each donor supplied 23.1 good embryos.
There was a considerable range in the number of embryos collected from each 
mouse. On very few occasions no embryos could be recovered, the most likely 
reason being failure of ovulation. Excluding these mice, however, the number of 
embryos collected from each mouse ranged from 6 to 66 (standard deviation - 11.9). 
In a series of collections the number of embryos recovered from each donor was 
recorded. Figure 3.2.1 shows a distribution graph representing these results.
Those embryos which had an obviously abnormal morphology eg fragmented or 
lysed, were rejected. The remaining embryos were pooled and held in either HEPES
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or phosphate buffered medium until they were transferred to the microinjection 
chamber. Only a proportion of the embryos placed in the microinjection chamber 
were considered suitable for injection, namely those in which at least one pronucleus 
could be easily identified.
A proportion of embryos were damaged by microinjection, the most obvious 
manifestation of this being the leakage of cytoplasmic contents and cell lysis. Of 
3783 embryos placed in the microinjection chamber, microinjection was attempted in 
2202 (58.2%) and 1583 (41.9%) were not obviously damaged as assessed by visual 
examination 1 hour after microinjection. Therefore, 28.1% of those injected were 
obviously damaged, usually lysed.
Figure 3.2.1. Number of Embryos Collected From Superovulated Mice.
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Figure 3.2.1. shows a distribution curve of embryo collection rates from superovulated mice.
The efficiency of microinjection was defined as the number of embryos 
surviving microinjection as a percentage of the total number of embryos in which 
injection was attempted. There was considerable day to day variation in the efficiency 
of microinjection and this was reflected in a similar variation in the proportion of 
embryos in which good visualisation of the pronuclei was observed. Good 
visualisation of the pronuclei was one of the factors which affected the number of 
embryos successfully injected, other factors included the quality of the microinjection 
needle and the quality of the medium although this was a subjective assessment.
The pronuclei swell progressively during the one-cell stage and are most easily 
injected when they are at their maximum size just before the nuclear membranes 
disappear (Hogan et a i ,  1986). In an attempt to assess the optimal time for
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microinjection, the efficiency of microinjection was recorded at different times of the 
day - these results are presented in Table 3.2.1. During this assessment, the day 
length in the animal house was automatically controlled and the time of lights-on and 
lights-off was kept constant. Microinjection was usually carried out between the 
hours of 2pm and 7pm but occasionally microinjection was started at 12 noon and on 
some occasions carried on until 8pm.
The efficiency of microinjection as measured by the number of embryos 
surviving microinjection did not vary significantly throughout the day. However, the 
proportion of injectable to uninjectable embryos was greatest between 2 and 4pm and 
declined later in the day (Table 3.2.1). The number of injectable embryos was 
significantly greater between 2-4 pm than between 4-6 pm (x^ =  26.1: P <  0.01) and 
was significantly greater between 4-6 pm than 6-8 pm (x^ =  51.4: P <  0.01).
Table 3.2.1. Time of Day - Effect on Efficiency of Microiiyection.
Time of day. 
(P.M.)
No. of embryos 
placed in chamber (%)
No. of embryos 
microinjectable (%)1
No. of embryos 
surviving injection (%)^
12-2 77 (100) 52 (67.5) 36 (69.2)
2-4 1626 (100) 1074 (66.1) 787 (73.3)
4-6 1427 (100) 814 (57.0) 565 (69.4)
6-8 653 (100) 262 (40.1) 195 (74.5)
1. The percentage of the embryos placed in the chamber in which microinjection was attempted.
2. The percentage of embryos in which microinjection was attempted surviving injection.
Those embryos which did not appear obviously damaged were placed in culture 
overnight and the number developing to the two-cell stage recorded.
3.2.3. Cleavage Rate O f Zygotes To The Two-Cell Stage
A total of 3115 zygotes were microinjected with Tris-EDTA buffer containing 
DNA and then placed in culture and of these, 2532 embryos cleaved through to the 
two-cell stage giving an overall cleavage rate of 81.3%. These results include those 
embryos microinjected with a number of different constructs and different DNA 
concentrations (for a description of the different constructs see Chapter 1). The 
cleavage rate for zygotes injected with a solution which did not contain DNA - either
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buffer alone or embryo culture medium being used - was 87.8%. Table 3.2.2. shows 
the cleavage rate for the different constructs and concentrations used.
Table 3.2.2. Cleavage Rate to the Two-Cell Stage After Mlcrohyection.
Construct [DNA] 1-cell 2-cell (%)
Tk-env 2/ig/ml 931 766 (82.3)
Tk-lacZ 2/tg/ml 42 30 (71.4)
CMV-lacZ 2/ig/ml 104 76 (73.0)
CMV-BGB 10/tg/ml 688 540 (78.4)
Tk-BGB 10/ig/ml 631 502 (79.6)
Tk-BGB/30 0.33/tg/ml 719 618 (86.0)
Total Injected With DNA - 3115 2532 (81.3)
Buffer Only - 146 128 (87.7)
Medium 16 - 19 17 (89.5)
Medium FBI - 16 14 (87.5)
Total Injected Without DNA - 181 159 (87.8)
Overall Total No. Injected - 3296 2691 (81.6)
Uninjected Controls 1023 855 (83.6)
The linear constructs; Tk-env, Tk-lacZ and CMV-lacZ were injected at a concentration of 2 /ig/ml 
whereas the circular constructs Tk-BGB and CMV-BGB were injected at a concentration of 10 /rg/ml 
and Tk-BGB/30 at a concentration of 0.33 ;tg/ml.
There was no significant difference between the two circular constructs injected 
at a concentration of 10 /tg/ml. When the three linear constructs are compared it 
appears that significantly more embryos cleaved to the two-cell stage after injection 
with Tk-env than with the two linear lac Z constructs (x^ =  7.7: P <  0.01). 
However, the number of embryos injected with the lac Z constructs was relatively 
small and although these experiments were conducted at different times this result 
may reflect differences in the quality of the DNA preparation.
The effect of DNA concentration can be examined by comparing the cleavage 
rate of those embryos microinjected with high and low concentrations of DNA and
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comparing those embryos microinjected with DNA against those embryos injected 
with a DNA free solution. The circular construct Tk-BGB was injected at two 
different concentrations, 10 pg/ml and 0.33 pg/ml. The cleavage rate to the two-cell 
stage was significantly greater for those embryos microinjected with the lower 
concentration (x^ =  9.7: P <  0.01).
In addition, a greater proportion of those embryos injected with either buffer or 
medium which did not contain DNA cleaved through to the two-cell stage than those 
injected with buffer carrying DNA. The difference was significant at the 5% level 
but not at the 1 % level (x^ =  4.9: P <  0.05).
A total of 1023 uninjected one-cell embryos were placed in culture after being 
held in the buffered medium for a period of time approximately equivalent to that of 
the injected group (embryos which were obviously abnormal were not included in 
either culture group). The cleavage rate in this group was 83.6%, there being no 
significant difference between this rate and that of the injected group. It is difficult to 
make a direct comparison between the two groups as those embryos in the injected 
group which were not considered suitable for microinjection were rejected. 
Therefore, embryos in the injected group were selected to a greater extent than those 
in the control group and this may have affected the result.
3.2.4. EMBRYO MORTALITY - In Vitro Preimplantation Development
In an experiment specifically designed to investigate the effect of pronuclear 
microinjection on the development of preimplantation embryos in vitro, embryos were 
injected with a number of different constructs and cultured through to the blastocyst 
stage in parallel with uninjected controls. The results are presented in Table 3.2.3. 
and Figure 3.2.2.
In this experiment 91% of controls developed from the one-cell to the two-cell 
stage and 86% of the resulting two-cell embryos developed to the expanded blastocyst 
stage when cultured in vitro. In the injected group 86% of microinjected embryos 
developed to the two-cell stage and 54% of these two-cells developed into expanded 
blastocysts. The cleavage rate from the one-cell to the two-cell stage did not 
significantly differ between the injected group and the control group (x^ =  2.4: P >  
0.05). However, a significantly greater number of embryos developed to the 
blastocyst stage from the two-cell stage in the control group when compared with the 
injected group (x^ =  57.7: P <  0.01).
Examination of the cleavage rate from the one-cell stage to the two-cell stage 
revealed that there was no significant difference in the number developing to the two­
cell stage between the DNA constructs and those embryos injected with buffer only
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(x2 =  0.3: P >  0.05). Similarly, there was no significant difference in the number 
of expanded blastocysts developing from the two-cell stage, between any of the 
groups of embryos injected with the different constructs nor the embryos injected with 
buffer only (results analysed using a 4x2 contingency table with 3 d.f. where x^ =  
2.0: P >  0.05).
Table 3.2.3. Cleavage Rate to the Blastocyst Stage After Microiiyectioii.
Construct 1-cell 2-cell 4-cell Morula Blastocyst 1-cell/Blast.
(%)
2-cell/Blast
(%)
Controls 228 207 200 180 178 (78.0) (86.0)
Buffer Injections 78 67 60 54 36 (46.2) (53.7)
Tk-BGB/30 93 85 77 67 41 (44.0) (48.2)
Tk-BGB 77 67 56 49 40 (52.0) (59.7)
CMV-BGB 85 69 50 44 37 (43.5) (53.6)
Total Injected 333 288 243 214 154 (46.2) (53.5)
l-cell/Blast. and 2-cell/Blast. are the proportion of embryos developing from the 1-cell stage and the 2- 
cell stage to the blastocyst stage respectively.
In the control group a total of 228 embryos were placed in culture and of these a 
total of 50 embryos failed to develop. These consisted of 21 one-cell embryos which 
failed to cleave to the two-cell stage (42% of total loss), 7 two-cell embryos which 
failed to develop to the four-cell stage (14% of total loss), 20 four-cell embryos which 
did not form morulae (40% of total loss) and 2 morulae which failed to develop to the 
blastocyst stage (4% of total loss).
The pattern of embryo loss is quite different in the injected group. A total of 
333 injected zygotes were placed in culture: of these 45 did not develop to the two­
cell stage (25% of total loss), 45 two-cell embryos failed to develop (25% of total 
loss), 29 four-cells did not form morulae (16% of total loss) and 60 morulae failed to 
develop into blastocysts (33% of total loss).
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Figure 3.2.2. Development of Micro injected Mouse Embryos
D evelopm ent of m ouse em bryos
controls
injected
1 -cell 2-cell 4-cell Morula B lastocyst
Stage of developm ent
Figure 3.2.2. shows the difference between control and microinjected embryos in their ability to 
develop to the blastocyst stage.
Within the control group the embryonic loss from the one-cell to the two-cell 
stage is significantly greater than the loss at the two to the four-cell stage (x^ =  6.1: 
P <  0.01) and the morula to the blastocyst stage (x^ =  12.4: P < 0.01). In 
addition, the embryonic loss between the four-cell and morula stage is significantly 
greater than the loss at the two to the four-cell stage (x^ = 7.2: P < 0.01) and the 
morula to the blastocyst stage (x^ = 13.7: P < 0.01).
In the injected group the loss from the one-cell to the two-cell stage does not 
significantly differ from that between the two to the four-cell stage or between the 
four-cell to the morula stage. However, the loss between the morula to the blastocyst 
stage was significantly greater than the loss incurred between the one to the two-cell 
stage (x^ = 17.7: P < 0.01), the two to the four-cell stage (x^ = 11.4: P <  0.01) 
and the four-cell stage to the morula stage (x^ = 18.8: P < 0.01).
3.2.5. EMBRYO MORTALITY - In Vivo Development Up To Midgestation
The difference in embryonic mortality between injected embryos and 
unmanipulated embryos during the first half of gestation was assessed by transferring
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two-cell embryos into the oviducts of pseudopregnant recipients. Culling these 
recipients between 9-11 days post-coitus allowed their pregnancy status to be 
established.
In this experiment 13 recipients received unmanipulated control embryos, 3 
recipients received embryos injected with Tk-BGB, 4 recipients received embryos 
injected with Tk-BGB and 2 recipients received embryos injected with CMV-BGB. 
Of the 13 recipients which received unmanipulated embryos 8 were pregnant and of 
the 9 recipients which received microinjected embryos 6 were pregnant. The results 
of this experiment are summarised in Tables 3.2.4. and 3.2.5.
Table 3.2.4. Embryo Development to Midgestation Stage After Microiiyection.
Controls Embryos Injected Embryos
Total Number of Recipients. 13 9
Total Number of Pregnant Recipients. 8 6
Number of Embryos Transferred. 225 201
Number of Embryos Transferred Into P-f. 147 151
Number of Uterine Swellings. 95 66
Number of Foetuses 83 47
Number of Viable Foetuses 79 43
Average Number of Embryos Transferred 17.3 22.3
*Average Number Embryos Transferred Into P + . 18.4 25.2
Average Number of Swellings 11.9 11.0
Average Number of Foetuses 10.4 7.8
Average Number of Viable Foetuses 9.9 7.2
*P+ represents those recipients which subsequently became pregnant.
The 8 recipients in the control group which were subsequently shown to be 
pregnant, received a total of 147 embryos. At day 9-11 65% of transferred embryos 
were represented as uterine swellings, 56% as identifiable foetuses with 54% of 
transferred embryos being judged as viable.
In the injected group 151 embryos were transferred into 6 recipients which 
subsequently became pregnant, of these 44% were represented as uterine swellings, 
31% as foetuses with 28% of transferred embryos appearing viable at day 9-11.
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Therefore, in those mice that became pregnant, significantly more transferred 
embryos resulted in swellings (x^ =  13.1: P <  0.01), foetuses (x^ =  19.4: P < 
0.01) and viable foetuses (x^ =  19.7: P <  0.01) in the control group when compared 
with the injected group.
A comparison between the number of viable foetuses recovered from the uterine 
swellings in the two groups reveals that a significantly lower number of viable 
foetuses were recovered from swellings in the injected group (x^ =  6.9: P <  0.01). 
As embryos dying before implantation are unlikely to stimulate a uterine reaction this 
would appear to be an indication of the post-implantation foetal loss.
In those recipients which became pregnant, an average of 13.4 embryos were 
transferred into the control group and an average of 25.2 embryos were transferred in 
the injected group. Although embryonic loss was greater in the injected group, as 
calculated by the number of transferred embryos resulting in uterine swellings, there 
was no significant difference in the number of swellings found in each group. An 
average of 12 swellings was found in the control group and an average of 11 in the 
injected. Therefore, it was possible that the embryonic loss was influenced by the 
recipients' capacity to carry a large number of foetuses. However, it is unlikely that 
this factor had a major influence as in the control group one recipient had 19 
swellings and yielded 19 foetuses and four other recipients had between 13 and 14 
swellings.
Table 3.2.5. Embryo Development to Midgestation Stage After 
Microinjection - Different Constructs.
Tk-BGB Tk-BGB/30 CMV-BGB
Number of Recipients 3 4 2
Number of Pregnant Recipients 2 2 2
Number of Embryos Transferred 73 68 60
♦Number of Embryos Transferred to P + . 51 40 60
Number of Swellings 19 22 25
Number of Foetuses 15 17 15
Number of Viable Foetuses. 12 16 15
*P+ represents those recipients which subsequently became pregnant.
Table 3.2.5. shows the comparison between the embryo transfer results of the 3 
different constructs used. There is no significant difference in the embryonic 
mortality of those embryos receiving Tk-BGB and CMV-BGB. The sample size was
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very small but a greater number of embryos survived to produce swellings and viable 
foetuses in the recipients receiving embryos microinjected with Tk-BGB/30 than either 
those receiving Tk-BGB or CMV-BGB injected embryos. The difference, however, is 
not significant (x^ = 2.8 and 3.5 respectively: both P >  0.05).
3.2.6. EMBRYO MORTALITY - In vivo Development Up To Midgestation - 
Uterine Transfers
Control and microinjected embryos were cultured through to the blastocyst stage 
and transferred into the uterus of pseudopregnant recipients. These recipients were 
culled at between 9-11 days of pregnancy and embryo mortality assessed by 
examination of the uterus and its contents.
In the control group 48 transferred embryos were represented by 41 swellings 
(85%). This loss was not significantly different (x^ =  0.7: P >  0.05) from the 
injected group in which 21 of the 27 transferred embryos were represented as 
swellings (77%). Therefore, the majority of transferred embryos implanted and 
initiated a uterine response.
However, in the injected group only 6 foetuses could be recovered from the 21 
uterine swellings (29%) whereas in the control group 35 foetuses were recovered from 
41 swellings (85%). Therefore, embryonic mortality between implantation and day 9- 
11 is significantly greater in the injected group (x^ =  20.0: P <  0.01). These results 
are in agreement with the results described in the previous experiment and although 
the sample size is small it emphasises that there is significant embryonic loss beyond 
the blastocyst stage. These results are shown in Table 3.2.6.
Table 3.2.6. Embryo Development to Midgestation After Microiqjection, In 
Vitro Culture and Uterine Transfer.
Controls Injected
Total Number of Recipients 3 3
Number of Pregnant Recipients 3 2
Total Number of Embryos Transferred 48 45
♦Number Transferred into P + . 48 27
Number of Uterine Swellings. 41 21
Total Number of Foetuses Recovered. 35 6
Number of Viable Foetuses Recovered. 35 6
♦P + represents those recipients which subsequently became pregnant.
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3.2.7. EMBRYO MORTALITY - In Vivo Development Up To Term
The great majority of microinjected and unmanipulated embryos transferred to 
pseudopregnant recipients were allowed to develop to term.
Forty-two recipients received unmanipulated control embryos and 71 recipients 
received injected embryos. The pregnancy rate in the control group was 40.5% and 
45% in the injected group, the difference not being significant (x^ =  0.2: P >  0.05).
In those recipients which became pregnant 35 % of transferred embryos survived 
to term in the control group whereas only 25 % of injected embryos survived to term. 
In those recipients which became pregnant the embryonic mortality in the injected 
group was significantly greater than that in the control group (x^ =  10.8: P <  0.01). 
These results are summarised in Table 3.2.7.
Table 3.2.7. Development to Term After Microinjection.
Controls
(oviduct)
Injected
Number of Recipients. 42 71
Number of Pregnant Recipients. 17 32
Number Transferred to Recipients 766 1446
♦Number Transferred to P+ 340 672
Number Bom 119 169
Number Surviving 96 145
Number Transgenic - 9
Percentage Pregnant 40.5% 45.0%
Average Number of Embryos transferred 18.2 20.4
♦Average Number Transferred to P+ 20.5 21.0
♦Percentage Bora/Transferred P + 35.0% 25.0%
Average Number Bora 7.0 5.3
Percentage Bora/Transferred to Recipients 15.5% 11.7%
Transgenic/Total Transferred. 0.62%
♦Transgenic/Transferred P+ 1.34%
♦P+ represents those recipients which subsequently became pregnant.
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Embryo survival results for in vitro culture to the blastocyst stage, embryo 
survival to midgestation and embryo survival to term after oviduct transfer are 
summarised in Figure 3.2.3.
Figure 3.2.3. Survival of Control and Injected Embryos to Three Different 
Stages of Development.
C ontio l. In jeo t.d Contiol* In jeo t.d Injected
*1 In vitro embryo culture, percentage of 2-cell embryos developing to the blastocysts stage
*2 Percentage of embryos developing to mid-gestation
*3 Percentage of embryos developing to term.
Table 3.2.8. shows the embryo transfer results recorded for the different 
constructs. With the exception of those recipients which received embryos injected 
with Tk-BGB there was no significant difference in the pregnancy rate between the 
different constructs used: Tk-env, Tk-BGB/30, CMV-BGB and CD2-myc (based on a 
2x4 contingency table with 3 d.f., x^ = 1.9: P > 0.05). None of the twelve 
recipients receiving Tk-BGB injected embryos were pregnant.
From those recipients which were ultimately pregnant the following results were 
obtained. Of the recipients which received Tk-env injected embryos 61% were 
pregnant, the embryonic survival rate in these recipients being 14%. Embryos 
injected with CMV-BGB were transferred into 3 recipients, 2 of which became 
pregnant with 32% of embryos developing to term. In the Tk-BGB/30 group 54% of 
recipients were pregnant and 33% of embryos transferred to these pregnant recipients 
produced offspring. Finally, 43% of embryos transferred, after being injected with 
CD2-//2yc, went to term. In this last group 40% of mice were pregnant. Comparisons 
between the in utero mortality of embryos injected with the different constructs
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reveals that the mortality of embryos injected with Tk-env is significantly greater than 
each of the other constructs, Tk-BGB/30, CMV-BGB and CD2-myc (x^ =  24.5, 48.9 
and 9.6 respectively, all P <  0.01).
These results are reflected in the average litter sizes bom to each pregnant 
recipient. The Tk-env group with a high mortality in utero had an average litter size 
of 2.8 whereas the Tk-BGB/30, CMV-BGB and CD2-myc groups had average litter 
sizes of 7.1, 7.0 and 9.7 respectively.
Table 3.2.8. Transgenic Mouse Production - Different Constructs.
Controls Tk- Tk- Tk-BGB CD2- CMV-
Oviduct Uterine env BGB 30 myc BGB
Number of Recipients 42 17 28 12 13 15 3
♦Number of P+ 17 9 17 0 7 6 2
Number of Embryos 
Transferred
766 328 532 237 289 330 58
♦Number of Embryos 
Transferred to P+
340 158 342 0 152 134 44
Number Bora 119 84 47 0 50 58 14
Number Weaned 96 84 37 0 36 58 14
Number Transgenic - - 5 0 0 2 2
Percentage Pregnant 41% 53% 61% 0% 54% 40% 66%
Average Number of 
Embryos/Recipient
18.2 19.3 19.0 19.8 22.2 22.0 19.0
♦Average Number of 
Embryos/P +
20.5 17.6 20.6 - 21.7 22.3 21.5
♦Percentage of Transferred 
Embryos Bora to P+
35% 53% 14% 0% 33% 43% 33%
Average Number Bora 7 9.3 2.8 0 7.1 9.7 7.0
*P+ represents those recipients which subsequently became pregnant.
Table 3.2.8. also shows a comparison between those recipients in the control 
group receiving two-cell embryos transferred into the oviduct with those receiving 
either morula or blastocyst stages into the uterus.
Embryo transfer into the oviduct resulted in a pregnancy rate of 40.5% whereas 
transfer into the uterus resulted in a pregnancy rate of 53%. The difference was not 
significant (x^ =  0.8: P > 0.05).
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The embryonic survival rate in those recipients which became pregnant after 
oviductal transfer was 35%, whereas in those recipients that became pregnant after 
embryos were transferred into the uterus the survival rate was 53 %. Therefore, there 
was significantly greater embryonic mortality in those recipients which received two­
cell embryos transferred into the oviduct than in those which had embryos transferred 
into the uterus after in vitro culture (x^= 14.7: P <  0.01). This result does not, 
however, account for the embryonic loss sustained during in vitro culture.
3.2.8. Transgenic Production - Sperm Vector Method
An attempt was made to produce transgenic mice following the method 
described by Lavitrano et al. (1989). This involved collecting unfertilised oocytes, 
incubating them in the presence of freshly collected epididymal spermatozoa and 1/x 
g/ml Tk-BGB, moving the embryos into embryo culture medium and transferring the 
resulting cleavage stage embryos into suitably primed recipients. Therefore, those 
embryos transferred had not been microinjected but had been collected as oocytes and 
fertilised in vitro.
In this experiment 155 embryos were transferred into 8 recipients (results shown 
in Table 3.2.9.). Five of these recipients subsequently became pregnant after 
receiving a total of 101 embryos. Forty-two (42%) of these embryos developed 
through to term. Neither the pregnancy rate (x^ =  1.3: P >  0.05) nor the embryonic 
mortality (x^ =  1.4: P >  0.05) differed significantly from the control embryo 
transfer results shown in Tables 3.2.7. and 3.2.8. .
Table 3.2.9. Transgenic Production Using Sperm Vector Method.
Total Number of Recipients 8
Pregnant Recipients 5
Percentage Pregnant 63%
Total Number of Embryos Transferred 155
Percentage Bora/Transferred 27%
♦Number of Embryos Transferred to P-H 101
♦Percentage Bora/ Transferred to P-h 42%
Number Bora. 42
Average Litter Size. 8.4
Number Surviving 41
*P+ represents those recipients which subsequently became pregnant.
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The details of the pregnancy results were not recorded for another 5 recipients 
which received embryos fertilised in the presence of Tk-BGB. These recipients 
produced another 17 offspring. None of the offspring produced by this method were 
transgenic.
3.2.9. Integration of Exogenous DNA Following Pronuclear Microiqjection
The numbers of transgenic animals produced using the different DNA constructs 
are shown in Table 3.2.10. Of the 37 offspring weaned after being microinjected 
with Tk-env, 5 (14.2%) proved to be transgenic.
From 14 mice microinjected with CMV-BGB only 2 were positive for the 
integrated transgene (14%). In addition, 15 day 9-11 foetuses were recovered after 
microinjection with CMV-BGB, 1 of which was positive for the transgene.
No offspring were born after microinjection with Tk-BGB. However, 12 
foetuses (9-11 days) were recovered and of these 3 were positive for the transgene.
Thirty-six offspring and 5 foetuses were analysed by Southern blotting after 
being microinjected at the zygote stage with Tk-BGB/30. None of these proved to be 
positive for the transgene. This finding agrees with the work of Brinster et a l ,  
(1985). These workers showed that if the injection concentration fell below 1 jitg/ml 
the integration frequency declined. A total of 58 offspring which had been 
microinjected with CD2-myc were weaned. Two of these mice were positive for the 
transgene when analysed by Southern blotting.
Therefore in total 145 offspring were produced 9 (6.3%) of which were 
transgenic and of 27 midgestation foetuses recovered 4 (14.8%) were transgenic. The 
figures are remarkably consistent for three out of the four groups as 14% of offspring 
injected with Tk-env, 14% of offspring injected with CMV-BGB and 15% of foetuses 
injected with either CMV-BGB or Tk-BGB were transgenic. However, only 3.4% of 
offspring injected with CD2-myc were transgenic. It is possible that transgenic 
foetuses expressing this construct died in utero as offspring derived from these two 
lines of mice did not express this construct in any of the tissues analysed.
Based on the number of transferred embryos which ultimately resulted in 
transgenic mice the efficiency of production for Tk-env, Tk-BGB, Tk-BGB/30, CMV- 
BGB and CD2-myc was 0.93%, 0%, 0%, 3.4% and 0.6% respectively.
In summary, the overall results reveal that 75% of embryos did not survive to term 
and only 1.3% of transferred embryos resulted in live transgenic mice. The fate of 
embryos transferred to pregnant recipients is represented in Figure 3.2.4..
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Table 3.2.10. Overall Efficiency of Transgenic Production.
Tk-env Tk-BGB CMV-BGB Tk-BGB/30 CD2MYC
(2 Mg/ml) (10 /ig/ml) (10 /ig/ml) (0.33 /ig/ml) (2 /ig/ml)
Number Injected Embryos Transferrec 532 237 58 289 330
Number of Recipients 28 12 3 13 15
Number of Pregnant Recipients 17 0 2 7 6
Number of Offspring Weaned 37 0 14 36 58
Number of Offspring Transgenic 5 0 2 0 2
Percentage Transgenic 14% 0 14% 0 3%
Overall Efficiency (%) 0.93% 0 3.4% 0 0.6%
Figure 3.2.4. Embryos Transferred to Pregnant Recipients/Proportion 
Transgenic.
Number of Embryos Transferred to Recipients Which Becam e Pregnant
23 .8 1 %
1 .3 4 %
Transferred, Not Born 
Born, Not Transgenic 
Proportion Born Transgenic
74 .8 5 %
0 1  
0  2 
■ s
Figure 3.2.4. shows the fate of embryos transferred to those recipients which ultimately became 
pregnant.
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TRANSGENIC PRODUCTION 
SECTION 3.3. - DISCUSSION
The ability to incorporate exogenous DNA sequences into the mammalian germ 
line has proved to be an extremely fruitful technique for addressing questions in many 
areas of biomedical science (for reviews see: Gordon and Ruddle, 1983; Palmiter and 
Brinster, 1985; Palmiter and Brinster 1986; Jaenisch, 1988; Cuthbertson and 
Klintworth, 1988). The successful production of transgenic animals was first reported 
in 1980 by Gordon et al. and shortly afterwards five other groups reported the 
introduction of cloned DNA into mice (Wagner E. et al., 1981a; Brinster et al., 
1981c; Costantini and Lacy, 1981; Wagner T. et al., 1981c; Harbers et al., 1981).
In this study nine transgenic lines were produced using three different DNA 
constructs. In 1985, Brinster et al. examined the factors which affected the efficiency 
of introducing foreign DNA into mice. Under optimal conditions of DNA form and 
concentration 24-31% of mice that developed contained integrated DNA sequences. 
This result is far superior to those reported in this study which range from 3.4% to 
14%. Brinster's work demonstrated that the integration frequency of linear molecules 
was five times more efficient than circular plasmids. This finding was not reflected in 
this study in which the proportion of transgenic offspring bom after microinjection 
with the circular plasmid was greater than that achieved with the linear DNA. 
However, in this study the sample size was comparatively small and the results 
achieved with linear DNA was considerably below that of Brinster's group.
Embryo Mortality After Pronuclear Injection
Embryo mortality following pronuclear microinjection was assessed at three 
different stages of development: at the blastocyst stage after in vitro culture, at mid­
gestation (day 9 to 11) and at term. Pronuclear microinjection significantly reduced 
the number of embryos developing to the blastocyst stage in vitro, 86% of 
unmanipulated two-cell embryos reached the expanded blastocyst stage whereas only 
54% of manipulated embryos developed to this stage. The mortality rate of embryos 
injected with buffer containing no DNA was comparable to those injected with DNA. 
It appears, therefore, that the presence of DNA in the microinjection solution does not 
significantly increase the mortality rate - at least during preimplantation development, 
although high concentrations of DNA did appear to significantly affect the number of 
embryos successfully completing the first cleavage division. In 1985 Brinster et al. 
examined preimplantation development to the morula and blastocyst stages. There 
was no difference in the culture rate to the morula and blastocyst stage between
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embryos injected with buffer or low concentrations of DNA. However, at 
concentrations of 10 /ig/ml or above the survival rate of cultured preimplantation 
embryos was further reduced. In the results presented here there was no significant 
difference in the embryo culture rate between embryos injected with buffer alone or 
DNA injected at either 0.33 /ig/ml or 10 /ig/ml although in this study only 
supercoiled plasmid DNA was injected at 10 /ig/ml. The reduction in preimplantation 
embryo viability following pronuclear microinjection has also been observed in other 
species. Rexroad and Wall (1987) found that microinjection of sheep embryos 
significantly reduced development to the thirty-two cell stage.
King (1985) reviewed the intrinsic and extrinsic factors which affect embryo 
development and emphasised that despite appearing healthy the potential for 
development can be reduced by the in vitro handling of embryos. Therefore, a 
number of workers have used alternative methods to assess embryo viability 
including: the rate of embryo development (Harlow and Quinn, 1982), the 
ultrastructural appearance of the embryo (McReynolds and Hadek, 1972), metabolic 
parameters (Butler et at., 1988) and by the degree of sister chromatid exchange (Saito 
et al., 1984). However, the definitive test of success in experimental manipulations 
of mammalian embryos is the transfer to foster mothers and subsequent development 
to term (Whittingham, 1981).
When the development of microinjected embryos was examined at midgestation 
significantly more transferred embryos were represented as foetuses in the control 
group than in the injected group, 54% and 28% respectively developing to 
midgestation. Comparing these figures it appears that increased losses of injected 
embryos continue after the preimplantation stage. This is supported by the finding 
that only 65% of obvious uterine swellings yielded viable foetuses in the injected 
group compared with 83% in the control group.
The two groups also differed in the number of embryos transferred, on average 
25 injected embryos were transferred to each recipient whereas only 18 control 
embryos were transferred to each recipient. If overcrowding at the time of 
implantation was an additional cause of embryo loss this would further reduce the 
proportion of embryos surviving in the injected group. However, the observation that 
significant embryo mortality occurred after the blastocyst stage was confirmed by 
transferring injected embryos at the blastocyst stage and assessing foetal loss at 
midgestation. In the injected group only 22% of transferred blastocysts were 
represented as foetuses at day 9-11 whereas 73% of control blastocysts developed to 
this stage. Wilmut et al. (1990) monitored foetal development using ultrasound 
scanning after the transfer of microinjected sheep embryos to recipient ewes and 
similarly showed that foetal mortality continued through development.
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The results presented here also suggest that the efficiency of transgenic 
production may be slightly greater if embryos are transferred as soon as possible after 
collection. Only 12% of manipulated two-cell embryos survived to day 9 following 
culture to the blastocyst stage and transfer to a pseudopregnant recipient whereas 
when injected embryos were transferred at the two-cell stage 28% survived to mid­
gestation. This pattern of increased loss after culture and transfer was not observed in 
the control group. However, Massip et al, (1984) have reported that the deleterious 
effects of handling preimplantation embryos are additive and Hahn and Schneider
(1982) noted that the observed decrease in viability after transfer is related to the 
duration of in vitro culture.
The embryonic mortality in the injected group was significantly greater than in 
the control group. In those recipients which became pregnant 35 % of unmanipulated 
embryos transferred at the two-cell stage developed to term whereas only 25% of 
manipulated embryos resulted in viable neonates. The 35% survival rate in the 
control group was probably an underestimate as most of the control embryo transfers 
were attempted at the start of the transgenic programme. Experiments conducted after 
more experience had been gained revealed that survival rates of 42% could be 
achieved after in vitro fertilisation, culture to the two-cell stage and transfer. In 1970 
Bronson and McLaren explored the factors which affected the success of mouse 
oviduct embryo transfer. These authors showed that the size of fluid volume 
transferred was important and that under optimal conditions a pregnancy rate of 63% 
and an embryo survival rate of 71 % could be achieved in the pregnant recipients.
The deferred loss of manipulated embryos observed in these results presumably 
results from genetic damage sustained at the time of microinjection. The stage of 
development at which individual embryos and foetuses die may reflect damage to 
genes which have a specific function to perform at some window of ontogeny. 
Chromosomal damage which involves genes required for important house keeping 
functions probably causes the loss of embryos at an early stage of development 
whereas genes required at a specific stage of development will cause embryonic 
mortality at that time or shortly after.
The nature and the extent of genetic changes that result from microinjection 
have not been investigated. Jaenisch (1988) has reported that the incidence of 
insertional mutagenesis in transgenic lines may be slightly greater for transgenic mice 
produced by pronuclear injection than by infection with retroviral vectors. However, 
creating transgenic mice (Van der Putten et al. , 1985) or sheep (Harvey et al. , 1990) 
by infecting early embryos with retroviral vectors or retroviruses does not appear to 
cause the high levels of embryo mortality which are associated with pronuclear 
microinjection. Therefore, insertional mutagenesis alone cannot account for the
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extent of embryo and foetal loss observed and it seems likely that the physical 
disturbances associated with microinjection causes non-specific damage to chromatin.
For obvious reasons most attention has been directed at those mice which 
survive and carry the transgene. Estimates of the proportion of transgenic mice 
carrying recessive lethal mutations have varied from 1% (Palmiter and Brinster, 1986) 
to 15% (Covarrubias et al., 1987). These are discovered when heterozygotes 
carrying the transgene at the same site of insertion are bred together in an attempt to 
produce homozygotes. In a proportion of cases, litters from these crosses are smaller 
than normal and homozygote animals are absent. More detailed reports have shown 
that a proportion of these embryos or foetuses die at various stages of development 
(Mark, Signorelli and Lacy, 1985; Wagner et al., 1983). Mutagenesis can be caused 
by natural (Panthier et al., 1988) or experimentally induced (Jaenisch et al., 1983; 
Soriano et al., 1987) infection of germ cells by murine retroviruses. In 1981 Jaenisch 
et al. infected embryos with MuLV. One of the transgenic lines resulting from this 
experiment contained a proviral insertion in the first intron of the «-1 (I) collagen 
gene and homozygotes for this integrated provirus failed to develop to term due to 
haemorrhage from a weakened vascular system (Jaenisch et al., 1983; Schnieke et al., 
1983; Lohler et al., 1984).
The chromosomal changes in some transgenic lines have been examined in 
detail. Wagner et al. (1983) were the first to report that insertional mutagenesis could 
be a sequel to pronuclear microinjection of one-cell embryos. These workers 
produced six lines of transgenic mice carrying human growth hormone sequences. 
Two of these six lines contained inserts that caused prenatal lethality in homozygotes 
for the transgenes. These transgenic lines were investigated further (Covarrubias et 
a l ,  1986; Covarrubias et a l ,  1987). Although these transgenes were inserted into 
different chromosomes there were a number of similarities between the two lines. 
Both caused embryonic mortality shortly after implantation (day 4-5) at the egg 
cylinder stage. In addition, there were extensive rearrangements of the flanking 
cellular DNA in both lines and a probable deletion in one of these two lines.
Southern blot data of transgenic lines reveals that insertion of transgene 
sequences is commonly associated with rearrangements of the flanking cellular DNA 
(Covarrubias et a l ,  1987) although this does not necessarily cause mutations. A 
more unusual example of embryo mortality associated with a transgenic line was 
reported by Mahon et al. (1988). When heterozygotes carrying this transgene were 
crossed with non-transgenic mice the resulting litters were only 40% of the size 
expected, however, of those offspring bom 50% were transgenic. Further analysis 
revealed that normal numbers of embryos implanted but around 60% failed to develop 
beyond day seven. Cytogenetic and molecular analysis showed that this line of mice
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carried a reciprocal translocation between chromosomes 6 and 17 and that the 
transgene was sited at or close to the breakpoint of one the translocated chromosomes.
In addition to lethal mutations examples of non-lethal mutations have been 
described. Woychik et al. (1985) produced a line of transgenic mice with limb 
deformities associated with the site of insertion, a severe limb deformity in 
homozygote mice has also been reported by McNeish et al. (1988). Palmiter et al.
(1983) produced a line of mice in which male transgenic mice were incapable of 
transmitting the transgene to their offspring although otherwise they appeared fertile 
and produced litters of normal size. These workers concluded that this was due to the 
disruption of a gene involved in spermatogenesis. In addition to recessive mutations it 
has been suggested that dominant mutations could also occur where the integrating 
transgene alters the regulation of an endogenous gene (Palmiter and Brinster, 1986).
Both retroviral infection and pronuclear microinjection can result in an 
approximately equal incidence of insertional mutagenesis. Whereas proviral 
integration appears to operate via an ordered and precisely controlled mechanism 
resulting in minimal disturbance to the endogenous genetic material, pronuclear 
microinjection can produce extensive rearrangements which include deletions, 
duplications and even translocations. These rearrangements may be promoted by the 
proposed unstable nature of the intermediate stages (Covarrubias et al. , 1987) or may 
be secondary to the pressure changes in the pronucleus caused by the injection process 
itself. It is thought that integration occurs at spontaneous breakpoints in the 
chromosomes but the role which microinjection plays in promoting these 
chromosomal breaks is unknown. However, it is likely that the physical disturbance 
associated with microinjection produces a large number of breaks in the chromosomes 
not necessarily associated with the presence of DNA and that this in itself leads to a 
number of rearrangements during the repair processes. This may explain the large 
proportion of deferred loss associated with microinjection.
Whatever the mechanism for producing the widespread genetic damage, inferred 
from the rate and timing of embryonic loss, it is clear that the application of 
transgenic technology will be a powerful method of generating mutagenesis. 
Naturally occurring mutations are comparatively rare in mammals and those agents 
(such as retroviruses) capable of inducing genetic damage in the germline of 
experimental animals have yielded a surprisingly diverse amount of useful information 
concerning the biology of these animals and mammalian biology in general. The 
attraction of this system is that the site of insertion is usually tagged by the transgene 
itself making the initial characterisation of the affected locus a little easier.
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Spermatozoa As Vectors For DNA Transfer
In 1989 Lavitrano et al. reported that it was possible to produce transgenic mice 
using a very simple and previously untried technique. These workers incubated 
mature sperm cells with plasmid DNA and found that the exogenous DNA became 
intimately associated with the spermatozoa within 15 minutes. Sperm treated in this 
way were capable of carrying the foreign DNA into the eggs at fertilisation with the 
resultant production of transgenic mice carrying the integrated plasmid sequences.
Although three methods of producing transgenic mice had previously been 
developed most workers producing transgenic mice have chosen to use pronuclear 
microinjection as it is technically the simplest approach and the only one shown to be 
capable of producing transgenic lines of domestic animals. Nevertheless it is a 
painstaking procedure and is of low efficiency with the majority of injected embryos 
not developing to term.
In contrast, in the experiments described by Lavitrano et al., 30% of offspring 
bom contained plasmid sequences and embryonic mortality was not reported as being 
significantly greater than expected after in vitro fertilisation, culture to the two-cell 
stage and transfer. This procedure obviated the need for expensive equipment and the 
high degree of technical skill normally required for transgenic mouse production and 
promised to make the production of transgenic animals and particularly transgenic 
livestock, much more accessible and efficient
The results presented in this study represent an attempt to produce transgenic 
mice using the protocol described by Lavitrano et al.. The lac Z containing plasmid 
Tk-BGB was incubated with freshly collected spermatozoa. The sperm was then used 
to fertilise freshly collected oocytes and those embryos which developed to the two­
cell stage were transferred. Five separate experiments resulted in 58 mice being bom. 
These mice were screened for the presence of Lac Z sequences but none of these mice 
were transgenic.
Other attempts to verify this approach have also met with failure. Brinster et al. 
(1989) published results from their own group and also pooled results from eight other 
groups. A total of 1312 mice were produced using 18 different gene constmcts some 
of which were linear and some supercoiled. None of the subsequent mice or foetuses 
produced showed evidence of DNA uptake in either an integrated or episbmal form.
To date no other groups have successfully managed to repeat this method of 
producing transgenic mice. However, a subsequent report from the same group 
(Gandolfi et al. , 1989) details the generation of transgenic pigs using a method very 
similar to that described for mice. In this work Gandolfi et al. (1989) incubated boar 
spermatozoa with pSV2CAT plasmid DNA and the transformed sperm was then used 
to surgically inseminate oestrous sows by depositing the sperm in the uterine homs.
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Twenty-one percent of resulting piglets were transgenic and all of them expressed the 
CAT gene.
The reasons underlying the inability of other research groups to repeat these 
results in mice and pigs remains to be elucidated. The ability to produce transgenic 
animals using this greatly simplified approach would significantly increase the 
accessibility of this area of research to many interested groups.
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CHAPTER - 4
LAC Z EXPRESSION IN THE PREIMPLANTATION MOUSE EMBRYO 
SECTION 4.1. - INTRODUCTION.
The primary objective of the experiments described in this chapter was to 
investigate the expression potential of the bacterial lac Z gene within the 
preimplantation embryo.
Initially this work was undertaken to compare the activity of two different 
promoters, HSV-Tk and CMV, both of which were linked to the indicator gene lac Z. 
The fate of exogenous DNA after microinjection was investigated by following the lac 
Z expression pattern through preimplantation development and an attempt was made 
to assess the role that méthylation of the introduced DNA may have played in 
modulating expression.
As a background to these studies the following literature review summarises the 
work of those authors who introduced nucleic acid into the preimplantation embryo 
either to elucidate mechanisms of gene and message regulation in the early embryo or 
to yield information on the activity of the foreign DNA itself. This is followed by a 
brief description of the role of DNA méthylation in the regulation of gene 
transcription.
The Introduction of Nucleic Acid into Preimplantation Embryos
The introduction of exogenous nucleic acid into oocytes and developing embryos 
can yield information on both the physiology of the tissue under study and the 
functional properties of the foreign nucleic acid. The use of murine oocytes and early 
embryos to explore the stability and regulation of exogenous nucleic acid was an 
extension of similar studies using the xenopus oocyte and the techniques developed in 
these experiments were quickly exploited to produce the first transgenic mice.
Microinjection with mRNA or DNA has provided information about the 
processing of nucleic acid by oocytes and embryos and has aided the understanding of 
the role which these cell types play in development.
Brinster et al. (1980, 1981b) demonstrated that mouse oocytes and fertilised ova 
were capable of translating foreign mRNA injected into the cytoplasm. Ebert et al.
(1984) showed that there were marked differences in the stability of mRNA between
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oocytes and fertilised ova. These workers injected ovalbumin and conalbumin mRNA 
into oocytes and fertilised one-cell embryos and demonstrated that the stability of 
these messages was 30 and 120 times greater respectively in oocytes than in fertilised 
ova. These observations reflect the different roles which these cell types play in 
development. Endogenous mRNA levels are relatively stable in unfertilised oocytes 
but after fertilisation certain species of maternal RNA are specifically degraded.
Injection of DNA into the nucleus also revealed differences in the nucleic acid 
metabolism at different stages of development. Genes transcribed by RNA 
polymerase III were expressed much more efficiently in oocytes than in fertilised one­
cell embryos (Brinster et al., 1981b) whereas the transcriptional activity of RNA 
polymerase type II genes was much greater in the fertilised egg than in the oocyte 
(Chen et al., 1986). Further studies by Chen et al. (1986) demonstrated that the rate 
of protein synthesis and decay was similar for both oocytes and fertilised embryos.
In the mouse the embryonic genome is activated at the two-cell stage (Bolton et 
al., 1984) and the transition from maternal to embryonic control is another area of 
early development which has been studied extensively. Microinjection of one-cell 
embryos has yielded information on this phenomenon. Viable one-cell embryos are 
unable to express genes introduced into the pronuclei (Chen et al., 1986; Bonnerot et 
al., 1987; Martinez-Salas et a l ,  1989). It has been suggested that they are deficient 
in the transcriptional machinery which is necessary to carry out this function, thereby 
reflecting the quiescence of the genome at this stage of development (Martinez-Salas 
et a l ,  1989). The time point at which embryos develop the capacity to express the 
foreign DNA coincides with activation of the embryonic genome (Martinez-Salas et 
a l ,  1989). Expression is not dependent upon cleavage to the two-cell stage as 
spontaneously blocked one-cells and one-cell embryos arrested with aphidicolin can 
express exogenous DNA at high levels. A number of workers have reported that 
blocked one-cell embryos transcribe genes more effectively than developing two-cell 
embryos and that cleavage to the two-cell stage is associated with a reduction in 
transcriptional activity (Stuart et a l ,  1984; Chen et a l ,  1986; Ao et a l ,  1988; 
Martinez-Salas é ta l ,  1989; W. Reikpers. comm.).
Martinez-Sales et al. (1989) have used the Luciferase gene {Luc) to measure 
•expression in preimplantation embryos. Expression levels were greatly reduced at the 
two-cell stage and this group suggested that progression to the two-cell stage is 
associated with the appearance of a negative regulatory influence. Consistent with 
this view they found that inclusion of enhancer elements (sequences which up-regulate 
gene expression) to the gene construct increased expression at the two-cell stage but 
were not required at the one-cell stage (Martinez-Salas et al., 1989).
Chen et al. (1986) and Ao et al. (1988) have assayed the transcriptional activity 
•of injected exogenous DNA at different stages of preimplantation development.
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Using the Thymidine Kinase gene, Chen et al. (1986) noted that enzyme activity did 
not appear until 12 hours after injection. Activity increased rapidly during the 
following 12 hours and remained level over the next 24 hours. These authors 
presented evidence to suggest that transcriptional activity declined markedly with 
cleavage and that it was possible that the plateau of activity observed represented a 
balance between residual synthesis and degradation. In addition, Ao et al. (1988) 
showed that expression of a gene construct coding for hypoxanthine phosphoribosyl 
transferase (HPRT) injected at the one-cell stage declined after the four-cell stage.
As well as using exogenous DNA to dissect the processes of the early embryo, 
the preimplantation embryo can be used as a vehicle to yield information concerning 
the DNA construct introduced. In 1982 Brinster et al. investigated the nature of the 
metallothionein (MT-I) promoter using preimplantation embryos. By fusing the MT-I 
promoter to the Thymidine Kinase (Tk) gene of herpes simplex virus (HSV), the 
enzyme product of which could be readily assayed, these authors were able to 
determine that the MT-I promoter was as effective as the normal HSV Tk promoter 
and that the activity of the MT-I promoter could be modulated by the presence of 
cadmium. Using this assay system these workers subsequently identified the elements 
within the MT-I promoter which were responsive to heavy metal stimulation (Stuart et 
a l ,  1984).
Murine embryos have also been used to investigate the action of antisense RNA. 
This system has enabled researchers to measure the reduced activity of the target gene 
and the concentration of antisense DNA required to exert this effect (Ao et al. , 1988; 
Bevilacqua et al., 1988).
Bonnerot et al. (1987) microinjected the lac Z gene of E. coll into fertilised ova 
and observed expression at the two-cell stage. These workers examined the activity of 
a number of promoters fused to the lac Z reporter gene. While the promoters of Rous 
Sarcoma Virus (RSV), Simian Virus 40 (SV40) and g-actin were equally capable of 
directing transcription in two-cell embryos, the long terminal repeat of Moloney 
Murine Leukaemia Virus (MoMuLV) was not functional even when high copy 
numbers of this construct were injected.
DNA Méthylation
Mammalian DNA can be modified by the addition of a methyl group to the 
pyrimidine base, cytosine. This event occurs almost exclusively at the CpG 
dinucleotide. DNA méthylation appears to be involved in the control of gene 
expression at several different levels including the transcriptional regulation of tissue 
specific and housekeeping genes (Yisraeli and Szyf, 1984; Stein et a l ,  1983; Bird et 
a l,  1985; Bird, 1986), the formation of active and inactive chromatin (Keshet et a l .
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1986; Michalowsky and Jones, 1989; Riggs, 1990), X-chromosome inactivation 
(Holliday and Pugh, 1975; Riggs, 1975; Monk, 1990) and in the differential 
modification of parental DNA (genomic imprinting) which has been reviewed by 
Surani et al. (1990).
In general, tissue specific genes tend to be methylated and inactive in all tissues 
except the tissue of expression where they are comparatively undermethylated (Naveh- 
Many and Cedar, 1981; Yisraeli and Szyf, 1984). Transfection studies have revealed 
that while unmethylated DNA transferred into tissue culture cells is active, methylated 
DNA constructs are not (Stein et a l ,  1982; Busslinger et al., 1983; Yisraeli et al.,
1986).
In contrast, housekeeping genes have a ubiquitous expression pattern. Many of 
these genes are characterised by clusters of CpG dinucleotides situated at the 5' end of 
the gene (Bird et a l ,  1985). These areas known as CpG islands are not usually 
methylated (Stein et a l ,  1983). The CpG islands associated with housekeeping genes 
on the inactive X-chromosome are, however, methylated (Toniolo et a l , 1988).
It is believed that méthylation also plays a role in development acting as a 
general mechanism of gene control. Several workers have investigated the 
méthylation status of DNA in different cell types involved in early embryonic 
development. Sanford et a l  (1987) analysed the DNA méthylation status of oocytes 
and spermatozoa. They examined both dispersed repeated sequences and specific 
genes and found that these DNA sequences were heavily methylated in sperm DNA 
and relatively undermethylated in oocyte DNA. Méthylation levels in preimplantation 
embryos appeared to be intermediate, implying that the méthylation status of the 
sperm and oocyte DNA was propagated through preimplantation development. Monk 
et al. (1990), who have also investigated the méthylation status of preimplantation 
embryos, have reported a reduction in overall méthylation levels between the morula 
and blastocyst stages.
Other workers have argued that de novo méthylation can occur in the early 
embryo (Jahner and Jaenisch, 1984). This group introduced Murine Leukaemia Virus 
(MuLV) into preimplantation embryos, the resulting provirus integrated into the host 
genome but was not expressed rendering the virus incapable of replication. Analysis 
of the adult mice originating from the infected embryos revealed methylated viral 
sequences (Jahner et a l ,  1982). These authors suggested that a méthylation event 
occurred during preimplantation development and that this was responsible for the 
méthylation of the viral genome. In addition, Surani et al. (1990) have recently 
reported that a de novo méthylation event occurs during preimplantation development. 
These findings and the observation by Adams that methylase enzyme activity is high 
in early cleavage stages (Adams pers. comm.) argue that DNA méthylation can occur 
in the early embryo and that the introduction of exogenous unmethylated DNA into a
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system which has high DNA methylase activity may well result in rapid méthylation 
of the introduced sequences.
In a series of experiments Buschhausen and co-workers (1987) examined the 
interaction between gene expression, DNA méthylation and the assembly of gene 
sequences into chromatin. Using a tissue culture system these authors microinjected 
both methylated and unmethylated forms of the Herpes Simplex Virus Thymidine 
Kinase gene (HSV-Tk) and assayed the resulting Tk activity. They found that initially 
both forms of Tk were capable of being expressed. Eight hours after injection, 
however, transcription from the methylated gene had peaked and by sixteen hours 
post-injection Tk activity in these cells could not be detected. Tk activity from the 
unmethylated construct was not affected. The time taken to inhibit expression of the 
methylated Tk gene was similar to the time required for the assembly of introduced 
DNA into chromatin reported by Graessmann et al. (1985).
Buschhausen et al. (1987) provided direct evidence for the role of chromatin in 
gene regulation by assembling both methylated and unmethylated Tk sequences into 
chromatin in vitro and microinjecting the resultant chromatin into tissue culture cells. 
They found that assembly of the unmethylated DNA did not inhibit transcription but 
that the methylated HSV-Tk chromatin was not transcribed.
These authors demonstrated that for méthylation to inhibit gene expression the 
DNA must be assembled into chromatin. In addition they showed, by examining a 
stably maintained episome, that extrachromosomal assembly of chromatin was 
sufficient to inhibit gene expression of methylated DNA and that integration of the 
gene construct into chromosomal DNA was not a prerequisite for transcriptional 
inhibition.
An important observation made by these authors was that in vitro assembly of 
HSV-Tk DNA did not reduce the expression of HSV-Tk unless the DNA is 
methylated. In contrast Martinez-Sales et al. (1989) argue that the reduction in 
transcriptional activity at the two-cell stage in preimplantation embryos is associated 
with the assembly of the introduced DNA into chromatin. Whether méthylation is 
also involved in the reduction in transcription of constructs introduced into 
preimplantation embryos is not known.
The Lac Z Gene
The analysis of preimplantation embryos requires specialised approaches to 
overcome the problems encountered due to the small size of the tissue under study and 
the minute amounts of DNA, RNA and protein which can be recovered.
The lac Z gene of E. coli is frequently used for cloning genes in prokaryotic 
systems. In eukaryotic systems the use of the lac Z gene has provided a convenient
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and sensitive biochemical (An et al. , 1982; Norton and Coffin, 1985) or cytochemical 
(Price et al., 1987; Goring et a l ,  1987; Allen et al., 1988; Liu et al., 1989) 
approach for studying gene expression.
The assay is rapid and simple to perform and enables gene expression to be 
directly visualised at the level of individual cells. The simplicity of the assay favours 
a high degree of repeatability and reduces the chances of experimental error caused by 
the employment of complex techniques.
The lac Z gene and its enzyme product jS-galactosidase have been successfully 
used to monitor gene expression and gene regulation in tissue culture cells (An et al. , 
1982; Norton and Coffin, 1985; Liu et al., 1989), preimplantation embryos (Bonnerot 
et al., 1987) and transgenic animals (Goring et al., 1987; Allen et al., 1988). In 
addition, the lac Z gene has also been used as a marker for lineage analysis (Price et 
a l ,  1987).
In this study the lac Z gene was introduced into one-cell embryos and j8- 
galactosidase activity assayed at different stages of preimplantation development.
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LAC Z EXPRESSION IN THE PREIMPLANTATION MOUSE EMBRYO 
SECTION 4.2. - MATERIALS AND METHODS
4.2.1. Plasmid Construction
(see general materials and methods)
4.2.2. Pronuclear Microiiqection of Fertilised Mouse Eggs 
(see general materials and methods)
4.2.3. Embryo Culture
(see general materials and methods)
4.2.4. Assay of /3-galactosidase Activity in the 
Preimplantation Embryo
a) Materials
Fixative 0.2 % glutaraldehyde (Sigma) in 0.1 M phosphate
buffered saline, pH 7.3 (Sigma)
Washing Solution. 0.05% bovine serum albumin (Sigma) in 0.1 M
phosphate buffered saline, pH 7.3 (Sigma)
Staining Solution. 5mM potassium ferricyanide (Sigma) and 5mM
potassium ferrocyanide (Sigma) in 0.1 M 
phosphate buffered saline, pH 7.3.
To 1 ml of this solution was added 30 /xl of 2% X-gal (Sigma) in dimethyl formamide 
(Sigma)
Embryos were washed, fixed and stained in 35 mm petri dishes (Nunc)
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b) Method
The lac Z gene of E. coli encodes the bacterial enzyme /3-galactosidase. This 
assay is based on the ability of jS-galactosidase to convert a colourless substrate, 5- 
bromo-4-chloro-3 indoyl /?-D galactopyrinoside (X-gal, Sigma), into a blue product 
which acts as a histochemical stain.
Embryos microinjected with lac Z DNA and control embryos were assayed for 
j8-galactosidase activity by incubating embryos in the presence of 5-bromo-4-chloro-3 
indoyl jS-D galactopyrinoside (X-gal, Sigma).
The embryos were removed from the culture medium and washed once before 
being fixed for five minutes at 4° C. Following this treatment the embryos were 
removed from the fixative solution and washed by moving them through six 100 /xl 
drops of 0.1 M phosphate buffered saline, pH 7.3, (Sigma) containing 0.05% bovine 
serum albumin (Sigma).
Finally, the embryos were transferred into 1 ml of staining solution and 
incubated overnight before being examined. To prevent evaporation the petri dish 
containing the staining solution was placed in a humidified box. Embryos were 
examined using an inverted microscope (Diavert, Wild).
This protocol was communicated to me by Azim Surani, to whom I am most 
grateful.
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4.2.5. In vitro DNA Méthylation Using Mammalian Methylase.
a) Materials.
Buffer M 50 mM Tris HCL pH 7.8 (Trisma Base HCL - Sigma)
1 mM EDTA (Ethylenediaminetetraacetic acid - Sigma) 
1 mM DTT (Dithiothreitol - Sigma)
0.01 % NaN3 (sodium azide - Sigma)
10 % glycerol (BDH)
To 100 ml of buffer M add 1 ml of PMSF (Phenylmethylsulfonyl fluoride) 
6 mg/ml ethanol (Sigma)
Stopper Solution 1 % SDS (Sodium dodecyl sulphate - Sigma)
2 mM EDTA (Sigma)
5 % butanol (BDH)
3 % p-amino salicylate, added just before use. (Sigma) 
0.125M N aC l
Before use 100 /xg/ml pronase is added (Sigma)
Enzyme mammalian methylase is extracted from mouse ascities 
cells (Adams pers. comm.)
Reaction Mixture 5 /xg of plasmid DNA 
20-30 /xl activated enzyme 
3 /xl SAM ImM - (S-adensylmethionine - Sigma) 
70 /xl buffer M
b) Method.
The reaction mixture was incubated for 4-6 hours at 37° C. The reaction was 
stopped by the addition of 300 /xl of stopper solution containing 300 /xg of pronase 
which destroys the methylase enzyme. Finally, the DNA was recovered and prepared 
for microinjection as described in general material and methods. This procedure was 
communicated to me by Dr. Adams. I am also indebted to Dr. Adams for his kind 
gift of activated methylase enzyme.
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4.2.6. In vitro DNA Méthylation Using Sss I Methylase
a) Materials.
NE Buffer 2 SOmMNaCl
10 mM Tris HCl, pH 7.9 at 25° C (Trisma Base HCL - Sigma) 
10 mM MgCk
1 mM DTT (Dithiothreitol - Sigma)
Enzyme Sss I methylase (New England Biolabs.)
Reaction 2 /xg of plasmid DNA
Mixture 2 /xl enzyme
1 /xl SAM at 160 /xM (S-adensylmethionine - New England Biolabs.) 
4 /xl NE buffer 2
b) Method.
The procedure was essentially the same as that described for the mammalian 
methylase, the reaction mixture being incubated for 24 hours at 37° C. Pronase was 
again included at the end of the reaction. Mock methylated DNA was prepared in the 
same way but in this reaction the co-factor S-Adenosylmethionine was absent. 
Finally, the DNA was recovered and prepared for microinjection as described in 
general material and methods.
73
LAC Z EXPRESSION IN THE PREIMPLANTATION MOUSE EMBRYO
SECTION 4.3. - RESULTS
4.3.1. Lac Z Expression In The Preimplantation Embryo - Introduction.
The main objective of the experiments described in this section was to 
investigate the short-term expression of exogenous DNA within the murine 
preimplantation embryo. To this end the reporter gene lac Z was used, lac Z encodes 
a bacterial j8-galactosidase enzyme, the presence of which can be determined using a 
simple colourimetric assay. Embryos were microinjected with a number of different 
constructs, all of which carried the lac Z gene. Analysis of embryo expression 
allowed a comparison to be made between the different constructs. Two of these 
constructs were used to examine the pattern of lac Z expression throughout 
preimplantation development following pronuclear microinjection.
A number of different events could affect the levels of jS-galactosidase activity 
in these embryos. A change in the transcriptional rate or the translational efficiency 
of the exogenous gene could modify expression levels over a period of time. Equally, 
changes in the half-life of the mRNA protein product could affect the pattern of 
expression. The rationale for this experiment was to examine the fate of exogenous 
DNA introduced into the mouse zygote, albeit indirectly through changes in the 
pattern of expression of the exogenous DNA. The possible reasons for the observed 
modulation of jS-galactosidase activity with time are discussed.
In these results stained embryos are defined as an embryo which has some 
discernible blue stain in at least one of the blastomeres. For the purposes of these 
results three-cell embryos are considered as two-cell embryos. In these experiments a 
number of embryos were assayed after the development of that embryo had ceased, 
such embryos are referred to as blocked embryos. Those that were assayed when they 
were at the expected stage of development are referred to as fresh or developing 
embryos. The majority of one-cell embryos examined in these results were blocked.
4.3.1.a) Preimplantation Embryo Expression With CMV-IacZ And Tk-lacZ.
CMV-lacZ (Figure 1.3.) is a linear construct in which expression of the E coli 
lac Z gene is directed by the Human Cytomegalovirus Immediate Early (CMV-IE) 
promoter.
Tk-lacZ is shown in Figure 1.2. and is essentially similar to CMV-lacZ but the 
CMV-EI promoter is replaced with the Herpes Simplex Virus Thymidine Kinase (Tk)
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promoter. One-cell embryos were microinjected with CMV-lacZ (2 /xg/ml) or Tk- 
lacZ (2 /xg/ml) and placed in culture. After microinjection of CMV-lacZ 40% of 
blocked one-cell embyros showed some evidence of lacZ expression, a blue stain 
indicating the presence of jS-galactosidase activity. This is significantly higher than 
the staining rate of 9.6% seen with two-cell embryos (x^ =  26.0: P <  0.01). There 
is no difference in the staining ratio between blocked and fresh two-cell embryos. 
None of the 7 four-cells recovered showed any evidence of lac Z expression. 
Although of a much smaller sample size the results are similar for embryos injected 
with Tk-lacZ, 25% of blocked one-cell embryos were stained but only 4.3% of two­
cell embryos stained blue. As with the CMV-lacZ injected embryos a greater 
proportion of blocked one-cell embryos stained blue than the two-cell embryos. 
These results are shown in Table 4.3.1..
A higher percentage of blocked one-cell embryos stained blue after injection 
with CMV-lacZ than with Tk-lacZ. Similarly, a slightly higher percentage of two­
cell embryos stained blue with CMV-lacZ than with Tk-lacZ, however, in neither case 
was the difference significant (x^= 0.9 and 1.4 respectively: both P >  0.05).
Table 4.3.1. CMV-lacZ and Tk-lacZ Expression (Number Stained).
Stage Number
Stained
CMV-lacZ
Total
Number
(%) Number
Stained
Tk-lacZ
Total
Number
(%)
1-cell 15 37 (40) 3 12 (25)
2-cell 23 240 (9.6) 2 47 (4.3)
4-cell 0 7 (0)
Figure 4.3.1. shows the number of embryos stained compared to the total number assayed at various 
stages of development.
4.3.l.b) Preimplantation Expression With CMV-BGB.
CMV-BGB is outlined in Figure 1.5 and is a plasmid in which the CMV-EI 
promoter directs expression of the lac Z gene. For most experiments CMV-BGB was 
used at an injection concentration of 10 /xg/ml. In order to examine the expression of 
lac Z at different stages of preimplantation development one-cell embryos were 
microinjected with CMV-BGB and placed in embryo culture medium. At different 
times after microinjection the embryos which had developed to the expected stage and 
the accompanying blocked stages were removed and placed in the staining solution.
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The number of responders at each stage of development, that is embryos 
showing some evidence of lac Z expression, is shown in Table 4.3.2. There is a close 
correlation between the embryo stage and the numbers of embryos responding. A 
high percentage of early stages (one and two-cell embryos) which were assayed 
responded whereas a significantly lower proportion of four-cells, morulae and 
blastocysts showed evidence of jS-galactosidase activity. For example, significantly 
more two-cell embryos stained blue than did four-cell, morula or blastocyst stages (x^ 
=  30.8, 10.0 and 29.2 respectively: all P <  0.01). Between the four-cell to the 
blastocyst stage there was no significant difference between the numbers responding 
(x2 =  0.2: P >  0.05, based on a 2x3 contingency table with 2 d.f.). However, 
significantly more blocked one-cell embryos responded than two-cell embryos (x^ =  
5.8: P <  0.05).
The one-cell embryos described above were all assayed more than 16 hours after 
microinjection and had failed to cleave to the two-cell stage within the expected time. 
In addition, a total of 49 one-cell embryos were assayed within four hours of being 
microinjected. None of these embryos showed any evidence of jS-galactosidase 
activity, this result is consistent with previous work which suggests that at this stage 
of development embryos are incapable of expressing exogenous DNA (Chen et al., 
1986; Bonnerot et al., 1987; Martinez-Salas et al., 1989).
Table 4.3.2. CMV-BGB Expression (Number Stained).
Development Stage 
At Staining
Number 
Stained Blue
Total 
Number Assayed
Assayed/Stained
(%)
1-ceim 0 49 (0)
1-cell^ 49 61 (80)
2-cell. 97 153 (63)
4-cell. 71 209 (34)
Morula 7 24 (29)
Blastocyst 66 193 (35)
a Assayed within 4 hours of microinjection.
b Assayed the following day, greater than 16 hours after microinjection.
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There is a good correlation between the number of embryos staining at a 
particular stage and the intensity of the stain at that stage. The average intensity of 
stain at a given stage of development was calculated by scoring individual embryos 
from 1-5 based on the intensity and extent of blue stain observed. Although 
subjective, this method gave a broad measure of /5-galactosidase activity in individual 
embryos. The average activity at each stage was calculated by expressing the total 
score as a percentage of the maximum score possible (i.e. if every embryo scored a 
maximum five). In order to separate this analysis from the number of embryos 
responding, only those embryos showing evidence of lac Z expression were included. 
These results are shown in Table 4.3.3. and in Figure 4.3.1. In general, early 
embryos (one and two-cell stages) showed a high level of jS-galactosidase activity with 
the majority showing a homogenous deep blue or indigo colour. The majority of 
four-cell embryos also showed a homogenous staining pattern although often the stain 
was of a lighter hue and a greater proportion of embryos displayed a mottled staining 
pattern. Later stages, namely morulae and blastocysts, displayed a much more 
heterogeneous pattern of expression and on average the level of evident jS- 
galactosidase activity was significantly less than earlier stages (x^ =  237.0: P < 
0 .01).
Using this method of analysis the four-cell stage appears to be intermediate for ^  
-galactosidase activity. The average activity of the four-cell stage is significantly less 
than earlier stages (x^ =  20.7: P < 0.01) and significantly greater than later stages 
(x2 = 86.8: P <  0.01).
Table 4.3.3. CMV-BGB Expression (Intensity of Stain).
Development
Stage
Actual
Score
Maximum Possible 
Score
Actual/Maximum Possible 
(%)
1-cell 212 245 (86)
2-cell 397 485 (82)
4-cell 254 355 (72)
Morula 17 35 (49)
Blastocyst. 112 295 (38)
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Figure 4.3.1. /3-gaIactosidase Activity in the Preimplantation Embryo.
Series 1. - Intensity of Stain in the 
Stained Embryos (%)
Series 2. - Number of Embryos 
Stained {%)
1-cell 2-cell 4-cell Morula Blastocyst
S ta g e  o f D e v e lo p m e n t
The X-axis represents the stage of embryo development. In series 1. the Y-axis represents the intensity 
of staining in that sub-population of cells which stained blue and in series 2. the Y-axis represents the 
percentage of embryos which stained blue.
4.3.l.c) Preimplantation Embryo Expression - Tk-BGB.
In order to compare the activity of the Tk promoter with the CMV promoter a 
small number of embryos were injected with Tk-BGB. Tk-BGB, shown in Figure 
1.4., is a plasmid similar to CMV-BGB with the CMV promoter being replaced by 
the Tk promoter.
Eighty-five zygotes were successfully microinjected with TK-BGB at a 
concentration of 10 /xg/ml, placed in embryo culture medium and cultured through to 
the blastocyst stage. Ninety-six hours after microinjection the resulting blastocysts 
and embryos blocked at different stages of development were assayed for /8- 
galactosidase activity. These results are shown in Table 4.3.4..
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Table 4.3.4. Tk-BGB Expression (Number Stained).
Stage of Number Total Stained
Development Stained Number (%)
Blocked 1-cell 8 13 (62)
Blocked 2-cell 10 16 (63)
Blocked 4 cell 1 3 (33)
Blocked morula 4 5 (80)
Blastocyst 12 48 (25)
Total Number = total number of embryos assayed
Although the numbers injected with Tk-BGB are relatively small there is no 
significant difference between the two plasmids in the number of embryos responding 
at any particular stage of development. Embryos injected with Tk-BGB show a 
similar pattern of lac Z expression to that of CMV-BGB. In general, early stages 
show a higher staining rate and are more extensively stained than later stages.
If the results of both transgenes are pooled then 11% of one and two-cell 
embryos are stained but only 33 % of morulae and blastocysts show evidence of blue 
stain. Table 4.3.5. summarises the results of embryos injected with Tk-BGB and 
CMV-BGB.
Table 4.3.5. Summary of CMV-BGB and Tk-BGB Expression.
CMV-BGB Tk-BGB
Stage of 
Development
Number
Stained
Total
Number
Stained
(%)
Number
Stained
Total
Number
Stained
(%)
1-cell 49 61 (80) 8 13 (62)
2-cell 97 153 (63) 10 16 (63)
4 cell 71 209 (34) 1 3 (33)
Morula and Blastocyst 73 217 (34) 16 53 (30)
In this table results obtained from blocked embryos have been pooled.
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4.3.l.d) /^-galactosidase Injection Of One-Cell Embryos.
In order to assess the stability of the lac Z product one-cell embryos were 
microinjected with j8-galactosidase enzyme at a concentration of 2 mg/ml. Injected 
embryos were placed in culture and the j8-galactosidase activity at different stages of 
development was assayed. One-cell embryos were assayed shortly after being 
microinjected.
The number of embryos displaying jS-galactosidase activity at different stages of 
development is shown in Table 4.3.6.a) and the level of /3-galactosidase activity in 
those embryos which did respond is shown in Table 4.3.6.b).
Table 4.3.6.a) /3-galactosidase Enzyme Activity (Number Stained).
Stage
of Development
Number
Stained
Total
Number
Stained
(%)
One-cell 16 28 (57)
Two-cell 30 55 (55)
Four-cell 19 33 (58)
Morula 9 16 (56)
Blastocyst 11 16 (69)
Table 4.3.6.b) /3-galactosidase Enzyme Activity (Intensity of Stain).
Stage of 
Development
Actual
Score
Maximum Score 
Possible
Actual/Maximum Possible 
(%)
One-cell 74 80 (93)
Two-cell 131 150 (87)
Four-cell 88 95 (93)
Morula 36 45 (80)
Blastocyst 39 55 (71)
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These results differ from the pattern observed after pronuclear injection with the 
lac Z gene. With j8-galactosidase injection the proportion of embryos which 
responded remained constant through preimplantation development. The level of jS- 
galactosidase activity of the responsive embryos is higher at all stages of development 
and only starts to decline at the morula stage.
4.3.2. Inhibitors Of Méthylation
As can be seen from the previous section there is a general decline in /8- 
galactosidase activity as preimplantation development proceeds following pronuclear 
injection at the one-cell stage.
In order to investigate the possibility that the introduced DNA may be subject to 
de novo méthylation in the preimplantation embryo and that this was, at least in part, 
responsible for the reduction in jS-galactosidase activity, microinjected embryos were 
cultured in the presence of known inhibitors of méthylation.
Certain substances have been used to inhibit méthylation in mammalian cells. It 
has been argued (Menezo et ah, 1989) that DL-homocysteine is one such substance 
which has this property and that it is of relatively low toxicity. DL-homocysteine was 
incorporated into the embryo culture medium supporting lac Z microinjected embryos 
in an attempt to ascertain if the pattern of lac Z expression could be modulated. In 
addition the effect of 5-azacytidine, a specific inhibitor of DNA méthylation (Jones, 
1985), on expression of the lac Z gene in preimplantation embryos was investigated.
4.3.2.a) Embryo Culture Rate With DL - Homocysteine
Initially, a number of embryos were cultured in various concentrations of DL- 
homocysteine in order to define the maximum concentration that could be used 
without significantly reducing the embryos capacity to develop. These results are 
presented in Table 4.3.7..
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Table 4.3.7. Embryo Culture Rate - Varying Concentrations of DL - 
Homocysteine.
Concentration
ofDLH(/xM)
1-cell 2-cell 4-cell Morula Blastocyst Icell/blast. 
(%)
2cell/blast.
(%)
50 16 12 12 10 11 (69) (92)
100 45 40 22 21 23 (51) (58)
250 46 42 40 35 37 (80) (88)
400 174 107 79 65 69 (40) (64)
500 169 93 86 74 73 (43) (78)
750 33 32 30 29 27 (82) (84)
1000 342 259 214 176 174 (51) (67)
1500 20 17 8 6 6 (30) (35)
2000 44 28 17 16 16 (36) (57)
2500 22 6 0 0 0 (0) (0)
5000 22 8 0 0 0 (0) (0)
10,000 22 2 0 0 0 (0) (0)
50,000 22 6 0 0 0 (0) (0)
Controls 454 320 291 264 259 (57) (81)
1 cell/blast = percentage of one-cell embryos developing to the blastocyst stage.
2cell/blast = percentage of two-cell embryos developing to the blastocyst stage.
The results in Table 4.3.7. show that the embryo culture rate declined with 
increasing concentrations of DL-homocysteine (DLH). The development rate for 
control embryos which were cultured in parallel was 81%. The average culture rate 
of those embryos grown in the presence of 50-750 /xM DLH was 74% whilst 67% of 
embryos developed when cultured in a concentration of 1000 /xM. Those embryos 
cultured in the presence of 1500-2000 /xM of DLH had a development rate of 49%.
The morphology of the embryos cultured in high concentrations of DLH was 
significantly altered. A number of embryos were placed in high concentrations of 
DLH (5000-50,000 /xM) and when examined at the two-cell stage the blastomeres 
appeared much smaller and darker than normal.
A greater number of controls cultured from the two-cell stage through to the 
blastocyst stage than those embryos cultured in the presence of DLH at a 
concentration of between 50-750 /xM (x^ =  5.1: P <  0.05). The culture rate of 
embryos at a concentration of 1000 /xM is significantly less than the controls (x^ = 
14.4: P <  0.01). At concentrations of 1500-2000 /xM the culture rate declines still 
further and at concentrations in excess of 2(XX) /xM embryos failed to culture.
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4.3.2.b) Lac Z Expression In Embryos Cultured With DL-homocysteine.
Embryos were injected with CMV-BGB (10 /xg/ml) and a proportion were
grown in medium containing 500-1200 /xM DLH in an attempt to ascertain if 
homocysteine influenced the expression pattern of the lac Z transgene. In this 
experiment one group of embryos was cultured for 48 hours at which point the 
resulting four-cell embryos and blocked embryos were placed in the staining solution. 
In another group, embryos were cultured for 96 hours and the resulting blastocysts 
and blocked stages were incubated in the staining solution at the end of the culture 
period. In pooled results 38% of microinjected embryos, cultured to the blastocyst 
stage in varying concentrations of DLH ranging from 500 /xM to 1200 /xM, showed 
evidence of lac Z expression. There was no difference in the proportion of embryos 
staining at any of the concentrations used. The staining rate of microinjected embryos 
cultured without DLH was 41%. These results and the accompanying blocked stages 
are shown in Table 4.3.8.a).
Table 4.3.8.b) shows the number of four-cell embryos staining blue in the test 
and control groups. DLH concentrations again ranged from 500-12(X) /xM in the test 
group, as there was no difference between the different concentrations used these 
results were again pooled. Twenty-one percent were stained blue in the test group 
and 21% were stained blue in the control group.
There is no significant difference in the number staining blue between those
embryos grown in the presence of DLH and in culture medium only. This is true for 
both the blastocysts (x^ =  0.1: P >  0.05) and the four-cell embryos (x^ =  0.01: P 
>  0.05) collected and placed in the staining solution. There is also no significant 
difference between the number of blocked stages staining blue between the two 
groups.
Table 4.3.8.a) CMV-BGB Expression with DL-Homocysteine (Number Stained 
at the Blastocyst stage).
Culture medium with DLH Culture medium without DLH
Stage Number
stained
Total
number
(%) Stage Number
stained
Total
number
(%)
B 1-cell 4 5 (80) B 1-cell 5 8 (63)
B 2-cell 7 9 (77) B 2-cell 10 17 (59)
B 4-cell 7 10 (70) B 4-cell 9 10 (90)
B morula 2 11 (18) B morula 5 12 (42)
blastocyst 24 63 (38) blastocyst 18 44 (41)
B = blocked.
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Table 4.3.8.b) CMV-BGB Expression with DL - Homocysteine (Number
Stained at the 4-Cell Stage).
Culture medium with DLH Culture medium without DLH
Stage Number Total (%) Stage Number Total (%)
stained number stained number
B 1-cell 10 10 (100) B 1-cell 5 5 (100)
B 2-cell 24 52 (46) B 2-cell 10 32 (31)
4-cell 12 58 (21) 4-cell 15 70 (21)
B = blocked.
The staining results were similar to those described in 4.3.1. In both groups - 
the blastocyst and the four-cell group - a similar staining pattern is observed. In 
general a greater number of the early stages stain blue compared with later stages i.e. 
significantly more one and two-cell stages stain blue and more extensively than those 
embryos at the morula and blastocyst stage (x^ =  7.5: P <  0.01). In total 24/28 
(86%) of one-cells, 51/110 (46%) of two-cells, 43/148 (29%) of four-cells, 7/23 
(30%) of morulae and 42/107 (39%) of blastocysts stained blue.
As mentioned earlier there was considerable variation in the degree of blue stain 
observed between individual embryos. This variation ranges from the identification 
of the occasional blue spot within a cell to all the cells staining blue with high levels 
of expression being represented by an intense indigo colour.
In general, intense staining was observed in the one-cell and two-cell embryos 
and good, even staining was observed in the majority of the four-cell embryos - the 
intensity of staining being slightly less in this group. In all three of these stages the 
staining in individual blastomeres tended to be homogeneous. In contrast, the 
majority of morulae and blastocysts stained showed only isolated blue patches. There 
was, however, a greater variation in the extent and intensity of stain observed in the 
morula and blastocyst stages with some embryos showing blue in most cells and some 
areas staining intensely. Figures 4.3.2.a-d. show examples of control and stained 
embryos.
In an attempt to quantify the levels of expression shown by each embryo the 
embryos were scored from 1-5 depending on: the number of blastomeres staining 
blue, the extent of the staining within the blastomeres and the intensity of the colour 
observed. Embryos reaching the blastocyst stage in either the DLH group or the 
control group were scored in this manner and the results are shown in Table 4.3.9.a).
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Table 4.3.9.a) CMV-BGB Expression with DL - Homocysteine (Intensity of
stain at Blastocyst Stage).
DLH Group Control Group
No. of Score Total Score % No. of Score Total Score %
Blastocysts. Possible Blastocysts. Possible
24 50 120 (42) 14 24 70 (34)
As can be seen from Table 4.3.9.a) there is no significant difference between 
the degree of staining in the blastocysts cultured in medium containing DLH and those 
cultured in medium lacking DLH (x^ = 1.0: P >  0.05).
Those embryos cultured to the four-cell stage were also scored after staining and 
these results are presented in Table 4.3.9.b). The total score in the control group 
exceeded those cultured in the presence of DLH, however, the difference was not 
significant (x^ =  2.8: P >  0.05).
Table 4.3.9.b) CMV-BGB Expression with DL - Homocysteine (Intensity of 
stain at the 4-cell Stage).
DLH Group Control Group
No. of 
4 cells
Score Total Score 
Possible
% No. of 
4 cells
Score Total Score 
possible
%
12 35 60 (58) 17 61 85 (72)
In conclusion, therefore, the presence of homocysteine in the culture medium 
did not affect observed levels of lac Z expression - at least at the concentrations 
employed.
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Figure 4.3.2.a. Control Two-Cell Embryos
Final magnification approximately 300x (Original in colour)
Figure 4.3.2.b. Control Blastocysts and Developing Blastocysts
Final magnification approximately 30Bx (original in colour)
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Figure 4.3.2.d. A Two-Cell Embryo Showing jS-galactosidase Activity
Final magnification approximately 900x (original in colour)
F igure 4.3.2.C. A Blastocyst showing /3-galactosidase Activity
Final magnification approximately 700x (original in colour)
4.3.2.C) Embryo Culture Rate With 5-azacytidine.
5-azacytidine has been extensively used in tissue culture to inhibit méthylation 
of the cytosine nucleotide in the DNA of mammalian cells (Jones, 1985). The ability 
of the embryos to develop in the presence of different concentrations of 5-azacytidine 
was examined. These results are shown in Table 4.3.10.
Table 4.3.10. Embryo Culture Rate - Varying Concentrations of 
5-azacytidine.
Concentration 
of 5-aza (/xg/ml)
1-cell 2-cell 4-cell Morula Blast. Icell/Blast.
(%)
2cell/Blast.
(%)
0.0001 25 11 7 4 6 (24) (55)
0.001 25 20 15 15 12 (48) (60)
0.01 27 18 12 8 11 (41) (61)
0.1 89 77 64 58 56 (63) (73)
0.2 12 10 7 3 3 (25) (33)
1.0 98 92 27 4 4 (4) (4)
10 26 22 0 0 0 (0) (0)
Controls 68 42 34 33 33 (48) (79)
There is no difference in the ability of the embryos to develop when cultured in 
concentrations of 5-azacytidine varying from 0.0001 to 0.1 ^g/ml. Fewer embryos 
developed in 0.2 /xg/ml than in 0.1 /xg/ml and only 4% cultured through to the 
blastocyst stage at a concentration of 1.0 fig/ml. No embryos developed when 
cultured at a concentration of 10 ftg/ml. At all concentrations the embryo culture rate 
was less than that of the controls as assessed by the number of two-cell embryos 
developing into expanded blastocysts. A greater number of controls cultured from the 
2-cell stage to the blastocyst stage than did embryos cultured in concentrations of 5- 
azacytidine ranging from 0.0001 to 0.1 ^g/ml but the difference was not significant 
(x^ =  1.9: P >  0.05). However, the development of 2-cell embryos was 
significantly reduced when they were cultured in the presence of 1.0 iiglmX 5- 
azacytidine (x^ =  79.4: P < 0.01).
In addition 15, 14 and 18 morulae were cultured in medium containing 1 
mg/ml, 10 jLtg/ml and 1 /xg/ml respectively, all 14 morulae developed to the blastocyst 
stage in the control group but none of the morulae in the test groups developed.
Twenty-one one-cell embryos were cultured in medium containing 1 /xg/ml and 
zill developed to the two-cell stage. At this point the embryos were removed, washed
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and transferred to fresh medium which did not contain 5-azacytidine and cultured. 
Only 4 (19%) of these embryos developed to the blastocyst stage. Similarly, 34 
embryos were placed in culture at the one-cell stage in medium containing 1 /xg/ml of 
5-azacytidine. Only 12 embryos reached the four-cell stage and these were then 
washed and transferred to medium lacking 5-azacytidine. Only 2 of these embryos 
developed to the blastocyst stage. In the control group, which was run in parallel 
with these test groups, 20 one-cell embryos were placed in culture and 17 developed 
to the blastocyst stage.
Therefore, on the basis of these results it appears that concentrations in excess 
of 0.1 /xg/ml of 5-azacytidine are deleterious to embryo development - although a 
proportion of embryos were capable of developing at higher concentrations.
4.3.2.d) Lac Z Expression With 5-azacytidine.
As a result of the above finding, microinjected embryos were cultured in 
medium containing 0.1 - 0.2 /xg/ml of 5-azacytidine. Thirty-five embryos were 
microinjected with CMV-BGB and 25 of these embryos cultured through to the 
blastocyst stage. Twenty-one embryos microinjected with CMV-BGB were cultured 
in medium only, of these 13 cultured through to the blastocyst stage. The resulting 
blastocysts and accompanying blocked stages were assayed for jS-galactosidase 
activity.
Of those embryos cultured to the blastocyst stage in the presence of 5- 
azacytidine 24% showed blue stain. These results were not significantly different 
from those embryos not brought into contact with 5-azacytidine (x^ =  0.4: P >  
0.05). In this group 15% of resulting blastocysts stained blue. These results are 
shown in Table 4.3.11..
Table 4.3.11. CMV-BGB Expression with 5-azacytidine (Blastocyst Stage).
Culture Medium with 5-azacytidine 
Stage Number Stained Total Number
Culture Medium without 5-azacytidine 
Stage Number Stained Total Number
One-cell 3 5 One-cell
Two-cell 1 2 Two-cell 1 1
Four-cell - - Four-cell 1 4
Morula 1 3 Morula 0 1
Blastocyst 6 25 Blastocyst 2 13
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Therefore, no significant difference was observed in the degree of staining nor 
the number of embryos staining between the microinjected embryos cultured in the 
control group or in the presence of the méthylation inhibitor 5-azacytidine.
4.3.3. Lac Z Expression O f Methylated CMV-BGB Plasmid.
In an attempt to investigate the factors which caused a decline in expression it 
was important to determine if the expression of the CMV-BGB plasmid could be 
altered by DNA méthylation.
CMV-BGB was methylated in vitro using a mammalian methylase. One-cell 
embryos were then injected with the methylated CMV-BGB and subsequent lac Z 
expression was compared with embryos microinjected with the unmethylated plasmid, 
both plasmids being injected at a concentration of 30 /xg/ml. Embryos were injected 
and cultured to the four-cell stage and in a separate experiment cultured to the two­
cell stage. These embryos and the accompanying blocked stages were then assayed 
for jg-galactosidase activity. The number of embryos showing jS-galactosidase activity 
in both groups is shown in Table 4.3.12..
Table 4.3.12. Lac Z Expression of Methylated CMV-BGB - Experiment 1.
Unmethylated Plasmid (CMV-BGB) 
Stage Number
Stained
Total
Number
Methylated Plasmid (mCMV-BGB)
Stage Number Total (%) 
Stained Number
One-cell 10 12
Two-cell 29 38
Four-cell 15 23
76%
65%
One-cell 4 
Two-cell 7 
Four-cell 0
11 36%
29 24%
36 0%
A greater number of one-cell embryos and significantly more two and four cell 
embryos (x^ =  18.0 and 31.5 respectively: both P <  0.01) stained blue after being 
microinjected with CMV-BGB than with the methylated form of CMV-BGB.
This experiment was repeated with the intention of comparing the methylated 
plasmid with plasmid which was mock methylated, that is plasmid which was 
subjected to the méthylation reaction but with the essential co-factor SAM (S-adenyl 
methionine) missing from the reaction mixture. As can be seen from Table 4.3.13. 
the results of this experiment appear to contradict those in Table 4.3.12.. In this 
experiment embryos were injected with both methylated and mock methylated CMV- 
BGB. In contrast to the results presented in Table 4.3.12. there was no significant
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difference in the staining rate between the methylated and mock-methylated groups 
and a number of embryos injected with methylated CMV-BGB stained blue.
Table 4.3.13. Lac Z Expression of Methylated CMV-BGB - Experiment 2.
Mock methylated plasmid (CMV-BGB) 
Stage Number
stained
Total
number
Methylated plasmid (mCMV-BGB)
Stage Number Total (%) 
stained number
1-cell
2-cell 
4-cell
1 0 %
17 41%
15 27%
1-cell 0
2-cell 6
4-cell 5
0
14
15
0 %
43%
33%
As these results were contradictory this experiment was repeated once more 
using Ssl methylase (a methylase enzyme with greater activity than mammalian 
methylase, Adams, per s. comm.). In this experiment embryos were injected with 
both methylated and mock methylated CMV-BGB at a concentration of 20 /xg/ml and 
cultured to the two-cell stage. The resulting two-cell and blocked one-cell embryos 
were assayed for j8-galactosidase activity. As can be seen from Table 4.3.14. no 
expression was detected in those embryos injected with the methylated DNA whereas 
expression in the mock methylated group was relatively high.
Table 4.3.14. Lac Z Expression of Methylated CMV-BGB - Experiment 3.
Mock methylated plasmid (CMV-BGB) Methylated plasmid (mCMV-BGB)
Stage Number Total (%) Stage Number Total (%)
Stained Number Stained Number
1-cell 7 11 64% 1-cell 0 6 0%
2-cell 9 13 69% 2-cell 0 21 0%
These results appear to confirm those of the first experiment and together these 
imply that the expression potential of introduced methylated DNA is less than that of 
the unmethylated equivalent. The reasons for the conflicting results are not known 
but it was possibly due to a reduction in the efficacy of the mammalian methylase 
enzyme as it had been stored for some time before being used in the second 
experiment.
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LAC Z EXPRESSION IN THE PREIMPLANTATION MOUSE EMBRYO
SECTION 4.4. - DISCUSSION
Introduction.
Introduction of the E. coli lac Z gene into mammalian cells allows the visual 
detection of gene expression at the level of the single cell using a simple assay system 
(Norton and Coffin, 1985). It is, therefore, suitable for examining expression in 
single preimplantation embryos (Bonnerot et al., 1987). Using pronuclear 
microinjection this reporter gene was introduced into fertilised one-cell embryos and 
its expression at different stages of embryo development was investigated.
Two plasmid constructs were used to investigate expression in the 
preimplantation embryo. These plasmid were similar, the only difference being the 
promoter used to drive expression of the lac Z gene. In CMV-BGB the immediate 
early promoter of cytomegalovirus was used (Thomsen et al. , 1984) and the Herpes 
Simplex Virus Thymidine Kinase promoter (McKnight et ah, 1981) was used in Tk- 
BGB. Both plasmids were used at a concentration of 10 /xg/ml for most experiments.
Comparison Of CMV And Tk Promoters.
The pattern of expression was similar for both plasmid constructs, however a 
greater number of embryos at the blocked one-cell and blastocyst stages stained blue 
with the CMV promoter than with the Tk promoter although the difference was not 
significant. Similar results were obtained when the linear constructs, Tk-lacZ and 
CMV-lacZ, were microinjected. A higher percentage of blocked one-cell and two­
cell embryos stained blue with the CMV-lacZ construct than with the Tk-lacZ 
construct. Taken together these results suggest that the transcriptional activity of the 
CMV promoter is higher than the Tk promoter in preimplantation embryos. Although 
the TK promoter has been used to express a number of genes in preimplantation 
embryos (Brinster et ah, 1982; Ao et ah, 1988; Martinez-Salas et ah, 1989) it has 
been described as a weak promoter (Allen et ah, 1988). When the Tk-lacZ construct 
was used to produce a number of transgenic lines it was shown that the transcriptional 
activity of the Tk promoter was heavily influenced by the site of integration (Allen et 
ah, 1988). In contrast, the CMV regulatory sequence appears to direct widespread 
expression in a large number of organs and systems (Schmidt et ah, 1990).
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Transcription At The One-Cell Stage.
A total of 49 one-cell embryos microinjected with CMV-BGB were assayed 
within 4 hours of microinjection, none of these embryos showed any evidence of ^- 
galactosidase activity. However, blocked one-cell embryos generally showed a high 
level of activity. It would appear, therefore, that one-cell embryos are incapable of 
expressing the exogenous gene until a period of time has elapsed. The high level of 
expression in the blocked one-cell embryos shows that the ability to express the 
introduced gene is dependent not on cleavage to the two-cell stage but on a period of 
time elapsing. This situation is analogous to that described for endogenous genes in 
one-cell embryos. Although a low level of mRNA synthesis has been reported at the 
one cell stage it is generally accepted that activation of the embryonic genome occurs 
early in the two-cell cycle with a small number of mRNA species appearing 2-4 hours 
after cleavage (Bolton et al., 1984). Treatment of one-cell embryos with aphidicolin 
prevents DNA synthesis and therefore DNA replication and as a result cleavage to the 
two-cell stage is blocked (Ikegami et al., 1978). However, such treatment does not 
prevent the synthesis of a set of proteins indicative of the G 1 phase of the two-cell 
stage (Bolton et al., 1984; Poueymirou and Schultz, 1987).
The results reported here are consistent with similar results reported by other 
workers. Chen et al. (1986) demonstrated the existence of a lag phase between the 
injection of exogenous DNA and the onset of expression of that DNA and Bonnerot et 
al. (1987) reported that it is only at the two-cell stage that the embryo acquires the 
ability to express introduced DNA.
A more detailed investigation was carried out by Martinez-Salas et al. (1989). 
Using aphidicolin to prevent DNA replication of injected zygotes, this group showed 
that a time lag of 16-20 hours was required before the onset of expression in these 
artificially blocked one-cells. When the one-cell embryos were held in aphidicolin for 
16 hours and then injected expression commenced immediately. They concluded that 
the onset of exogenous gene expression was dependent upon an embryo signal which 
was not related to DNA replication or cleavage and suggested that injected genes were 
being regulated by the same factors which determine the timing of zygote gene 
expression.
Staining Pattern In Early Embryos.
In the one-cell and two-cell embryo stages there was a clear distinction between 
those embryos which stained and those which did not. There were only a few one and 
two-cell embryos in which only a low level of expression was identified and which 
stained only partially or at a low intensity. It is possible that these results do
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represent a normal distribution curve but that this pattern is distorted by the limited 
sensitivity of the assay at both ends of the spectrum.
Alternatively, these embryos might represent two distinct groups with a different 
capacity to respond to the introduction of the lac Z gene. It is possible that in a 
proportion of embryos the DNA solution was not correctly deposited into the 
pronuclei or that damage to the nuclear membrane caused leakage of most of the 
injected solution. Martinez-Salas (1988) reported that 30-80% of plasmid DNA is 
lost soon after injection and suggests this is caused by leakage to the cytoplasm where 
the DNA is rapidly degraded.
The embryo donors were C57BL6/CBA FI hybrids. This is the genotype of the 
oocyte and as embryonic activation does not occur until the two-cell stage (Bolton et 
al. , 1984) it is also the genotype of the early embryo. Meiosis in the oocyte of an FI 
hybrid will result in a number of different genes segregating and producing one-cell 
embryos with a unique mRNA and protein profile. It is possible that this may result 
in the presence of DNA binding proteins which could either enhance or suppress the 
expression of the introduced gene. Therefore, unlike embryos from an inbred line, 
the population used in this study is genetically heterogeneous which may partially 
explain the variable response observed. It has previously been shown, at least with 
integrated transgenes, that although the temporal and spatial pattern of expression 
remains the same the level of expression varies markedly depending on the genetic 
background of the transgenic mouse (Sapienza et al., 1989; Allen et al., 1990).
In this study, the pronuclei which appeared most accessible were injected and 
while the majority would probably be male pronuclei as they are larger and therefore 
easier to inject it is reasonable to assume that a significant proportion of female 
pronuclei were also injected. Martinez-Salas et al. (1989) report that expression of an 
introduced gene can vary considerably depending on which pronuclei are injected. 
Using the luciferase (lue) gene Martinez-Salas et al. found that expression after 
injection into the male pronuclei was twice that observed after microinjection of the 
female pronuclei.
A major problem in using the lac Z gene in this assay system is that it is 
difficult to quantify the level of expression - in these experiments this was achieved by 
subjective examination. If the intensity of blue stain is not a linear representation of 
transcriptional activity then it is possible to understand why relatively small changes 
in mRNA expression were not accurately reflected in the degree or intensity of blue 
stain observed and why some embryos do not stain at all while the majority stain 
intensely. However Brinster et al. (1982) showed, using the Herpes Thymidine 
Kinase (Tk) gene linked to the mouse Metallothionine promoter (MT-I), that there is a 
linear relationship between the concentration of the injected DNA and the resultant 
level of expression.
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Description Of Staining Pattern
p-galactosidase activity declined with embryo development. The staining 
pattern was similar for both constructs CMV-BGB and Tk-BGB in that a high 
percentage of one and two-cell embryos stained blue but a significantly lower 
proportion of four-cells, morulae and blastocysts stained. As development proceeded 
not only did the number of embryos showing evidence of lac Z expression decline but 
the intensity and extent of stain in individual embryos also decreased. The majority 
of stained one-cell, two-cell and to a lesser extent four-cell embryos showed a 
homogenous staining pattern and high level of P-galactosidase activity. However, the 
staining pattern observed in later stages was much more heterogeneous with the 
majority of these stages displaying only a few blue spots.
Pooling the results of both plasmid constructs reveals that 77 % of one cells and 
63% of two cell embryos responded to the presence of the lac Z gene whilst only 34% 
of four-cells and 33% of morula and blastocyst stages showed any blue stain after 
microinjection at the one-cell stage. A responsive embryo was defined as an embryo 
showing any evidence of P-galactosidase activity. The level of expression of morula 
and blastocyst stages, however, was significantly below that of four cell embryos 
based on the intensity and extent of blue stain seen in individual embryos. With this 
exception there was a good correlation between the proportion of embryos responding 
and the degree of expression observed in individual embryos. This has been reported 
previously by Martinez-Salas et al. (1989). These workers showed that when 
expression of the reporter gene luciferase was increased by introducing an appropriate 
enhancer not only did the activity increase but the number of embryos responding also 
increased. There would, therefore, appear to be a close correlation between the level 
of gene expression and the number of responsive embryos.
Interpretation O f Staining Pattern
In order to compare the level of gene expression between different stages of 
preimplantation development over a relatively short time course, it is important to 
distinguish between expression and the evidence of that expression. The length of 
time P-galactosidase activity persists in preimplantation embryos is primarily 
dependent on two parameters - the initial level of enzyme introduced and the half-life 
of the enzyme in the embryo cells, p-galactosidase enzyme was introduced into one­
cell embryos. The proportion of embryos staining blue did not decrease with 
preimplantation development and the intensity of stain decreasing only slightly at the 
morula stage. These results show that given a sufficiently high initial concentration of
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enzyme, /3-galactosidase activity can persist through preimplantation development and 
it is likely that j8-galactosidase activity does not accurately reflect the time at which 
lac Z transcription is down-regulated.
The pattern of embryo staining observed at different stages of preimplantation 
development is consistent with a burst of transcriptional activity at the one or the two­
cell stage and a decrease in transcriptional activity around the two to four-cell stage. 
Similar results for microinjection experiments have been reported by Chen et al. 
(1986) and Ao et al. (1988). Given the results achieved with jS-galactosidase enzyme 
it is possible that the staining observed in morula and blastocyst stages resulted from 
residual jS-galactosidase activity. These results do not, however, rule out some 
transcriptional activity at or after the four-cell stage. In the blastocyst group a wide 
variation in the intensity and extent of blue stain was observed. It is not possible, 
however, to distinguish if this represents residual jS-galactosidase activity or continued 
transcription at the morula and blastocyst stages in a sub-population of embryos.
Possible Reasons For Decline In /?-galactosidase Activity
One possibility for the observed decline in /8-galactosidase activity is that the 
plasmid DNA is being degraded in the nucleus. Existing evidence does not favour 
this hypothesis as it has been reported that plasmid DNA, whether it replicates or not, 
is stable in the nucleus of murine blastomeres for up to 3 days (Martinez-Salas et al. , 
1988 and Martinez-Salas et al. , 1989). Wirek et al. (1985) report that some reduction 
in the amount of introduced DNA is evident by 72 hours post-injection and suggest 
that the DNA is either degraded or no longer extractable because it integrates into 
cellular DNA or is recombined into larger oligomers. Indeed, Brinster et al. (1985) 
report that 24 hours after the introduction of supercoiled DNA the concentration of 
DNA remains the same but there were changes in the distribution of supercoiled, 
nicked circular and linear molecules. In 1988 Ao et al. introduced a supercoiled 
plasmid coding for the Tk gene but regulated by the MT-I promoter. They 
demonstrated that DNA transcription was capable of being stimulated 15 hours after 
microinjection by the addition of cadmium to the culture medium, indicating that the 
regulatory and coding sequences of the injected plasmid were still present at this time.
In conclusion, it would appear unlikely that significant degradation is 
responsible for the observed decline in jS-galactosidase activity reported in this study.
The interpretation of the results is further complicated by the inclusion of the 
autonomous replicating sequence within the CMV-BGB and Tk-BGB plasmids (Ariga 
et al., 1987). This sequence contains a putative origin of replication and the presence 
of this element may have resulted in extrachromosomal replication of the plasmid. If 
this were the case, it lends credence to the suggestion that the observed decline in j8-
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galactosidase activity was due to influences acting at the transcriptional or post- 
transcriptional level.
Although a good correlation between lac Z mRNA levels and enzyme activity 
has been reported (Norton and Coffin, 1985), changes in the stability of the jS- 
galactosidase enzyme or the efficiency of translation of lac Z mRNA cannot be ruled 
out. Changes in the stability of endogenous stored maternal RNA are known to occur 
around this time in preparation for the onset of embryonic gene activation 
(Bachvarova and De Leon, 1980; Clegg and Piko, 1983 and Ebert et al. 1984). A 
more accurate assessment of the effect of developmental stage on transcription would 
have been gained by assaying mRNA levels directly.
A number of workers have reported that expression of introduced genes in 
spontaneously blocked and aphidicolin-arrested one-cell embryos is considerably 
greater than at the two-cell or later stages of development (Stuart et al. , 1984; Chen et 
al., 1986; Ao et al., 1988; Martinez-Salas et al., 1989; W. Reik, pers. comm.). This 
finding is consistent with the results reported here in which the number of blocked 
one-cell embryos staining blue is considerably greater than the number of two-cell 
embryos staining and with the general finding of high transcription activity early in 
development.
Martinez-Salas et al. (1989) have examined this phenomenon using the Tk-luc 
gene and found that expression levels in blocked one-cell embryos were 21 fold 
greater than developing two-cell embryos. Although the addition of an enhancer 
sequence could increase the level of expression in two-cell embryos it was not 
required in one-cell embryos. These workers found a very high inverse correlation 
between Tk promoter activity and the rate of assembly of plasmid DNA into 
chromatin. At 45 hours post-injection when lue expression peaked in blocked one-cell 
embryos and developing two cell embryos, 70% of the DNA in two-cell embryos but 
only 10% of DNA in one-cell embryos was in the supercoiled form. It would appear, 
therefore, that injected DNA is not efficiently assembled into chromatin until the two­
cell stage and that this allows the exogenous DNA to be expressed efficiently in the 
blocked one-cell embryo. Workman and Roeder (1987) have reported that 
sequestration of DNA into nucleosomes prevents transcription factors binding to the 
promoter.
This might imply that transcription is high in the blocked one-cell and early two­
cell embryo resulting in high levels of lac Z mRNA and jS-galactosidase accumulating 
and that expression is increasingly inhibited as more and more plasmid DNA is 
assembled into chromatin following the one-cell stage. If plasmid assembly is a 
progressive phenomenon through early embryo development this could result in high 
levels of expression initially (for example, the early two-cell stage) with a subsequent 
decline in transcriptional activity. Therefore, it is possible that the reduction in jS-
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galactosidase activity observed at the four-cell stage in these results is related to the 
assembly of the lac Z plasmids into chromatin.
As mentioned, Martinez-Salas et al. (1989) showed a correlation between 
sequestration of introduced plasmids into chromatin and a major reduction in 
transcriptional activity of the introduced plasmids. However, transcription of DNA 
within chromatin is dependent on the conformation of that chromatin, active or 
inactive, and not with assembly into nucleosomes per se. Buschhausen et al. (1987) 
microinjected plasmids expressing the Tk gene into the nuclei of mouse cells and 
found that both in vitro methylated and unmethylated constructs expressed the Tk gene 
initially. By 8 hours post-injection expression from the methylated but not the 
unmethylated plasmid had started to decline. Assembly of plasmid DNA into 
chromatin before microinjection did not inhibit transcription of the unmethylated Tk 
gene but no transcription occurred if the methylated DNA was assembled into 
chromatin and introduced into the cells. This work demonstrated that méthylation of 
gene sequences did not reduce transcription unless those sequences are associated with 
chromatin.
Therefore, one possible contributory reason for the expression pattern described 
may be that the introduced sequences are being subjected to chromatin assembly 
and/or de novo méthylation in the early embryo.
Staining Pattern Of Microiiyected Embryos Cultured In The Presence Of 
Méthylation Inhibitors
In an attempt to examine the role of DNA méthylation in transcriptional 
regulation of foreign DNA in the preimplantation embryo, microinjected embryos 
were cultured in the presence of inhibitors of DNA méthylation - DL-homocysteine 
and 5-azacytidine.
S-adenosylmethionine (SAM) is an important co-factor in the méthylation of 
DNA, RNA and protein. It has been shown that depletion of the endogenous SAM 
pool can result in a reduction in methyl transferase activity involving nucleic acids 
(Kramer et a l ,  1987). Menezo et al. (1989) incubated embryos with 500 /xM of L- 
homocysteine and showed that endogenous levels of SAM were depleted and that the 
presence of L-homocysteine significantly reduced the number of embryos developing 
to the blastocyst stage. These authors suggested that development was compromised 
as a result of the induced inhibition of méthylation activity. In this current study the 
rate of embryo development declined with increasing concentrations of DL- 
homocysteine but more than 50% of one-cell embryos cultured to the blastocyst stage 
when 1(X)0 /xM of DL-homocysteine was included in the culture media. In these
98
experiments a racemic mixture of D and L homocysteine was used, whereas Menezo 
et al. (1989) used only the active L-homocysteine. The reduced concentration of the 
active ingredient probably explains the difference in these results.
Those embryos which were microinjected and cultured in DL-homocysteine 
(500 - 1200 pM) were not significantly different from those cultured in the absence of 
this substance either in the numbers stained, the intensity of staining or the overall 
pattern of lac Z expression. In these experiments the embryos were cultured to the 
blastocyst stage for two reasons. Firstly, as the numbers which stain and the intensity 
of that stain were both much reduced compared to earlier cleavage stages, it might be 
easier to observe a difference between the two groups and secondly the longer the 
embryos were in contact with the méthylation inhibitor the more the méthylation 
pattern between the two groups was liable to diverge.
The nucleotide analogue 5-azacytidine is a strong inhibitor of DNA méthylation 
and has been used extensively to induce transcription from methylated DNA (Jones, 
1984; Jones, 1985; Jeggo and Holliday, 1986; Michalowsky and Jones, 1989). A 
small number of embryos were injected with CMV-BGB and cultured in the presence 
of 5-azacytidine. The jS-galactosidase activity of these embryos was not significantly 
different from the control group.
In conclusion, co-culturing embryos in the presence of méthylation inhibitors 
did not modify the observed pattern of jS-galactosidase activity. These results do not 
provide evidence to support the hypothesis that the transcription activity of the 
exogenous DNA is being down-regulated by méthylation of the DNA in early 
embryos.
Alternatively, it is possible that méthylation is affecting transcription of the 
introduced plasmids but that méthylation is not being sufficiently inhibited or reversed 
by the presence of the méthylation inhibitors either because they are present at too low 
a concentration or their action is delayed. Treatment with homocysteine may require 
some time to reduce SAM levels sufficiently to interfere with methylase activity and 
by this stage the introduced DNA may already be extensively methylated. For 5- 
azacytidine to act as a méthylation inhibitor it must be incorporated into the DNA. In 
tissue culture experiments generalised déméthylation is usually accomplished by the 
use of relatively high concentrations of 5-azacytidine over a period of time often using 
multiple treatments (Flatau et al. , 1984; Michalowsky and Jones, 1989). In this study 
levels above 0.1 /xg/ml significantly impaired embryo development whereas 
concentrations used in tissue culture experiments have ranged from 1-3 /xg/ml (Jeggo 
and Holliday, 1986).
It is possible that de novo méthylation is a progressive event which causes a 
quantitative reduction in expression over a period of time. De novo méthylation of 
endogenous or exogenous DNA may be a gradual process in vivo requiring a number
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of DNA replication cycles, indeed Monk et al. (1990) report that de novo méthylation 
is a slow process occurring over several days. If this were the case in the early 
embryo, it is unlikely to have a major effect on transcription during the first 24-48 
hours after fertilisation.
The evidence that DNA méthylation within the preimplantation embryo is an 
important physiological event is contradictory. There is no direct evidence from the 
status of the embryos' endogenous genes to suggest that a significant de novo 
méthylation event occurs during preimplantation development. Gametes show a 
marked difference in the extent of DNA méthylation with oocytes being 
undermethylated and sperm DNA being heavily methylated. This appears to be true 
for both overall levels of méthylation and for specific sequences (Monk et al., 1987; 
Sanford et a l ,  1987). Circumstantial evidence exists to suggest that this situation is 
propagated through early embryonic development as the degree of méthylation in the 
preimplantation embryo is intermediate (Sanford et al., 1987). There is a general 
reduction in DNA méthylation during development from the morula to the blastocyst 
stage and a reduction in methylase activity at this time (Monk, 1988).
On the other hand Adams (pers. comm.) has reported that levels of the 
endogenous methylase are very high in the one-cell embryo and that these levels are 
maintained to the eight-cell stage at which point they start to decline. Certainly, the 
early embryo appears to have the capacity to methylate DNA as de novo méthylation 
of specific sequences has been reported in the early preimplantation embryo (W. Reik 
and S.K Howlett, unpublished data cited by Surani et al., 1990).
Further, for some genes méthylation appears to be a secondary event which 
occurs after the inhibition of transcription and serves to enforce and perpetuate the 
original signal. Embryonal carcinoma cells serve as a model for undifferentiated 
embryonic cells such as exist within the eight-cell embryo. After infection of these 
cells with the retrovirus MuLV the provirus integrates but transcription of the provirus 
is blocked. However Gautsch and Wilson (1983) report that the provirus only 
becomes methylated much later and suggest that transcriptional inactivation serves as 
the signal for méthylation and not vice versa. It appears, therefore, that méthylation 
can be both the cause and effect of transcriptional inactivity.
In Vitro Méthylation O f DNA
In order to ascertain if méthylation of the lac Z plasmid CMV-BGB would 
reduce the transcriptional activity of the lac Z gene this plasmid was methylated in 
vitro and microinjected into one-cell embryos. Although the numbers are small the 
results of two separate experiments imply that pre-methylation of the DNA can reduce 
the transcriptional activity of constructs introduced into the early embryo.
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This result shows that the transcriptional activity of the transgene is sensitive to 
the effects of méthylation. Further, it suggests that the unmethylated construct was 
not methylated in vivo to the same extent as the methylated construct at the onset of 
gene expression. It does not, however, rule out méthylation being involved in the 
observed reduction in transcriptional activity. A small number of embryos did display 
jS-galactosidase activity after being microinjected with the methylated construct 
demonstrating that in vitro méthylation of the construct did not completely block 
expression.
In a third experiment no difference was observed in j8-galactosidase activity 
between the methylated and the mock methylated plasmid. One possible reason for 
this result is that the activity of the methylase enzyme used had declined by the time 
this experiment was conducted. However, this finding emphasises the need for 
further experiments to establish the effect of in vitro méthylation on DNA 
transcription in early embryos.
Future Prospects
The preferred and most direct way of determining if exogenous DNA is being 
methylated in the early embryo would be to examine the introduced DNA for its 
méthylation status at some time point after injection. This could be achieved by 
cutting DNA extracted from the blastocysts with méthylation sensitive enzymes and 
amplifying the resulting fragments using the polymerase chain reaction (PCR). 
Properly designed this experiment should provide evidence of in vivo méthylation of 
the transgene although a quantitative result would be more difficult to achieve.
A combination of reverse transcription and PCR is a possible method for 
identifying specific mRNA species in individual embryos. Such an approach would 
be a much more sensitive indicator of transcriptional activity of specific genes 
including introduced transgenes.
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CHAPTER 5. - INFECTION OF OVINE EMBRYOS WITH FeLV 
SECTION 5.1. - INTRODUCTION
Introduction
The primary purpose of the experiments described in this chapter was to 
examine the susceptibility of ovine preimplantation embryos to retroviral infection in 
vitro. Retroviral vectors have been used to produced transgenic mice and the work 
described here represents the initial step in a project designed to investigate the 
feasibility and suitability of adapting this approach to the production of transgenic 
sheep. The retrovirus selected for these experiments was the Type B Feline 
Leukaemia Virus (FeLV-B) and embryos were infected by injecting virus supernatant 
under the zona pellucida of the preimplantation embryo.
This experiment involved a moderately sized embryo transfer programme and 
this provided the opportunity to examine aspects of ovine embryo transfer. The 
results of both the embryo transfer work and the embryo infection are presented in 
this chapter.
Background
Retroviruses are a large family of viruses, the members of which can interact 
with many different species. They differ from other viruses in their mode of 
replication. These viruses have a single stranded RNA genome which replicates 
through a DNA intermediate, the provirus. This intermediate is an integral part of the 
retrovirus lifecycle and retroviruses carry an enzyme, reverse transcriptase (Temin 
and Mitzutani, 1970; Baltimore, 1970), which allows the RNA viral genome to be 
used as a template to produce the double stranded DNA copy. This copy is then 
efficiently inserted into the genome of the host cell. These viruses, therefore, have 
the capacity to transfer their viral genes into the host chromosome.
Transgenic animals have been broadly defined as those animals carrying, in the 
germ line, gene sequences of non-parental origin. Analysis of the mouse genome has 
revealed the presence of a large number of widely dispersed regions that show 
homology with retroviral sequences (Harel et a l ,  1967; Jenkins et al., 1982). These 
proviral sequences are present in the genome and are transmitted from one generation 
to the next according to mendelian expectations (Rowe, 1972). It is widely believed 
that these endogenous proviruses have arisen from the infection of the germ line with
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ectopic murine retroviruses at some previous generation (Buckler et a l ,  1982), indeed 
crossing certain inbred strains of mice can result in their progeny acquiring new 
proviral sequences. In these mice activation of the endogenous provirus produces a 
spontaneous viraemia which can result in the infection of very early embryos and the 
acquisition of new proviral copies in the germ line (Rowe and Kozak, 1980; Jenkins 
and Copeland, 1985). It would appear, therefore, that following the broadest 
definition, the creation of transgenic animals can be a naturally occurring 
phenomenon.
Germ Line Integration Of Viral DNA
In 1974 Jaenisch and Mintz showed that microinjection of Simian Virus (SV40) 
DNA into the mouse blastocyst could result in a percentage of the resulting offspring 
carrying SV40 specific DNA in at least a proportion of their tissues. Germ line 
transmission was not observed in these animals.
In 1975 Jaenisch et al. successfully infected mouse preimplantation embryos 
(four to eight cell stages) with Murine Leukaemia Virus (MuLV). Analysis of one 
viraemic offspring revealed that virtually all tissues of this animal carried similar 
amounts of viral DNA in each cell. These workers went on to show that infecting 
preimplantation embryos with exogenous MuLV could result in viral sequences being 
retained in the germ line with the proviral sequences being transmitted to the progeny 
of the infected offspring (Jaenisch, 1976). In these experiments incorporation of viral 
sequences into the germ line was accomplished by removing the zona pellucida and 
exposing the early embryo to concentrated stocks of retrovirus. In 1981 Jaenisch et 
al. showed that infecting embryos was also possible using blastocyst microinjection 
and that germ line integration of provirus was possible using this method albeit at a 
very low frequency.
The Design Of Retroviral Vectors
The intrinsic ability of retroviruses to efficiently and stably insert their viral 
genes into the chromosomes of host cells together with their capacity for non-lytic 
infection of a wide range of cell types makes these viruses ideal vehicles for gene 
transfer experiments.
Acutely transforming retroviruses differ from slowly transforming retroviruses 
due to the presence of additional genes within the viral genome (Duesberg and Vogt, 
1970; Bishop, 1983; Bishop and Varmus, 1982). These additional sequences are
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derived from cellular sequences and arise as a result of recombination events between 
the provirus and the adjacent cellular DNA (Varmus, 1982; Bishop, 1983). Acutely 
transforming retroviruses are in themselves usually replication defective, due to the 
displacement of viral protein coding sequences by the cellular sequences, but can be 
replicated when cells are co-infected with replication competent virus. Therefore, the 
recombinant viral genome can act as a vector for transferring cellular gene sequences 
from one cell to another and from one chromosomal position to another.
These observations have led to the development of retroviral vectors designed to 
deliver specific genes to target cells (for review see Donehower, 1987). There are 
two requirements which are necessary for these vectors to function. Certain non­
coding sequences at the 5 and 3 prime ends of the genome must be retained whilst the 
viral proteins must be supplied by the complementary expression of the requisite viral 
genes within the cell (i.e. supplied in trans). Infecting the cell with replication 
competent viral sequences can provide the structural and functional proteins required 
but this approach results in a mixed population of vector and wild type virons being 
shed by the infected cell. The identification of the cis-acting sequences, which must 
be present in order to allow the viral genome to be packaged, led to the development 
of cell lines which could be used to produce helper free retroviral vectors. One of the 
first packaging cell lines was developed by Mann et al. (1983). These workers 
introduced, into the host chromosome, a retroviral genome which supplied all the 
necessary viral proteins but which could not itself be packaged into the virus particle 
due to a deletion of cis-acting sequences (the psi sequences) - these sequences being 
responsible for packaging the retroviral genome. The subsequent introduction of 
genes flanked by 5 and 3 prime retroviral sequences including the packaging signal 
allows these genes to be incorporated into the viral capsid.
It has been shown that recombination events can rescue replication competent 
virus from the helper cell lines (Hu et al., 1987), therefore, a number of 
modifications have been made to packaging cell lines in order to reduce the likelihood 
of these events (Miller and Buttimore, 1986; Markowitz et al., 1988; Dougherty et 
al., 1989). Only those sequences absolutely necessary are retained within the 
retroviral vector and to further reduce the possibility of unwanted recombination 
events the viral coding gene sequences have been separated and introduced into 
different chromosomal sites.
Production Of Transgenic Mice Using Retroviral Vectors
Van der Putten and co-workers (1985) showed that it was possible to introduce 
foreign genes into the mouse germ line using a retroviral vector to infect
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preimplantation embryos. In these experiments the retroviral vector carried a mutant 
dihydrate reductase gene. Embryos were infected using a mixed population of wild 
type helper virus and a recombinant vector but these workers also showed that it was 
possible to infect preimplantation embryos in the absence of helper virus. In 
experiments using a combination of wild type and recombinant virus 20-40% of 
embryos infected and transferred were bom, up to 40% of offspring were positive for 
wild type virus sequences and 20% of offspring contained vector sequences. When 
embryos were infected with the retroviral vector exclusively 2% of offspring were 
positive for the presence of foreign gene sequences. Huszar et al. (1985) also showed 
that genes, in this case the bacterial neo gene, could be introduced into the mouse 
germ line using a retroviral vector. In these experiments embryos were infected by 
co-culturing the embryos with cell lines releasing either murine leukaemia virus vector 
or both vector and wild type MuLV. Slightly earlier embryonic stages were used in 
studies carried out by Rubenstein et al. (1986) who also used a retroviral vector to 
deliver the neo gene and assessed the genetic status of the resulting foetuses at day 17 
of gestation. In these experiments it was shown that embryos cultured from both the 
two and four-cell to the morula stage were also susceptible to retroviral vector 
infection.
LTRs Can Interfere With Expression And Compromise Safety
Retroviruses carry sequences which direct the formation of the long terminal 
repeats (LTRs) situated at either end of the integrated provirus. These LTRs contain 
the endogenous viral enhancer and promoter sequences - the presence of which has a 
number of disadvantages in retroviral vectors.
The activity of the LTR is suppressed when retroviruses or retroviral vectors are 
introduced into preimplantation embryos or embryonal carcinoma cell lines (Stewart 
et al., 1982; Jahner et al., 1982). This block in expression is permanent and 
reactivation is a rare event occurring only in some adult tissues of the resultant 
offspring (Jaenisch et al., 1981).
Soriano et al. (1986b) showed that it is possible to get both tissue specific and 
ectopic expression of genes introduced into the germ line with retroviral vectors. The 
jS-globin gene was expressed in haematopoeic tissues by including j8-globin's own 
promoter within the retroviral vector. Stewart et al. (1987) also showed that neo gene 
expression could be directed by an internal Thymidine Kinase promoter within a 
retroviral vector.
With an intact LTR there is still the possibility that endogenous retroviruses 
could supply helper functions and allow the spread of virus vector. In addition, the
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transforming potential of retroviruses - even those that lack viral oncogenes - is well 
recognised. This occurs due to insertional mutagenesis, the promoter and enhancer 
elements contained within the LTR can locally activate cellular genes including proto­
oncogenes (Teich et al., 1982; Bishop, 1983).
These problems can be circumvented by designing a vector - the self inactivating 
vector (Yu et al., 1986) - which contains a deletion in the 3' LTR. Due to the mode 
of retroviral replication the 3' LTR is used as a template for the formation of both the 
5' and 3' LTR in the new integrating provirus. These deletions remove from the 
LTRs those regulatory elements which interfere with internal promoters and cause the 
induction of cellular genes.
Production O f Transgenic Domestic Animals
The first technique used to introduce selected DNA sequences into the mouse 
germ line was pronuclear microinjection (Gordon et al., 1980; Brinster et al., 1981c). 
This technique is now widely and successfully used to produce transgenic animals but 
it is not without some disadvantages as the technique is associated with embryo loss. 
In addition, pronuclear microinjection results in the integration of a varying number 
of copies of the DNA construct at a single site, usually arranged in head to tail 
tandem arrays.
The use of retroviral vectors is not associated with significant embryo mortality 
and the insertion of a single proviral copy into the host genome simplifies 
measurements of quantitative expression. Further, the integration of a single copy 
makes cloning of the integration site far easier (Schnieke, et al., 1983; Soriano et al., 
1986b).
An alternative method of producing transgenic mice is to utilise embryonic stem 
cells (Bradley et al., 1984). This approach has a number of advantages. Gene 
sequences can be introduced into these cell lines and those cells expressing the novel 
sequences selected. In addition, a consequence of this approach is that exogenous 
genes can be targeted to specific loci allowing the transgene to exploit the regulatory 
sequences of endogenous genes or to directly ablate the function of endogenous genes 
(Smithies et al., 1985; Thomas et al., 1986; Mansour et al., 1988; Thompson et al., 
1989).
All three approaches have been successfully used to generate transgenic mice. 
Pronuclear microinjection, however, has proved to be a most accessible technology 
and is, therefore, the most commonly used method to produce transgenic animals. To 
date only this method has been exploited to introduce genes into the germ line of 
domestic animals although research to develop retroviral vectors (Ban et al., 1989)
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and embryonic stem cells suitable for use in domestic animals is continuing (Evans et 
a l,  1990).
There are a number of factors which make pronuclear microinjection more 
difficult in sheep (Wilmut et a l , 1990). Unlike the situation in mice it is not possible 
to collect large numbers of embryos all at the one-cell stage. This is partly due to the 
restricted availability of embryos and the greater variability in the stage collected. 
Cytoplasmic vesicles present in the early embryos of domestic animals obscure the 
pronuclei. In sheep this can be circumvented by differential interference contrast 
(DIG) microscopy and in pigs and cattle by a combination of centrifugation and DIG 
microscopy.
Despite these difficulties pronuclear injection is the only technique that has been 
successfully used to produce transgenic domestic animals. However, the efficiency of 
this procedure remains low. Wilmut et a l  (1990) report that around 0.85% of 
injected ovine embryos are represented as transgenic lambs. It is possible that 
retroviral vectors could increase the efficiency of producing transgenic livestock partly 
due to the capacity of retroviruses to infect - at least in mice - a number of 
preimplantation stages but mainly due to their capacity to infect and integrate their 
genes with high efficiency in a manner which does not usually damage the target cell.
In this study Feline Leukaemia Virus (FeLV) was tested for its ability to infect 
sheep preimplantation embryos. FeLV was selected because it has been molecularly 
characterised and was known to infect ovine cells in culture (O. Jarrett, pers. comm.). 
As tlhis study involved a moderately sized embryo transfer programme the factors 
affecting the efficiency of ovine embryo transfer were also examined.
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INFECTION OF OVINE EMBRYOS WITH FeLV 
SECTION 5.2. - MATERIALS AND METHODS
5.2.1. Experimental Design
This work had one primary objective: to determine the susceptibility of the 
ovine preimplantation embryo to retroviral infection. This is a requisite experiment in 
the development of a retroviral vector for use in sheep. In order to carry out this 
experiment it was necessary to collect the embryos, microinject virus stock under the 
zona pellucida and transfer the embryos into recipient ewes. After transfer the 
embryos were allowed to develop in vivo for a further 6-8 weeks and the resultant 
foetuses were collected at slaughter and analysed for the presence of integrated 
provirus. The ewes were synchronised using intravaginal progesterone sponges, the 
treatment lasting for between 11-14 days. Those ewes selected as embryo donors 
received a superovulatory dose of PMSG, whereas those ewes destined to be 
recipients received a small dose of PMSG to help synchronise ovulation. The donors 
were given access to an intact male ram wearing a raddled harness and time of oestrus 
onset was taken as the time the ewes were first seen marked. The recipients were 
placed with a vasectomised ram, similarly harnessed, in order to determine the 
approximate time of oestrus onset.
Embryo collection was timed so as to maximise the number of two-cell embryos 
gathered. After a number of collections had been carried out, the oestrus to operation 
interval was adjusted in an attempt to improve the yield of two-cell embryos. 
Following collection, embryos were exposed to concentrated stocks of FeLV by 
microinjecting virus containing supernatant under the zona pellucida. Embryos were 
transferred into the most synchronous recipients in order to maximise the viability of 
the embryos. After surgery both the donors and recipients were group housed with an 
intact ram. This had the duel benefit of checking both the current pregnancy status 
and assessing the ability of the ewes to establish and support a post-operative 
pregnancy. Six to eight weeks after embryo transfer the ewes were slaughtered and 
the contents of their uteri collected. The foetuses collected were analysed for the 
presence of proviral sequences derived from the infecting FeLV.
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5.2.2. Synchronisation And Superovulation
Draft Scottish Blackface ewes were used in this experiment. Before entering the 
programme the health and condition of the ewes was assessed. In general those 
animals judged as being in good condition were selected as embryo donors and those 
in slightly poorer condition as the recipients.
Oestrus synchronisation of ewes was achieved by the use of progestagen 
(fluorogestone acetate) impregnated intravaginal sponges (Chronogest - Intervet). 
After 11-14 days treatment the sponges were removed. The donors were 
superovulated by an intramuscular injection of between 1200 and 1500 iu of Pregnant 
Mare Serum Gonadotrophin - PMSG (Folligon - Intervet). PMSG was administered 
to the donors between 0 and 24 hours before sponge removal. On average, sponges 
were removed 12 hours earlier in the recipients and 500 iu of PMSG was administered 
at this time or 8 hours before sponge removal. The donors were mated by natural 
service and the time of first mating was recorded. Oestrus onset in the recipients was 
assessed using a vasectomised ram.
5.2.3. Embryo Collection And Transfer
During the 24 hour period prior to surgery, food and water were withheld from 
the ewes. Anaesthetic induction was carried out using 6% Sodium Pentobarbitone 
(Sagatal - May and Baker) at a dosage rate of 0.44 ml/kg and delivered into the 
cephalic vein via a butterfly needle (Miniven - Laboratoire Portex).
The ewe was placed in dorsal recumbency and intubated with a Magills No. 11 
endotracheal tube (Leyland) using direct visualisation with a 16 inch laryngoscope. 
The ewe was clipped and prepared for surgery by washing with Savlon (Hospital 
Concentrate, ICI) and swabbed with a pevidine/alcohol (70%) solution (Pevidine - 
Berk Pharmaceuticals)
A midline incision was made approximately 5-6 inches long just cranial to the 
mammary tissue. Entry to the abdomen was made by incising through the linea alba 
and the uterus was exteriorised through the incision. The ovaries were examined and 
the number of corpora lutea (CL) noted on each side.
5.2.3.a) The Donors
The oviducts were flushed in a retrograde direction, i.e. from utero-tubal 
junction towards the ampulla. The embryo collecting dish was covered with sterilised 
aluminium foil in an attempt to reduce airborne fungal contamination of the medium. 
The assistant collected the flush by inserting a glass U-shaped capillary tube (GC 100-
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10 Clarks Electromedical Instruments) into the oviduct from the fimbrial end and 
directing the other end through the aluminium foil covering the collecting dish. Using 
a blunt butterfly needle attached to a 20 ml syringe the surgeon directed 12-16 ml of 
ovum culture medium (Flow) through the oviduct by injecting into the uterine tip - 
having clamped the uterus just caudal to the injection site between finger and thumb. 
This procedure was then repeated for the other side and any difficulty encountered 
when flushing (e.g. build up of pressure or leakage of medium) was recorded.
In a proportion of ewes the ovaries and uterus were irrigated with heparinised 
saline.
The abdominal wall was closed with simple interrupted sutures of 4 metric 
monofilament nylon (Monilon 4 metric, Arnolds Veterinary Products). The 
subcutaneous tissue was repaired with 3 metric catgut (Ethicon) using a continuous 
horizontal mattress suture. Finally the skin was closed with either 3 metric 
monofilament nylon, interrupted mattress sutures, or Michel clips using a Michel 
applicator (Martins).
2 ml of penicillin (Duphapen L.A. - Duphar Veterinary Ltd.) was administered 
by intramuscular injection to prevent post-operative sepsis. The ewes were observed 
until laryngeal function returned at which time they were extubated, placed in sternal 
recumbency and allowed to recover in a well bedded pen.
5.2.3.b) The Recipients
Surgical access for the recipients was as described for the donors. The fimbral 
end of the oviduct was held up and a fine glass pipette containing the eggs was 
inserted 3-4 cm into the proximal end of the oviduct. The eggs were then discharged 
by blowing gently down the attached plastic tubing. Throughout the procedure the 
tissues were liberally flushed with heparinised saline. Wound closure and aftercare 
was as described for the donors.
5.2.4. Virus Production
Feline Leukaemia Virus sub-group B (FeLV-B) was grown in feline embryo 
cells (FeA cells). This virus was selected because it was previously shown to 
successfully infect tissue culture lines derived from ovine tissues (O. Jarrett pers. 
comm.). The virus was harvested, concentrated and stored using standard techniques 
(Onions et ah , 1987). The titre of the final viral stock was in the range 5 - 7.2 x W  
focus forming units/ml (ffu/ml).
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5.2.5. Embryo Manipulation
The ovine embryos were collected and handled in Ovum Culture Medium 
(Flow) supplemented with Foetal Calf Serum, penicillin and streptomycin (Gibco). 
Embryo manipulation was carried using a Leitz micromanipulator and a diavert 
microscope as described in general material and methods. An injection pipette with a 
tip diameter of approximately 5 /xm was used to microinject virus-containing fluid 
into the extracellular space between the blastomeres and the zona pellucida of the 
embryo. Sufficient fluid was injected to cause the zona pellucida to expand markedly. 
After microinjection the embryos were held at 37® C until they were transferred. 
Those embryos which had sustained obvious damage were discarded.
5.2.6. Post-operative Management of Ewes
In the period after collection/donation both the donors and recipients were 
housed and run with a harnessed ram. The ewes were examined daily to record the 
date of marking by the ram, and they were blood sampled in order to assay 
progesterone levels either 17 days after they were last in oestrus or the day of 
marking. In this way it was possible to assess the pregnancy status of both donors and 
recipients. In addition, the capacity of the ewes to become pregnant after surgery 
could be examined using this approach.
Progesterone levels were assessed using a commercial elisa kit (Farmkey).
5.2.7. Collection And Analysis of Foetal Material
Between 40 - 60 days after transfer the ewes were slaughtered and the number, 
position and approximate age of both healthy and degenerate foetuses was recorded. 
The foetal and placental tissue were separated and stored at -20® C to await analysis. 
Preparation of DNA and analysis by Southern blotting were carried out by Dr. Hettle 
as described in general material and methods.
I l l
INFECTION OF OVINE EMBRYOS WITH FeLV 
SECTION 5.3. - RESULTS
Introduction
The primary aim of this work was to discover if ovine preimplantation embryos 
were susceptible to infection with Feline Leukaemia Virus. This work constitutes the 
first step in the development of a FeLV based retroviral vector suitable for use in 
sheep.
Preimplantation embryos (one-cell - eight-cell stage) were collected by flushing 
the oviducts of superovulated donor ewes. Infection with FeLV was attempted by 
microinjecting virus stock under the zona pellucida of the embryo. After 
microinjection the embryos were held in media for a short time and those embryos 
which had sustained no obvious damage were placed into the oviduct of a 
synchronised recipient.
This work was carried out as two separate experiments with the first experiment 
involving the recovery of embryos from 38 embryo donors. A proportion of these 
embryos were subsequently transferred into a total of 16 recipients. This work took 
place from October to December and therefore fell into the first half of the breeding 
season for Scottish Blackface sheep. The second experiment was carried out in the 
following January and involved a total of 22 donors and 15 recipients.
A total of 60 ewes selected as embryo donors were synchronised and 
superovulated and of these, 59 showed signs of oestrus at which time they were mated 
to a fertile ram. All 59 had ovulated as assessed by ovarian examination at the time 
of collection. The ewe which was not observed as being in oestrus did not ovulate. 
All synchronised recipients showed signs of oestrus and ovulated.
5.3.1. The Interval Between Sponge Removal And Oestrus Onset
The mean interval between sponge removal and oestrus onset in the embryo 
donors was 25.2 hours with a range of between 20 and 34 hours (S.D. =  3.2). In the 
recipient group the mean interval was 40.2 hours with a range of between 28.5 and 49 
hours (S.D. = 4 .3 ) , one ewe which took 80 hours to enter oestrus was excluded from 
the analysis. Therefore, the recipients took significantly longer (Student T test, t =  
15.2 with 59 d.f.: P < 0.01) to enter oestrus after sponge removal than the donors.
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Ewes were examined every 6 to 8 hours and oestrus taken as the time a ewe was 
first seen marked by the ram. Obviously there was a significant sampling error in this 
method as ewes could be marked shortly after being examined, however, even if this 
sampling error is accounted for (by assuming every recipient was marked shortly after 
being examined) the recipients still took significantly longer to enter oestrus after 
sponge removal (Student T test, t =  7.1 with 59 d.f.: P <  0.01).
The major difference in treatment between the two groups relates to the use of 
PMSG. These results demonstrate that the administration of PMSG, primarily used to 
superovulate the ewes, hastens the onset of oestrus. However, there are two distinct 
differences in the way PMSG was used between the donors and recipients - i) a 
significantly greater dosage of PMSG was administered to the donors (average 14(X) 
iu) compared to that given to the recipients (average 350 iu) and ii) the length of time 
before sponge removal that PMSG was administered. On average PMSG was injected 
20 hours before sponge removal in the donors and 6 hours before sponge removal in 
the recipients. In order to determine which of these two factors were important - the 
dosage or the timing of PMSG treatment - these variables were examined further.
5.3.1. a) The Relationship Between The Dosage Of PMSG And Time Taken To 
Enter Oestrus After Sponge Removal
In order to examine the influence of PMSG dosage on the sponge removal to 
oestrus interval, those ewes in which PMSG was given at a standard time before 
sponge removal but which received slightly different doses were compared. Two 
groups of donors were compared - those that received 1000-1250 units and those that 
received 1500 units. The results presented in Table 5.3.1. show that small differences 
in PMSG dosage between the donors are not reflected in a difference in the time taken 
to come into oestrus. Both groups, however, received a superovulatory dose of 
PMSG and the difference between the dosage the two groups received may be too 
small to allow a similar difference to be detected in the time taken to enter oestrus.
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Table 5.3.1. Sponge Removal/Oestrus Interval - PMSG Dose.
Dose (iu) Sample Number Average
of PMSG Sponge Removal/Oestrus Interval (hours.)
1000-1250 8 23.1 hours
1500 22 25.5 hours
The response to PMSG, as measured by the number of oocytes that ovulated, 
varied widely between individual ewes (see below). In order to exclude this large 
individual variation from the analysis the effects, rather than the dosage, of PMSG 
were compared with the time taken for the ewes to enter oestrus. This was achieved 
by grouping the donors on the basis of response and assessing if there was a 
relationship between these groups and the average time taken to enter oestrus after 
sponge removal. The results are presented in Table 5.3.2. and show that those 
classified as unresponsive (1-2 CL/ewe) had a slightly longer interval between sponge 
removal and oestrus onset. However, the difference between this group and those 
ewes ovulating between 3-6 CL was not significant (Students T-test, t =  1.2 with 13 
d.f.: P >0.05).
Table 5.3.2. Sponge Removal/Oestrus Interval - PMSG Response.
No. of CL* Sample Size Average Interval (hours.)
0-2 5 27.6 hours
3-6 10 23.9 hours
7-10 10 24.9 hours
104- 5 24.1 hours
* Corpora Lutea
As can be seen from Table 5.3.1. and Table 5.3.2. small differences in PMSG 
dosage or differences in response to PMSG do not correlate with differences between 
ewes in the time taken to enter oestrus after the withdrawal of progestagen treatment.
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5.3.1. b) The Relationship Between The Timing O f Injection O f PMSG Before 
Sponge Removal And Oestrus Onset
Table 5.3.3. shows the average time taken for a ewe to enter oestrus after 
PMSG injection. These results exclude from the analysis both the dosage of PMSG 
given (within the donor and recipient groups) and the time of sponge removal and 
show that the PMSG to oestrus onset interval is remarkably similar between the 
donors and recipients.
Table 5.3.3. Interval Between PMSG Administration and Oestrus Onset.
Average
Group Interval* Range S.D.
Donors 47.5 hours 41 .5-58 3.27
Recipients 46.5 hours 35-57 4.40
* Average interval from PMSG administration to onset of oestrus.
These results suggest that time of PMSG administration might be an important 
factor in determining the time of oestrus onset. However, it is not possible to draw a 
definite conclusion from these results as the relative importance of dosage, time of 
sponge removal and time of PMSG injection cannot be separated.
5.3.1. c) The Relationship Between Length O f Sponge Treatment And The 
Sponge Removal To Oestrus Interval
The length of time ewes were treated with progestagen sponges was either 12 or 
14 days for the donors, or 11 or 13 days for the recipients. Those donors which had a 
14 day treatment entered oestrus on average 24.9 hours after sponge removal and in 
those treated for 12 days this interval was on average 25.6 hours. The recipients 
treated for 13 days had an average interval of 40.0 hours and those treated for 11 days 
had an average interval of 40.5 hours. Therefore, the length of progestagen treatment 
does not appear to significantly affect the time taken to enter oestrus after sponge 
removal in either donors or recipients (Students T-test, t =  0.7 with 32 d.f. and 0.3 
with 25 d.f. respectively: P >  0.05).
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5.3.2. The Response To PMSG - Number of Corpora Lutea
The average response to a superovulatory dose of PMSG in the donors was 7.1 
corpora iutea/ewe with a range of 1-24 and a standard deviation of 4.7. The ewes 
show a wide variation in their ovarian response to PMSG, these wide variations being 
well recognised in both sheep and cattle. The average response of the donors in 
Experiment 2 was slightly higher than that of Experiment 1, an average of 7.9 CLs 
compared with 6.6 but the difference was not significant (Students T-test, t = 1.0 
with 57 d.f.: P > 0.05). Figure 5.3.1. shows the range and distribution of ovulation 
rates of PMSG treated ewes.
Figure 5.3.1. Ovulation Rate O f PMSG Treated Sheep
OVULATION RATES
No. of Ewes 3
1 2 3 4  5 6 7 8 9 1 0 1 1  12 13 14 15 16 17 18 19 2 0 2 1  2 2 2 3 2 4  
CL Count a t  Time of Collection
Figure 5.3.1. shows a distribution graph of ovulation rates in PMSG treated sheep.
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5.3.2. a) Batch/Dose Variation Of PMSG - Response
A number of different batches and doses of PMSG were used throughout the 
course of this work the details of which are outlined in Table 5.3.4.a) and 5.3.4.b). 
There appeared to be some variation in the biological activity of the different batches 
of PMSG. However, because of the small sample size and the large variation in 
response of individual ewes it was not possible to definitely conclude if some batches 
differed significantly from the rest, but at least one batch, which produced a total of 6 
CLs from 4 ewes, was suspected as having low biological activity and its use was 
discontinued.
In Experiment 1, 10 donors were superovulated with between 1200 and 1250 
units of PMSG and 24 donors received 1500 units. There was no significant 
difference in the superovulation rate between the two groups (Student T-test, t =  1.1 
with 32 d.f.: P >  0.05). These results, therefore, demonstrate that small differences 
in dosage were not reflected in significant differences in response.
Table 5.3.4.a) Ovarian Response to PMSG. Donors - Experiment 1
Batch Dose Sample Size
Average 
CL count Range.
1 1000 2 1.5 1-2
1 1250 2 1.5 1-2
2 1250 8 8.2 2-11
2 1500 7 10.7 4-17
3 1500 7 6.0 1-7
4 1500 3 7.0 5-9
5 1500 7 7.1 4-11
Table 5.3.4.b) Ovarian Response to PMSG, Donors - Experiment 2
Average
Batch Dose Sample size CL count Range
2 1600 12 8.3 1-24
6 1500 9 7.0 1-13
7 1500 1 10.0 10
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5.3.2. b) Recipient Response To PMSG
A relatively small dosage of PMSG (between 250-7CX) iu) was administered to 
the recipients, the intention being to shorten the time taken for this group to enter 
oestrus after sponge removal but not to increase the ovulatory response of the ewes.
The average response in the 33 recipients synchronised was 2.6 CL/ewe with a 
range of 1 to 15 CL/ewe. Of the 16 recipients primed in Experiment 1 the average 
CL count was 1.6 and none of the ewes had more than 2 CLs. Two distinct groups 
could be identified in Experiment 2, 10 ewes which ovulated only 1 or 2 oocytes and 
7 ewes which ovulated between 3 and 15 oocytes/ewe. The average response in this 
group was 7.7.CL/ewe, all the ewes in this group received the same batch and dose of 
PMSG. The most reasonable explanation for this response is that this batch had 
sufficient biological activity to produce a superovulatory effect at the dosage of 700 
units/ewe.
5.3.3. Embryo Collection Rate
The average ovulation rate in the donor ewes was 7.1 with an overall collection 
rate of 58%. The ovulation rate in Experiment 2 was higher than that of Experiment 
1 but the collection rate in Experiment 2 was significantly below that of Experiment 1 
(x^ =  20.8: P <  0.01). The collection rates are presented in Table 5.3.5.
Table 5.3.5. Embryo Collection Rate.
No. Ewes No. CLs
Average CL/ 
Ewe
No. Ova 
Collected
Average Ova/ 
Ewe
(%) 
Collected *
Exp 1 38 243 6.6 164 4.4 (67.5)
Exp 2 22 173 7.9 78 3.5 (45.0)
a. The number of ova collected expressed as a percentage of the number of CL counted.
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5.3.3. a) The Effect Of Embryo Stage On Collection Rate
In Experiment 2 the embryo collections could be divided into two categories: 
those which resulted in only one-cell embryos being recovered and those in which 
more advanced stages were collected. These results are shown in Table 5.3.6. The 
collection rates in those flushes which yielded only one-cell embryos were 
significantly less than those flushes which only yielded more advanced stages (x^ =  
7.8: P <  0.01). The sample sizes are small, however, with only 9 flushes yielding 
one-cell embryos and 8 flushes yielding more advanced stages.
Table 5.3.6. Effect of Embryo Stage on Collection Rate.
Experiment 2 Number of 
Flushes
Number
Collected.
Number
Ovulated
Collection 
Rate (%)
Flushes containing 
only one-cells.
9 24 64 (38)
Flushes containing 
only advanced cells.
8 42 68 (62)
However, when the results of both Experiments 1 and 2 are pooled, this pattern 
is not observed. In collections which yielded only one-cell embryos, 67 out of a 
possible 122 embryos were collected giving a collection rate of 56% and in collections 
which yielded more advanced stages 175 embryos were collected from a possible 275 
- a collection rate of 64%. Unlike the results of Experiment 2 the difference between 
the two groups was not significant (x^ =  2.7: P >  0.05).
5.3.3. b) The Relationship Between The Level Of Superovulation And 
Collection Rate
To assess if the level of superovulation affected collection rates the efficiency of 
collecting embryos from ewes that had a CL count of below 7 was compared with 
those that had a collection rate of 7 and above. The results are presented in Table
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5.3.7. and they show that the difference between the two groups is not significant (x^ 
=  0.9: P >  0.05).
Table 5.3.7. Effect of Ovarian Response on Collection Rate.
Number Number Number Average/ Collection
No. of CLs. of Ewes Ovulated Collected Ewe ^ Rate (%)
less than 7 31 113 70 2.3 (62)
greater than 7 29 303 172 5.9 (57)
1. Average number of embryos collected per ewe.
5.3.4. Stage Of Embryo Collected
The experiment was designed to maximise the number of two-cell embryos 
collected. Infection at an early stage in development minimises mosaicism with 
respect to proviral integration. Infection at a later stage could possibly result in the 
cells of the developing foetus having a different number and pattern of proviral 
integrations. Although one-cell embryos were injected it was not the preferred stage 
as in most cases it was difficult to assess the fertilisation status of the embryos. For 
these reasons it was thought desirable to collect and use two-cell embryos, in addition 
the greater amount of space surrounding the blastomeres in the two-cell embryo made 
microinjection easier.
However, there was considerable variation in the embryo stages recovered at 
collection (see Figures 5.3.2 a,b,c). Of the 37 donors in Experiment 1, 23 yielded 
embryos which were all of the same stage, 13 ewes yielded two different stages of 
embryo - 7 of which consisted of one-cell embryos and a more advanced stage - and 1 
ewe yielded 3 different stages. In Experiment 2, 14 ewes yielded one stage only, 4 
ewes gave 2 different stages and 4 ewes gave no embryos.
The considerable overlap of different stages both from the same ewes and 
between different ewes made it difficult to collect a high percentage of two-cell 
embryos. In an attempt to establish the fertilisation status of the one-cell embryos a 
proportion of these embryos collected in Experiment 1 were placed in culture. A total 
of 62 one-cell embryos were cultured and 46 developed to more advanced stages (M. 
Waterson, pers. comm.). This indicates that the majority of one-cell embryos 
collected during Experiment 1 were probably fertilised.
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5.3.4. a) Effect Of Sponge Removal To Collection Interval On Embryo 
Stage
The relationship between the time from sponge removal to operation and the 
stage collected is shown in Table 5.3.8. Within each experiment there was a poor 
correlation between the stage flushed and the interval between sponge removal and 
collection. Similarly the interval between the time the ewe was first noticed in oestrus 
and the time of collection did not correlate closely with the stage collected.
Table 5.3.8. Embryo Stage - Effect of Collection Time.
Average Embryo Stage Average Sponge Removal to Collection Interval (Hours). 
Collected
Exp. 1 Exp. 2
1-1.9 75.2 90.8
2-2.9 75.4 91.0
3-3.9 73.8 -
4-4.9 75.5 -
5-5.9 78.0 -
6-6.9 - 96.5
7-7.9 - 97.5
8.0+ 74.0 92.0
Early collections during Experiment 2 yielded only one-cell embryos and in 
order to determine if this was a reflection of the stage or the fertilisation status of the 
embryo the sponge removal to collection interval was increased. Therefore, the 
average sponge removal to collection interval was 75.6 hours in Experiment 1 and 
91.8 hours in Experiment 2. As can be seen from Figures 5.3.2.b) and 5.3.2.c) this 
resulted in a greater percentage of more advanced stages being collected. Excluding 
one-cell embryos the average stage collected was 3.0 in Experiment 1 and 6.9 in 
Experiment 2.
In addition, the pattern of embryo stages collected shown in Figure 5.3.2.c) 
indicates that it is possible that the majority of one-cell embryos collected in 
Experiment 2 were unfertilised.
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5.3.5. Subsequent Fertility In The Donors
After embryo collection the donors were run with an intact ram in order to 
assess subsequent reproductive performance. Forty-two percent became pregnant by 
natural service at the first oestrus after the operation (Table 5.3.9.). A pregnancy rate 
of 42% to first service is considerably below that expected for natural service in ewes, 
therefore, it is probable that post-operative inflammatory changes and subsequent 
adhesions affected the ability of the ewes to establish a pregnancy.
Table 5.3.9. Pregnancy Rate of Donors After Collection.
Number of Ewes Put 
the Ram
Number Marked 
By Ram
Number Pregnant at 
Post mortem
Exp. 1 32 24 14*
Exp. 2 13 12 2
* An additional 3 ewes were found to be pregnant from this time, however, these ewes were not 
marked.
5.3.5. a) Accuracy Of Pregnancy Diagnosis
Two methods of pregnancy diagnosis were employed for both donors and 
recipients. Harnessed rams were used to identify ewes in oestrus and in addition, 
ewes were blood sampled and their progesterone levels assayed. Slaughter of the 
ewes 6-8 weeks after they were first induced allowed a definitive diagnosis of their 
pregnancy status and it was, therefore, possible to examine the accuracy of pregnancy 
diagnosis using these two methods.
When blood progesterone samples were taken on either day 17 of the cycle or 
on the day of marking they proved to be accurate in 42 out of the 45 ewes sampled.
Using rams alone to identify those ewes in oestrus proved to be less accurate 
with only 35 out of 45 ewes being identified. However, using the ram as an 
indication of when to sample the ewes proved to be the most efficient system of 
pregnancy diagnosis.
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5.3.6. Oestrus Cycle Length Of Donors After Synchronisation And
Collection
The cycle length from the induced oestrus to the subsequent oestrus was 
recorded and the results shown in Figure 5.3.3. Fifty-one percent of ewes had a cycle 
length of between 16-18 days inclusive, 23% of ewes had a cycle length of greater 
than 18 days and 23% of ewes had a cycle length of less than 16 days. The overall 
average was a cycle length of 16.5 days. In Experiment 1 all ewes returned to oestrus 
after superovulation within 15 to 19 days inclusive.
The variation in cycle lengths is much greater in Experiment 2 where only 50% 
of ewes had a cycle length of between 15 and 19 days with 15% of ewes having a 
cycle length of longer than 20 days and 30% of ewes returning to oestrus 6 to 8 days 
after the induced oestrus.
Figure 5.3.3. Oestrus Cycle Length of Donors Following Induced Oestrus.
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5.3.7. The Short Cycle Donors
Six donors in Experiment 2 had an abnormally short oestrous cycle ranging 
from 6 to 8 days. It was not possible to identify any factor or treatment which was 
unique to this group of ewes. These ewes responded successfully to synchronisation, 
were identified in oestrus after sponge removal, ovulated and yielded embryos. The 
average CL count of these ewes was 10.8 - the average for ewes having normal cycles
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being 6.9. The majority of the ewes that were used had been previously primed at an 
earlier date and not used for surgical collection. However, the history of these ewes 
did not vary significantly from the other 14 donors in Experiment 2. It is possible 
that the stage of the breeding season might predispose ewes to these short oestrous 
cycles. All of the donors manifesting this anomaly were observed in the second half 
of the breeding season.
5.3.8. Recipients - Pregnancy Results
The pregnancy results are shown in Table 5.3.10. In total, 37% of transferred 
embryos were represented as foetuses when the uteri were examined at slaughter 40- 
60 days after transfer. 74% of recipients became pregnant and in these ewes 48% of 
transferred embryos were represented as foetuses. These ewes yielded a total of 35 
healthy foetuses and 1 degenerating foetus.
Table 5.3.10. Recipient Pregnant Rate.
Exp. 1 Exp. 2 Total.
Number of Recipients 16 15 31
♦Number of P+ Recipients 13 10 23
Pregnancy Rate. 81% 66% 74%
Total Number of Embryos Transferred. 51 44 95
Average Number of Embryos Transferred. 3.2 2.9 3.1
♦Total Number of Embryos in P+ Ewes. 43 30 73
Number of Foetuses Recovered. 19 16 35
Overall Embryo Survival Rate. 37% 36% 37%
♦Embryo Survival Rate in P + Ewes. 44% 53% 48%
*P+ represents those recipients which subsequently became pregnant.
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5.3.8. a) Factors Affecting Recipient Pregnancy Rate - CL Count
The average CL count of the ewes which became pregnant was 1.5 CL/ewe and 
the average CL count of the non-pregnant ewes was 1.2 CL. These results exclude 
the recipients that showed a superovulatory response. In this group ewes with CL 
counts of 3, 7 and 15 all became pregnant but a ewe with a CL count of 8 did not 
become pregnant.
5.3.8. b) Factors Affecting Recipient Pregnancy Rate - Stage Of Embryo 
Transferred
In Experiment 2 four ewes received exclusively one-cell embryos, the fertilised 
status of which was not defined and none of these ewes became pregnant. No other 
stage was significantly associated with either pregnancy or non-pregnancy.
5.3.8. c) Factors Affecting Recipient Pregnancy Rate - Embryo Status
Seven ewes received 19 unmanipulated embryos which were transferred within 6 
hours after collection. Five of these ewes were pregnant at slaughter yielding 7 
foetuses. One ewe received 3 embryos (2 of which were mock injected) which were 
cultured for 24 hours, this ewe did not establish a pregnancy. In addition, 2 ewes 
received a mixture of control and injected embryos, both of these ewes were pregnant 
but the resulting foetuses were excluded from analysis.
Twenty-one ewes received 68 microinjected embryos, this resulted in 16 
pregnancies yielding a total of 25 foetuses.
Therefore, 37% of unmanipulated embryos developed into foetuses and 37% of 
manipulated embryos developed and although the sample size is small it did not 
appear that microinjection significantly decreased the survival rate of the manipulated 
embryos (x^ =  0.02: P >  0.05). Similarly, there was no significant difference 
between the survival rates of control and manipulated embryos in those ewes which 
subsequently became pregnant, with 50% of unmanipulated embryos and 46% of 
manipulated embryos being recovered as foetuses (x^ =  0.1: P >  0.05). These 
results are shown in Table 5.3.11..
The pregnancy success results for the experimental group are improved if those 
ewes which received only one-cell embryos are excluded from the results. Of 17 
ewes which received only cleaved, injected embryos, 16 ewes were pregnant. 
Therefore, it appears that sub-zonal microinjection did not significantly affect
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subsequent viability although a small number of embryos (15%) were damaged at the 
time of microinjection and these embryos were not transferred.
Table 5.3.11. Iqjected Elmbryos - Recipient Pregnancy Rate.
Control embryos Injected embryos
Number of Recipients 7 21
♦Number of P+ Recipients. 5 16
Pregnancy Rate. 71% 76%
Total Number of Embryos Transferred. 19 68
Average Number of Embryos Transferred. 2.7 3.2
♦Total Number of Embryos in P+  Ewes. 14 54
Number of Foetuses Recovered. 7 25
Embryo Survival Rate. 37% 37%
♦Embryo Survival Rate in P+ Ewes. 50% 46%
♦P+ represents those recipients which subsequently became pregnant.
5.3.9. Efficiency Of Pregnancy Diagnosis In Recipients
None of the 23 ewes which were pregnant after embryo transfer were identified 
by the ram as being in oestrus and all of these ewes had progesterone (P4) levels 
consistent with pregnancy 17 days after transfer.
Of the 8 ewes which were ultimately not pregnant 7 were marked by the ram as 
being in oestrus and 7 had P4 levels consistent with oestrus.
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One ewe which was not marked by the ram and was subsequently found to be 
not pregnant had a high P4 level - the most likely explanation being that this ewe was 
pregnant at the time of sampling and that pregnancy was subsequently lost.
All 7 ewes which were marked by the ram and were not pregnant had a cycle 
length of 16 to 19 days inclusive and had an average cycle length of 17.7 days.
5.3.10. Embryo Migration
Seventeen ewes received 2-4 embryos in one oviduct only. At slaughter it was 
found that 8 had only one foetus on the same side as transfer, 8 ewes had one foetus 
on each side and 1 had only one foetus on the contralateral side. Therefore, embryos 
migrated in at least 9 out of the 17 ewes and of the 25 foetuses found 9 had migrated 
to the contralateral side. This confirms the finding that embryo migration is the usual 
outcome when two ova are ovulated from the one side in sheep (Doney et a l , 1973).
5.3.11. The Effect Of CL Site On Pregnancy
Five recipients, which had 1-2 CL on one ovary, received 2 embryos on each 
side. Of the ten embryos transferred into each side 7 were found on the side with the 
CL and 3 were found in the side without the CL(s).
5.3.12. Necropsy Findings
In 51 out of the 59 donor ewes and in 29 out of the 31 recipients the 
reproductive tract was retrieved at slaughter. This allowed post-operative changes to 
be examined 6-8 weeks after the operation.
There was considerable variation between ewes in the degree of post-operative 
changes recorded at slaughter. Some ewes showed very extensive changes with many 
adhesions between uterine horns, between the uterine body and the horns, between 
ovarian bursa and the ovaries and/or the ovarian bursa and the uterus. In addition, 
adhesions were also seen between the reproductive tract and other tissues such as the 
broad ligament, omentum and bladder. Other ewes, however, showed very few 
adhesions with just the occasional strand of fibrous tissue being identified. A wide 
range between these two extremes was seen. In general there was significantly less 
evidence of post-operative adhesions in the recipients compared with the donors 
reflecting the considerably greater surgical handling the donors received. It also
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appeared that a reduction in post-operative changes was correlated with an increase in 
surgical experience.
The oviducts of 32 donors were examined at post mortem in an attempt to assess 
their patency and/or the degree of bursal adhesions around the ovary. In 14 ewes it 
was possible to cannulate both oviducts, in 11, one oviduct could be cannulated and in 
7 ewes neither oviduct could be cannulated as they were either not patent or due to 
ovarian bursal adhesions access to the oviducts was not possible. Of 14 recipients 
examined, both oviducts could be cannulated in 10 ewes, in 3 ewes one side could be 
cannulated and in 1 recipient both oviducts could not be cannulated.
Interestingly, in at least 7 donors a pregnancy was established from the side that 
had an oviduct which could not be cannulated. This pregnancy was established from 
the first natural service after surgery. In 4 of these donors neither oviduct could be 
cannulated at 6-8 weeks after surgery.
5.3.13. DNA Analysis Of Foetuses
Foetuses which developed from transferred embryos were recovered from the 
uteri of pregnant recipients at slaughter 6-8 weeks after the time of transfer. A total 
of 35 healthy foetuses and one degenerating foetus were recovered.
Of these, 7 foetuses had developed from unmanipulated embryos, 3 were 
recovered from ewes which had received both injected and uninjected embryos and 25 
could only have developed from injected embryos. Seventeen of these 25 foetuses 
were analysed. DNA was prepared from both embryonic and placental tissue (where 
possible) and analysed by restriction enzyme digest and Southern blotting for the 
presence of the FeLV provirus, this work being carried out by S. Hettle.
Figure 5.3.4. is a diagrammatic representation of the FeLV provirus showing 
the relevant restriction sites. The integrated provirus should give a constant internal 
fragment of 1.2 Kb and one other fragment, greater than 0.5 Kb in length when 
completely digested with Kpn I enzyme. When digested with Hind HI two variable 
fragments should be produced, one greater than 1.3 Kb and the other greater than 5.1 
Kb.
A DNA probe corresponding to the U3 region of the provirus was used in this 
analysis. It can be seen from the autoradiograph shown in Figure 5.3.5. that the U3 
probe used did not hybridise to DNA from the uninjected foetal material (control 
samples). In addition, Figure 5.3.5. shows samples isolated from foetus 146 which 
hybridise strongly to the probe. Foetus 146 has hybridisation bands of 1.2, 3.7 and
6.5 Kb in size when digested with Kpn I and bands of 1.85, 3.6 and 6.0 Kb when 
digested with Hind III.
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Figure 5.3.4.
Diagram of the FeLV-B Provirus Showing the Relevant Restriction Sites
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Figure 5.3.5. Southern Blot Analysis of Embryonic and Placental DNAs 
Isolated from Foetus 146 and Control Foetal Tissue
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Figure 5.3.5. Southern blot analysis of embryonic and placental DNAs isolated from sub-zonally 
micro injected sheep foetus 146 and from control foetal tissue. DNAs isolated from these tissues were 
digested with restriction enzymes Kpn I and Hind III. Sizes of bands are shown in kilobase pairs (kb) 
alongside each band.
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In samples isolated from another ewe (AK805) the following hybridisation bands 
were found - 1.2 Kb, 4.4 Kb and 7.0 Kb when digested with Kpn I and 4.3, 10 and
18.5 Kb when digested with Hind III.
Placental tissue from foetus 146 was digested with Kpn I and Hind HI enzymes 
and placental tissue from AK805 was digested with Kpn 1. In all cases the results 
from the placental tissue paralleled that of the embryonic tissue.
The 1.2 Kb fragment resolved with the Kpn I digest from both foetuses, the 6.0 
Kb band from foetus 146 and the 10.0 Kb band from foetus AK805 when digested 
with Hind III were approximately double the intensity of the other bands. This 
indicates that two copies of the bands were identified within the chromosomal DNA.
Therefore, out of 17 foetuses screened 2 proved to be transgenic. FeLV 
proviral sequences were found in both the embryonic and placental tissues of both 
foetuses. The pattern of hybridising fragments in the Southern blots indicates that 
both embryos may have undergone two separate integration events i.e. the cells of 
both foetuses contain 2 proviral copies of FeLV at different integration sites. These 
results are summarised in Table 5.3.12..
Table 5.3.12. Summary of Fragment Sizes from Foetuses 146 and AK805.
Restriction 
Enzyme Used
Expected 
Fragment Sizes
Fragment 
Sizes in 
Foetus 146
Fragment 
Sizes in 
Foetus AK805
1.2 1.2 1.2
Kpn > 0.5 3.7 4.4
6.5 7.0
> 1.3 1.85 4.3
Hind III > 5.1 3.6 10.0
6.0 18.5
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INFECTION OF OVINE EMBRYOS WITH FeLV 
SECTION 5.4 - DISCUSSION
The success of sheep multiple ovulation and embryo transfer (MOET) depends 
on a number of factors. In this experiment it was important to maximise the number 
of samples available for analysis, in this case day 40 to 60 foetuses which had been 
exposed to FeLV as preimplantation embryos. It was necessary, therefore, to 
optimise those parameters which could influence the final number of developing 
foetuses. This includes factors which affect both the number of good quality embryos 
available for injection and suitable for transfer in addition to those factors which affect 
the pregnancy rate and the number of transferred embryos which develop into 
foetuses.
Factors Affecting The Supply Of Embryos
A number of different criteria are believed to affect the ovarian response to 
gonadotrophins. These include the breed (Saumaude et a l ,  1978; Armstrong and 
Evans, 1983), the age (Moore, 1982) and possibly the nutritional status (Moore,
1982). In general the more fecund breeds show a much greater response to the use of 
superovulatory drugs (Bindon et al.^ 1971). The ovarian response in breeds of 
differing fecundity appears to be correlated with the ovarian sensitivity to 
gonadotrophins and not to the circulating level of gonadotrophins (Cahill et a l,
1979). Driancourt (1987) examined those aspects of the follicular population which 
are important in the response to gonadotrophins and found that follicles greater than 2 
mm were negatively correlated and follicles of between 0.8 - 2 mm were positively 
correlated with the number of oocytes ovulated.
Sheep and other domestic species show a wide individual variation in their 
response to gonadotrophin treatment and the inability to induce a predictable and 
repeatable response remains a major constraint in embryo transfer programmes 
(Moore, 1982). This can result in either too many or too few embryos being 
available for transfer. Recipients can be reprimed if there are insufficient embryos 
available for transfer but embryo wastage can occur if large numbers of embryos are 
collected.
The type of gonadotrophin and the follicle stimulating hormone/luteinising 
hormone (FSH/LH) ratio of that gonadotrophin can influence both the average 
response and the range of the response (Chupin et a l ,  1984; Armstrong and Evans,
1983). Armstrong and Evans (1983) also found that FSH produced a higher and less 
variable response than PMSG. A dose/response relationship has been established for
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sheep, the optimal dosage varying with breed and weight of the ewes concerned 
(Moore, 1982). The use of PMSG is, at high doses, associated with an increased 
number of unovulated follicles and a corresponding decrease in the number of ova 
shed (Moore, 1982; Armstrong and Evans, 1983). The batch (Murphy et a l ,  1984) 
and the timing (Moore and Shelton, 1964) of gonadotrophin treatment can also 
influence the response.
The average response in this study was 7.1 CL/ewe with a range of 1-24 
CL/ewe. The ovulation rate of the untreated Blackface ewe is relatively low and this 
breed is not considered to be prolific. Moore (1982) has stated that the differences in 
ovulation rates between breeds are reflected by similar differences in the ovulatory 
response to exogenous gonadotrophins. The response to PMSG treatment observed 
here is compatible with results reported for breeds of similar fucundity and the 
considerable variation in the ovulatory response to PMSG previously reported was 
reflected in this study.
In 1979 Willadsen pointed out that the fertilisation rate after superovulation was 
significantly decreased in ewes with high ovulation rates. It appears that the use of 
PMSG can adversely affect both sperm transport (Evans and Armstrong, 1984) and 
sperm viability (Hawk et al. , 1987) both of which result in reduced fertilisation rates 
although this problem can be circumvented by intrauterine insemination (Trouson and 
Moore, 1974). The type of gonadotrophin used may also affect the number of 
oocytes fertilised. Schiewe et at. (1990) reported that the fertilisation rate is 
significantly higher with FSH or hMG (human Menopausal Gonadotrophin) treatment 
than with PMSG treatment. In the results reported here 45% (108/242) of all 
embryos collected were at the one-cell stage, however, it was not possible within the 
design of this current experiment to definitively establish the fertilisation status of 
these one-cell embryos. In Experiment 1, however, 62 one-cell embryos were placed 
in culture and 46 (74%) developed beyond the one-cell stage. In addition, a number 
of one-cell embryos were transferred with 4 recipients receiving a total of 11 one-cell 
embryos but none of these recipients became pregnant.
A number of factors can influence the developmental stage of embryos collected 
at a given time after synchronisation. These include the time of ovulation, the 
interval between ovulation and fertilisation and the rate of cleavage (reviewed by 
Wilmut et a l ,  1985b). Betteridge (1977) observed that variation among embryos is 
greater in animals induced to superovulate. Further, there is even greater variation 
when embryos are collected from different donors, even if they come into oestrus on 
the same day (Wilmut et a l , 1985a).
The results presented here reflect these observations. Excluding one-cell 
embryos, 16% of ewes yielded more than one stage and variation between donors was
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even greater. Some of this variation may also be due to morphologically normal but 
retarded embryos.
The collection rate in this study was 58% and there was considerable variation 
in recovery rates between ewes. No single reason could be identified to account for 
this variation as the procedure was essentially similar for all ewes. However, in 
Experiment 2 those ewes yielding only one-cell embryos had a significantly lower 
recovery rate. The overall rate of embryo recovery in this study was comparatively 
low. Gordon (1983) states that a collection rate of around 80% in embryo transfer 
programmes is common and Robinson et al. (1989) report recovery rates in excess of 
90% when using retrograde flushing of the oviduct on day 3 (oestrus day =  0).
Premature Luteal Regression
A small number of donor ewes re-entered oestrus within 6-8 days of the induced 
oestrus. Wallace et al. (1989) have defined normal luteal function as an increase in 
progesterone commencing within 4 days of behavioural oestrus and rising to exceed 1 
ng/ml for at least 8 days thereafter. These authors classified luteal function as 
inadequate when the CL either failed to secrete progesterone completely or caused a 
transient increase lasting only 12 to 36 hours. The ewes in this current study were not 
sampled daily for progesterone levels but samples taken on the day of behavioural 
oestrus were not consistent with levels found during the luteal phase. These ewes 
were not treated differently and did not appear to differ in response to treatment 
(based on ovulation counts) compared to those exhibiting normal luteal function. 
However, short cycling ewes were only observed in the second half of the breeding 
season.
Short luteal phases after exposure to the male are common during the transition 
period at the start of the breeding season (Knight et ah, 1981). In addition, induction 
of oestrus during anoestrus can result in abnormal luteal function but previous priming 
with progesterone can overcome these effects (McLeod et al., 1982).
Premature luteal regression was a frequent observation when early post partum 
ewes (day 21) were induced to ovulate (Wallace et al., 1989). The high incidence of 
inadequate luteal function was thought to be due to the high levels of prostaglandin in 
the involuting uterus - this effect was noted both during the breeding and non­
breeding season. Luteal dysfunction was also noticed in an embryo transfer 
programme in which ewes were synchronised using the prostaglandin PGF2a. The 
abnormal luteal function in this study did not correlate with the superovulatory 
hormone used but was associated with the PGF2a treatment (Schiewe et al., 1990). 
The association between prostaglandin treatment and premature luteal regression had
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previously been reported by Willadsen in 1979. Willadsen also stated that premature 
luteal regression had also been observed in PMSG treated ewes which were not 
injected with prostaglandins. In cyclic goats superovulated with PMSG premature 
luteal regression occurs regardless of whether progesterone intravaginal pessaries 
(MAP - 6 alpha - methyl - 17 alpha - acetoxyprogesterone) or prostaglandin injections 
(PGF2a) were used for synchronisation (Armstrong et aL, 1982; Armstrong et aA, 
1983a; Armstong et al., 1983b; Stubbing et al., 1986). Armstrong et al. (1983a) 
have suggested that in goats multiple ovulation induction can give rise to abnormal 
endocrine events which in turn cause release of endogenous PGF2of from follicles or 
uterus.
In 1991 Schiewe et al. specifically examined the phenomenon of premature 
luteal regression (PLR) and found that its occurrence was associated with the use of 
PGF2a although one the of eight ewes in the study, synchronised with medroxy 
progesterone acetate, also showed PLR. Further, these authors noted that in ewes 
undergoing premature luteal regression progesterone secretion was compromised 
within 60 hours of ovulation and that a reduction in the number of small luteal cells 
was evident three days after oestrus. Schiewe et al. (1990) have summarised the 
factors which may be contributory to abnormal luteal function as: inadequate hormone 
preparation of the preovulatory follicle; early release of a luteolysin and 
hypersensitivity of the luteal tissue to a luteolysin.
However, it is not clear what role these factors play in the short oestrus cycles 
observed in the present study as none of the predisposing factors previously described 
were relevant to the design of this study.
Factors Affecting Embryo Survival And Pregnancy Rate
An average of three embryos were transferred to each ewe and 74% of 
recipients were pregnant 40-60 days after transfer. Only 37% of transferred embryos 
were recovered as morphologically normal foetuses after day 40 of gestation. 
However, 48% of those embryos transferred to ewes which subsequently became 
pregnant developed beyond day 40.
In breeding ewes, maintained in good conditions, embryonic mortality has been 
estimated at 20-30% (Edey, 1979). Although chromosomal abnormalities, 
approximately 6% (Long and Williams, 1980), are responsible for a proportion of this 
mortality, all of the factors which contribute to this early embryonic loss have not 
been elucidated. Ashworth et al. (1989) have suggested that embryo survival can be 
influenced by periovulatory plasma progesterone concentrations and that variations in 
progesterone concentration could contribute to embryo loss. Williams and Long 
(1980) examined superovulated oocytes and embryos and found that the incidence of
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chromosomal abnormalities associated with fertilisation was significantly increased in 
these embryos. The earlier in development such embryos are collected the greater the 
likelihood that they will be classified as normal and transferred.
The recovery and short term storage of embryos exposes them to a variety of 
potential insults which could adversely affect subsequent development. These include 
fluctuations in temperature and osmolarity of the handling media (Brinster, 1965a). 
Certain batches of serum have been shown to be toxic to embryos (Kane, 1987) and 
toxicity can also arise from other sources such as ethylene oxide residues present on 
equipment coming into contact with media (Schiewe et al. , 1984).
Effect Of Sub-Zonal Viral Injection On Embryo Development
There was no significant difference between the survival rates of manipulated 
and unmanipulated embryos or between the pregnancy rates of ewes receiving either 
unmanipulated or manipulated embryos.
Sub-zonal viral injection is less invasive than pronuclear microinjection as the 
integrity of the plasma and nuclear membranes is not breached in this technique. In 
this study 15% of embryos were assessed as being damaged by the procedure and 
were not transferred. Other workers report that pronuclear microinjection results in 
49% (Ward et a l ,  1986) to 30% (I. Wilmut, pers. comm.) of embryos being lysed.
Rexroad and Wall (1987) investigated the effects of pronuclear microinjection 
on early embryonic development. Twenty-nine percent of microinjected embryos and 
86% of unmanipulated embryos transferred to synchronised recipients developed 
beyond the thirty-two cell stage. However, most published data on the effects of 
pronuclear injection on embryo development is based on the number of live lambs 
bom (Hammer et al. , 1985; Murray et al. , 1988; Simons et al. , 1988).
Simons et al, (1988) also noted the number of midgestation foetuses. These 
workers transferred a total of 511 embryos. One hundred and nineteen foetuses 
(23%) were identified at midgestation by ultrasonic scanning and 92 live lambs and 17 
dead foetuses were recovered at term. This group have observed, using ultrasonic 
scanning, that foetal death of injected eggs continues to occur throughout pregnancy 
(Wilmut cr û/., 1990).
Although recipients were culled at the end of the first trimester of pregnancy in 
this study, it appears that embryo survival rates of subzonally injected embryos were 
comparable with standard embryo transfer results but superior to survival rates 
observed after pronuclear microinjection.
Pregnancy rates and the proportion of embryos represented by foetuses increases 
if transfers involving one-cell embryos are excluded from the results. Of those
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recipients receiving only injected cleaved stages 15 out of 16 were pregnant and 46 % 
of transferred embryos were recovered as foetuses.
Hammer et al. (1985) were the first to produce a transgenic sheep and these 
workers reported an integration frequency of 1.3%. This figure was considerably 
below the integration frequency quoted for mice leading some authors to suggest that 
there may be some intrinsic species differences limiting the efficiency of gene 
integration in sheep (Ward et al. , 1986) or that conditions for ovine microinjection 
were suboptimal (Pursel et al., 1987). However, more recent reports suggest that 
integration frequencies in sheep comparable with the range reported in mice can be 
achieved. Simons et al., (1988) have reported that 6 lambs out of 92 screened were 
transgenic, an integration frequency of 6.5% and Murray et al. (1988) reported 7 
transgenic lambs from 93 screened (7.5%) although the overall efficiency was low 
with only 0.5% of injected embryos resulting in a transgenic lamb.
In this study proviral sequences were detected in 2 foetuses out of 17, an 
integration frequency of 11.8%. Although the numbers involved were small it does 
indicate that retroviral vectors may allow genes to be transferred into sheep embryos 
at a greater frequency than can be achieved by pronuclear injection. The overall 
efficiency reported by Wilmut et al. (1990), based on the number of injected embryos 
resulting in transgenic animals, is 0.84%. The overall efficiency of the work 
presented here is 3.7% although the results cannot be directly compared as the end 
point of this experiment was the day 40 to day 60 foetus.
The results presented here show that it is possible for FeLV to infect the early 
ovine embryo and that the resulting provirus can integrate into the ovine genome. 
Three different methods have been used to produce transgenic mice: pronuclear 
microinjection (Gordon et a l ,  1980); the use of retroviral vectors to infect early 
embryos (Van der Putten et a l ,  1985) and the introduction of gene sequences into 
embryonic stem cells which are then used to generate chimeric animals (Bradley et 
a l ,  1984; Robertson et a l ,  1986). However, only pronuclear injection has been 
successfully used to produce transgenic domestic animals. Three factors make the 
production of transgenic livestock by pronuclear microinjection more difficult than in 
mice (Wilmut et a l ,  1990): fewer embryos are available; there is greater variability 
in the developmental stage recovered and the presence of cytoplasmic vesicles in the 
embryos of domestic animals obscures the pronuclei. In sheep, differential 
interference contrast microscopy (DIG) allows the pronuclei to be visualised and this 
problem has been overcome in cattle and pig embryos by the combined use of 
centrifugation and DIG (Pursel et a l ,  1989). Despite these problems transgenic pigs, 
sheep (Hammer et a l , 1985) and cattle (Roshlau et al., 1989) have been produced by 
a number of groups using pronuclear microinjection.
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The use of retroviral vectors could circumvent some of these problems. The 
cell stage does not appear to be critical as there are no data to suggest that infectivity 
varies between different preimplantation stages although the more advanced the 
embryo stage, the more likely the resulting founder animal will be mosaic (Van der 
Putten, 1985; Husar et al., 1985; Rubinstein et al., 1986). The approach described 
here is technically less demanding and considerably less invasive than pronuclear 
microinjection.
The frequency of proviral integration in the foetuses analysed was 11.8% 
suggesting that the development of this approach may increase the efficiency of 
producing transgenic sheep.
Wild type retrovirus (Jaenisch, 1976; Jaenisch et al., 1981; Soriano and 
Jaenisch, 1986a), retroviral vectors (Van der Putten, 1985; Husar et al., 1985; 
Rubinstein et al., 1986; Soriano et al., 1986b) or a combination of both have been 
used to transfer gene sequences into the early embryos of mice. The overall 
efficiency of using retroviruses to produce transgenic mice appears to be highly 
dependent on the titre of virus used. At high titres greater than 50% of offspring 
carry proviral sequences (Jaenisch, 1976; Jaenisch et al., 1981; Soriano and Jaenisch, 
1986a).
Mouse embryos are usually infected by removing the zona pellucida and co- 
cultivating them with cells which actively release retroviral particles for between 12- 
24 hours (Van der Putten et al., 1985). As retrovirons are unstable at 37° C this 
approach exposes the blastomeres to infecting particles for extended periods of time. 
This study demonstrates that for infection to occur, prolonged exposure to freshly 
released viral particles was not required.
As whole foetuses were analysed by Southern blotting it was not possible to 
estimate the degree of mosaicism and there is no direct evidence to suggest that 
integration of proviral sequences occurred before these cell lineages diverged. 
Differentiation of foetal tissue from placental tissue occurs before that of cell lineages 
within the foetus (Noden and DeLahunta, 1985). It appears likely, therefore, that all 
foetal cells, including the germ cells, contained the proviral sequences. Production of 
transgenic lines of mice using retroviruses or retroviral vectors is readily achieved 
despite the high levels of mosaicism that result from infecting early embryos. The 
embryos in this study were infected at the two-cell to four-cell stage of development, 
whereas in similar studies producing transgenic mice, embryos were usually infected 
at a slightly later stage of development (two-cell to sixteen-cell stage, Rubenstein et 
al., 1986; Van der Putten et al., 1985; Husar et a l ,  1985). It is, therefore, likely 
that the mosaicism of these transgenic foetuses would be less than that seen in mouse 
studies.
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Embryonic activation in mouse embryos occurs at the two-cell stage (Bolton et 
al., 1984). As retroviral infection of mouse embryos has been carried out at or after 
this stage it is not known whether the cellular receptors utilised by the retrovirus were 
of maternal or embryonic origin. As embryonic activation does not occur until the 
eight to sixteen cell stage in the sheep embryo the viral receptors exploited in this 
experiment were likely to be of maternal origin. This raises the possibility that it 
may be feasible to infect sheep embryos earlier than the two to four cell stage such as 
one-cell embryos or even oocytes.
In conclusion, these results show that FeLV is capable of infecting ovine 
embryos and that the technique used to infect these embryos was not especially 
deleterious to subsequent development.
At present it is unlikely that this method will gain widespread acceptance for 
developing lines of transgenic sheep for release to the commercial sector. Experience 
with the mouse model has shown that complex interactions between endogenous and 
exogenous retroviral sequences are unpredictable and not uncommon. It is likely, 
therefore, that transgenic sheep produced by this method would be restricted to 
research usage unless long term work in this field reveals that such fears are 
unconfirmed.
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CHAPTER 6 - A TRANSGENIC MOUSE MODEL OF T-CELL LYMPHOMA
SECTION 6.1. - INTRODUCTION
In this chapter the production of two lines of transgenic mice is described and 
the phenotypic changes caused by their altered genotype analysed. The action of the 
human c-myc proto-oncogene was targeted to the T-cell compartment by linking the c- 
myc gene to the dominant control region (DCR) of the human CD2 gene. The 
resulting transgenic lines showed a predisposition for T-cell lymphoma. The 
incidence of tumour development was relatively low with only 16% of mice 
succumbing over a wide age range. Significant pre-neoplastic changes in 
haematopoetic cell populations were not observed and transgene expression could not 
be detected in healthy lymphoid tissues. However, high levels of transgene 
expression were present in all of the resulting tumours. These results suggest that the 
presence of the CD2-myc transgene predisposed these mice to T-cell lymphomas but 
that random activation events were required to initiate tumourigenesis. This 
hypothesis is supported by the finding that MuLV infection of CD2~myc mice greatly 
accelerated tumour formation.
Using Transgenic Mice To Study The In Vivo Action Of Oncogenes
The evidence that genetic damage is intrinsic to tumour development comes 
from separate and distinct lines of oncology research. A fundamental observation is 
that cancer cells very often manifest chromosomal damage (Knudson, 1987; Knudson, 
1986; Yunis, 1983). Such chromosomal aberrations can result in the loss of gene 
function due to coding and regulatory sequences being disrupted. The perturbation of 
transcriptional control can occur following the translocation of a gene when that gene 
comes under the influence of different regulatory regions (Adams et al. , 1983). Gene 
amplifications can also result in an alteration of the expression potential of genes 
(Collins and Groudine, 1982; Yokota et a l ,  1986).
The long-standing observation that mutagenic agents can also be carcinogenic, 
that there appears to be a hereditary predisposition for some forms of cancer (Ponder,
1980) and that the susceptibility to tumour development is negatively correlated with 
the efficiency of DNA repair mechanisms (Hanawalt and Sarasin, 1986) all emphasise 
the importance of genetic damage in the process of oncogenesis.
Increasingly, knowledge is being acquired pertaining to those cellular genes 
which have a role to play in the control of growth and differentiation. The mutation 
or inappropriate expression of these genes can change the normal cellular gene (proto­
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oncogene) into a gene which is capable of collaborating in a series of events which 
ultimately result in tumour development. The genetic targets of these changes broadly 
fall into two categories depending on whether regulatory or structural changes result 
in increased expression or biological efficiency (oncogenes) or whether the genes are 
down regulated or their functional competence inhibited (tumour suppressor genes). 
Whereas oncogenes exert their effect in a dominant fashion, due to the presence of the 
gene product, tumour suppressor genes are recessive as it is the absence of the gene 
product which results in the increased susceptibility to tumourigenesis.
Retroviruses play an important role in oncogenesis, particularly in the 
development of animal tumours. Research into retroviral induced tumourigenesis and 
retroviral biology in general have greatly extended our understanding of the genetic 
basis of cancer (for review see Tsichlis and Lazo, 1991). Retroviruses are self- 
perpetuating mutagenic agents as they have the ability to integrate into the host 
genome, this process being an essential part of the retroviral lifecycle.
Recombination events between viral and cellular sequences can result in the host 
gene being captured by the retrovirus and being moved from cell to cell, from 
chromosomal position to position and even from animal to animal. This process, 
known as transduction, has resulted in the identification of a large number of 
oncogenes (Varmus, 1982, Bishop, 1983). Retroviruses carrying cellular gene 
sequences with transforming potential are known as acutely transforming retroviruses 
and were identified as far back as 1911 when Rous discovered that chicken sarcomas 
could harbour an infectious tumourigenic agent. Initially, these sequences were 
considered to be viral in origin but later analysis showed them to be homologues of 
cellular genes and it was realised that host cells harboured genes with an oncogenic 
potential - the proto-oncogenes (Bishop and Varmus, 1985; Bishop, 1987). However, 
the transduction of cellular oncogenes is not a prerequisite for retroviral induced 
tumourigenesis as the process of proviral insertion can itself be mutagenic (for review 
see Tsichlis and Lazo, 1991). Insertion close to or within cellular genes involved in 
growth or differentiation can result in the activation of these genes because of the 
promoter and the enhancer sequences contained within the provirus. If this process 
results in the activation of a gene which confers a selective advantage on the cell then 
this event can contribute to neoplastic development. This was demonstrated in 1981 
when proviral insertion was shown to activate the proto-oncogene myc (Neel et a l ,  
1981; Hayward et a l ,  1981). The natural and experimental infection of animals with 
a variety of retroviruses has resulted in a host of oncogenes being discovered (Tsichlis 
and Lazo, 1991).
Oncogenes have the ability to assist in neoplastic development due to their 
involvement in the transduction of signals responsible for growth and differentiation 
but within this generic term these genes have different sites of action and perform
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different functions. Genes coding for growth factors, growth factor receptors, 
membrane associated or cytoplasmic proteins involved in signal transduction and 
nuclear proteins can all participate in oncogenesis as a consequence of alterations in 
their structure or expression potential.
It would appear likely that increased or constitutive expression of growth factors 
will cause the pathological expansion of specific cell groups, a process which may 
contribute to tumour development in vivo. In vitro, the progression from growth 
factor dependent to growth factor independent proliferation is considered a definitive 
event in the multistep progression to the tumour phenotype.
It is not necessary for growth factors to be secreted from the cell in order to 
carry out their function. Dunbar et al. (1989) have shown that interleukin-3 (IL-3) 
retained within the cell can function in an autocrine manner to support growth. 
Examples of proviral insertion deregulating endogenous growth factors include: a 
myelomonocytic leukaemia cell line in which the IL-3 gene is constitutively expressed 
(Ymer et al., 1985) and mutant haemopoeitic cells which are growth factor 
independent due to proviral induced deregulation of granulocyte-macrophage colony- 
stimulating factor (Stocking et al., 1988). In addition, there is evidence to suggest that 
insertional mutagenesis of colony-stimulating factor-1 (CSF-1) may have co-operated 
with myc in inducing myelomonocytic tumours (Baumbach et ah, 1988).
Growth factor receptors also appear to be potential oncogenes. Analysis of 
murine myeloid tumours induced by F-MuLV revealed that in a proportion of the 
resultant tumours proviral insertion had activated the c-ftns proto-oncogene (Sola et 
al., 1988), the function of which is to act as a receptor for CSF-1. Examples of 
membrane associated proteins are coded for by the ras gene family, members of 
which can give rise to products with oncogenic properties when present in mutated 
forms.
The ras gene family is composed of three closely related members; c-Ha-ras, c- 
Ki-ros and N-ray. Ha-r^w and Ki-ras are the cellular homologues of the oncogenes 
found in the Harvey and Kirsten strains of murine sarcoma retroviruses. The products 
of these genes are located in the inner aspect of the cell membrane and are involved in 
the transduction of signals associated with mitogenic stimuli. Mutations of these 
genes can result in an increase in the biological potency of the resultant products, due, 
at least in part, to an alteration of the capacity of the cells to regulate these proteins 
(Rayter et ah, 1989). The ras superfamily appears to be involved in a large number 
of cellular activities and is regulated in a complex manner which operates at a variety 
of different levels (for review see Evans et al., 1991). One interaction which has 
recently been demonstrated is that which exists between platelet derived growth factor 
receptor and ras. The addition of platelet derived growth factor (PDGF) to quiescent 
cells results in increased phosphorylation of tyrosine residues of the roj-GAP
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(GTPase-activating protein) protein complex (Molloy et al., 1989). The ras gene 
product has been shown to be capable of complementing a number of nuclear 
oncogenes, including myc, in the development of the tumour phenotype (Langdon et 
al., 1988). Other oncogene products which operate in the cytoplasm or associated 
with the cell membrane include the pim-l product which is a serine/threonine kinase 
(Selten et al., 1986; Domen et al., 1987).
Nuclear Oncogenes
A number of oncogenes code for proteins which function within the nucleus. 
This group includes the myc oncogenes, a gene family comprised of three well 
characterised genes (c-myc, N-myc and L-myc) and three more poorly defined genes - 
R-myc, S-myc, and h-myc (DePinho et al., 1987; Ingvarsson et al., 1988). C-myc, 
N-myc and L-myc are functionally very similar, share extensive regions of homology 
and are functionally conserved across the vertebrate species (for reviews see Cole, 
1986; Kelly and Siebenlist, 1986).
C-myc is expressed in a wide variety of tissues and is associated with cellular 
proliferation, in contrast, the expression pattern of N-myc and L-myc is restricted to 
specific cell lineages, usually at an early stage in that lineages differentiation 
(Mugrauer et al., 1988; Downs et al., 1989). Whereas N and L-myc expression is 
mainly confined to developing tissues c-myc expression is much more ubiquitous 
being found in both developing and mature tissues (Zimmerman et a l ,  1986).
This expression pattern is consistent with the role these genes play in neoplastic 
development. C-myc was first identified in chicken sarcomas induced by Avian 
Leukosis Virus (Neel et al., 1981; Hayward et al., 1981). Since that time c-myc 
involvement has been detected in a wide variety of tumours and is the gene most 
frequently found to be activated by retroviral induced insertional mutagenesis (Tsichlis 
and Lazo, 1991). Activation of N and L-myc is associated with a more restricted 
tumour type, N-myc having been shown to be involved in tumours of primitive cell 
origin and T-cell tumours (Nisen et al., 1986; van Lohuizen et al., 1989a) whereas 
activated L-myc has been found in small cell lung carcinomas (Nau et al., 1985). 
Unlike the ras oncogene, the product of which is a mutant form of the normal cellular 
protein, the c-myc proto-oncogene participates in tumourigenesis as a result of 
inappropriate expression of the normal cellular protein (Leder et al., 1983; Cole, 
1986).
There is strong circumstantial evidence that myc can function as a transcriptional 
factor but definitive proof for this role is still lacking. The c-myc product is thought 
to be involved in gene regulation due to its nuclear localisation and its ability to bind 
DNA. The protein contains structural domains, specifically the helix-loop-helix
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(HLH) and leucine zipper (LZ) motifs, which are common to a number of 
transcriptional factors (Landschulz, et a l ,  1988; Murre et al., 1989). Further, c-myc 
can regulate its own expression, the deregulation of c-myc due to translocation as 
occurs in Burldtt's lymphoma results in the transcriptional suppression of the 
remaining allele (Dunnick et a l ,  1983; Leder et a l ,  1983). Similarly, targeted 
expression of myc transgenes results in the transcriptional activity of the endogenous 
gene being repressed (Adams et a l ,  1985). Whether this acts directly or is mediated 
through other factors is not clear as Stewart et al. (1984) have described a situation 
where autoregulation of myc expression does not appear to occur. It is now known 
that the myc interacts with another cellular protein named max. Myc and max bind 
more strongly than myc does to itself and this heterodimer has been reported to bind a 
specific DNA sequence (Blackwood and Eisenman, 1991).
Myc may also play a role in DNA replication as the addition of anti-sense oligo­
nucleotides to human peripheral T-cells results in inhibition of DNA synthesis 
(Heikkila et a l ,  1987). Iguchi-Ariga et al. (1987) have shown that c-myc 
immunoprecipitates with a putative origin of replication and Classon et al. (1987) 
reported that levels of c-myc were correlated with extrachromosomal replication of 
SV40 DNA. However, Kaczmarek et al. (1986) reported that fibroblasts were 
capable of entering S-phase despite the presence of c-myc specific antibodies.
That myc is intimately involved in cellular self-renewal is beyond doubt. The 
introduction of myc into primary cell lines can result in proliferation (Palmier! et al.,
1983), growth factor independence (Rapp et a l ,  1985) and immortalisation of the cell 
line (Mougneau et a l ,  1984; Bartlett et a l ,  1988; Land et a l ,  1986) whereas, the 
introduction into a previously immortalised cell line can result in transformation 
(Kelekar and Cole, 1986; Keath et a l ,  1984). This growth stimulatory affect in vivo 
manifests itself in hyperplasia of targeted tissues in transgenic mice (Langdon et a l , 
1986) and by the involvement of myc in many different tumours.
Further endogenous myc levels seem to be positively correlated with 
proliferating tissue (Makino et a l ,  1984) and suppressed in tissues approaching 
terminal differentiation (Lachman and Skoultchi, 1984; Griep and Deluca, 1986). 
The addition of specific growth factors to quiescent cells to induce growth is 
correlated with increased levels of c-myc expression (Kelly et a l ,  1983; Coughlin et 
a l ,  1985), whilst the overproduction of myc appears to block differentiation 
(Prochownik and Kukowsa, 1986) and the application of c-myc antisense RNA to cell 
lines accelerates terminal differentiation (Griep and Westphal, 1988). There is little 
evidence to suggest that myc alone is capable of transforming cells or tissues to the 
fully malignant phenotype. In primary cell lines the active presence of another 
oncogene, typically ras, is required for transformation (Land et a l ,  1983) and in 
transgenic mice expressing exogenous c-myc further events as defined by clonality and
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kinetics of tumour development appear to be required for the fully neoplasic 
phenotype to be expressed (Adams and Cory, 1991).
Tum our Suppressor Genes
The term oncogene describes those genes in which the mutation or deregulated 
expression of the gene increases the likelihood of a cell undergoing transformation. 
Tumour suppressor genes can be defined as those genes which express a protein, the 
presence of which makes transformation of a cell less likely.
Mutations abrogating the function of these genes are likely to be recessive as it 
is the absence of the gene product which contributes to tumour development and for 
this to occur, inactivation of both alleles is required. Two such genes have attracted 
considerable interest, the p53 gene and the Retinoblastoma Susceptibility gene (RB). 
The Li-Fraumeni syndrome of humans is a genetically inherited condition in which 
one of the two p53 alleles is non-functional due to a point mutation. Subsequent 
somatic mutations of the remaining alleles renders people with this genotype 
vulnerable to tumour formation (Srivastava et al., 1990). The addition of the wild- 
type p53 gene to transformed cell lines reduces their growth rate (Baker et al., 1990) 
and the wild type gene can inhibit transformation in cells expressing mutant p53 and 
ras genes (Finley et al., 1989). Some indication of the importance of this gene in 
preventing tumour development is realised by a recent publication which revealed that 
mutations in the p53 gene are the most frequently observed genetic lesion in 
spontaneous human tumours (Vogelstein, 1990)
Retroviral induced insertional mutagenesis of the p53 allele has been reported. 
Wolf and Rotter (1984) have described an Abelson MuLV induced tumour cell line in 
which proviral insertion caused functional deletion of the p53 product, the presence of 
the normal allele could not be detected, presumably because it was also deleted. 
Hicks and Mowat (1988) have characterised a cell line derived from F-MuLV induced 
erythroleukaemias in which independent proviral integration in both alleles was 
detected.
Another tumour suppressor gene is the Retinoblastoma Susceptibility gene (RB). 
A predisposition for the childhood cancer retinoblastoma can be an inherited condition 
due to germline loss of one of the two alleles coding for the RB gene product. 
Subsequent somatic damage to the other allele leads to the tumour phenotype. 
Treatment and survival of patients with this condition revealed that they were prone to 
a large number of other tumours later in life.
146
Using Transgenic Mice To Study Oncogenesis
Transgenic mice have proved to be a valuable resource for the investigation of 
oncogene function and the tumourigenic process in general as these animals allow an 
investigation into the consequences of specific gene expression in specific tissues in 
vivo (for reviews see: Adams and Cory, 1991; Cardiff et al., 1991; Pattengale et al., 
1989; Hanahan, 1988, Bems et al., 1989). As well as complementing tissue culture 
studies, and other in vivo models, the transgenic system has a number of unique 
advantages.
The action of an oncogene or putative oncogene can be investigated by 
expressing the gene and characterising the resulting phenotypic changes. Expression 
can be either broad spectrum using constitutive regulatory sequences or targeted to a 
specific tissue. In this way the manner in which an oncogene functions within a 
particular tissue context can be better understood allowing the question of 
complementation between specific tissue types and oncogenes to be addressed. The 
presence of the transgene in the germline results in mice that have a hereditary 
predisposition to a particular tumour type and the generation of transgenic mice 
carrying oncogenes can therefore result in the establishment of a permanent resource. 
Indeed, the targeting of a specific tissue with an appropriate oncogene can be a means 
of generating particular cell lines which would not normally be available. In the 
transgenic model the ability to target oncogene expression to specific tissues is limited 
only by the availability of suitable regulatory signals, whereas in vitro studies are 
restricted by those cell lines which are amenable to study.
Transgenic studies have lent credence to the hypothesis that a series of events 
are required to bring about the truly malignant phenotype. The knowledge that an 
animal is likely to develop a specific tumour at a particular age range allows a detailed 
and wide ranging investigation of those crucial early events which precede the fully 
neoplastic phenotype. In addition, those secondary events which induce the 
manifestation of the fully malignant tumour can be examined using a series of tumour 
tissues all of which were subjected to common initiating events. Finally, transgenic 
mice allow the synergy between different oncogenes to be examined within the 
context of the living animal, this being achieved either by crossbreeding different 
transgenic lines or by infecting mice with retroviruses carrying viral oncogenes.
The E/i-Myc Mice
The first study to use transgenic mice as a model system for leukaemic 
conditions utilised the Ep-myc construct (Adams et al., 1985) and since that time mice
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bearing this construct have been studied extensively (Langdon et al. , 1986; Harris et 
a l ,  1988b; Sidman et a l ,  1988; Strasser et a l ,  1990; Rosenbaum et a l ,  1990; 
Adams and Cory, 1991; Haupt et a l ,  1991). Translocations which place the c-myc 
gene under the influence of immunoglobin regulatory elements can result in the 
development of Burkitt's lymphoma in humans and mouse plasmacytomas (for review 
see Cory, 1986). In these transgenic mice, expression of the human c-myc gene is 
regulated by the immunoglobin heavy chain enhancer (Ep) in order to mimic the 
situation which arises after these translocations.
A high incidence of lymphoma development was found in the resulting 
transgenic mice with 90% of offspring dying by 4 months of age. All of the tumours 
occurred within the B-cell lineage with the target cell being either the pre-B or B-cell. 
None of the tumours examined carried the T-cell marker Thy-1 (Adams et a l ,  1985). 
The c-myc gene carrying its own regulatory elements was also introduced into the 
mouse germline in this study but this construct failed to produce any observable effect 
in the recipient mice.
Follow-up studies with these transgenic mice revealed that myc expression could 
induce preneoplastic changes within the B-cell lineage (Langdon et a l ,  1986). Early 
stages had a greatly expanded population of pre-B cells with a reduced number of 
mature B-cells. These pre B-cells were large and blast like in appearance, a higher 
proportion than normal were proliferating and they were found in profusion outside 
the bone marrow instead of being restricted to this site. These results clearly showèd 
that myc could increase cell cycle activity in this target cell. These cells did not, 
however, produce tumours when cells were transferred to histocompatible recipients 
(Langdon et a l ,  1986) and were not autonomous in culture (Harris et a l ,  1988a). 
The involvement of two cell types (pre-B and B-cells) in tumour development implies 
that myc induced tumourigenicity is not restricted to the one stage and/or that with 
some clones differentiation occurs after transformation. That the latter is possible was 
demonstrated when pre-B tumour cell lines were cultured in vitro and it was found 
that these cells could undergo maturation to the mature B-cell phenotype (Harris et 
a l ,  1988b). It has been suggested that high levels of myc expression can block 
differentiation (Prochownik and Kukowsa, 1986) but these results imply that at least a 
degree of differentiation can occur in these mice. The ability of cells to differentiate 
while heavily under the influence of myc has also been reported by Spanopoulou et al.
(1989). T-cells transformed by myc at the double positive stage (CD4-I-, CD8+) can 
progress to the more mature single positive stage.
The development of only monoclonal or oligoclonal tumours suggested that 
subsequent events are required for the c-myc expressing cell to progress to the fully 
transformed phenotype (Adams et a l , 1985). This observation appears to be true for 
most transgenic mice expressing oncogenes in both lymphoid (Moroy et a l ,  1990;
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Hariharan et al., 1989; Spanopoulou et al., 1989; Rosenbaum et al., 1989; Yee et 
al., 1989;) and non-lymphoid tissues (for review see Hanahan, 1988) with only a few 
exceptions being reported (Quaife et al., 1987; Bautch et al., 1987; Williams et a l ,  
1988; Muller et al., 1988). Adams and Cory (1991) have postulated that the presence 
of a large population of progenitor cells susceptible to transformation made the 
likelihood of secondary events very high, ultimately leading to the development of 
fully malignant clones. This hypothesis is supported by the finding that on different 
genetic backgrounds the size of the expanded pre-B cell population, induced by the E/* 
-myc transgene, varied and that this variation correlated with tumour incidence 
(Adams and Cory, 1991). However, in many oncogene-bearing transgenic mice pre­
neoplastic, disturbances do not occur or are too subtle to be detected.
Influence Of Genetic Background On Oncogene Action
Working with the lac Z gene Allen et al. (1990) have compared mice of 
different genetic backgrounds carrying the same transgene. These authors found that 
the temporal and spatial pattern of the transgene was not altered but that the level of 
transgene expression differed markedly indicating that different genetic backgrounds 
could either permit or restrict transgene expression. Harris et al. (1988a) found that 
the genetic background could affect both the kinetics and the susceptibility of mice 
carrying the myc transgene. A low rate of tumour development (6% per week) and an 
average lifespan of 16 weeks was found in C57BL/6 mice whereas on an SJL 
background tumours developed at a linear rate of 36% per week and the average 
lifespan was reduced to 7 weeks. Balb/c mice represented an intermediate phenotype 
with these mice developing tumours early in life but the subsequent rate of onset being 
fairly low. Yukawa et al. (1989) compared the Ep-myc transgene in pure-bred 
C57BL/6(B6) and C3H/HeJ mice and found that whilst B6 mice developed 
lymphomas of the B-cell lineage - like all previous descriptions of the Ep-myc 
transgene - C3H/HeJ mice developed mainly T-cell lymphomas. It would appear, 
therefore, that the genetic background can affect not only the kinetics and rate of 
tumour onset but also the lineage. The reasons for the change in target cell are not 
fully understood as Yukawa et al. (1989) reported that myc expression occurs in both 
cell types and there is no preferential activation of either cell. These studies highlight 
the difficulty in extrapolating too much information from the effects of the transgene 
in one particular strain or hybrid of mouse as interactions between transgene and 
genetic background can alter the outcome.
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Tissue Specificity Of Oncogenic Transgenes
Using the same regulatory unit allows the actions of different oncogenes to be 
compared within a particular tissue compartment. Adams and Cory (1991) and others 
(Rosenbaum et al., 1990; Moroy et al., 1990; Harris et al., 1988a; Rosenbaum et al. , 
1989; Harris et al., 1988b; Harris et al., 1990; van Lohuizen et al., 1989b) have used 
the immunoglobin enhancer (Ep) regulatory unit to pursue this approach and have 
compared a number of different oncogenes with this system. One caveat with this 
approach is that sequences associated with the transgene itself may affect the resultant 
expression pattern. A good example of this has been reported by Moroy et al.,
(1990). These workers produced transgenic mice carrying the L-myc gene regulated 
by the immunoglobin heavy chain enhancer (Ep) but unlike the analogous Ep-N-wyc 
mice which express the transgene in the B-cell compartment Bp-L-myc mice 
preferentially express the transgene in the T-cell lineage. The result is that Ep-N-myc 
display a B-cell disturbance and almost all develop tumours of the B-cell lineage 
(Rosenbaum et al., 1989) whereas Ep-L-myc mice have an expanded T-cell 
population and develop mainly T-cell tumours.
However, the targeting of different oncogenes to the same tissue can yield 
information on how tissue type complements oncogene action. For example the Ep 
regulatory unit has been used to target both myc (Adams et al., 1985) and \-abl 
(Rosenbaum et al., 1990) expression. In both cases expression occurs at high levels 
in B-cells but whereas myc produces pre-B and B-cell tumours, only plasmacytomas 
arose in three out of the four E\x-w-abl transgenic lines generated with the w-abl 
construct, implying that the plasma cell is especially vulnerable to abl transformation 
in these lines. The development of plasmacytomas in these mice often appeared to 
require spontaneous activation of the myc gene as rearrangement of the endogenous 
myc gene was found in over 80% of tumours analysed.
In w-abl mice the transgene appears to be active in both B and T-cell lineages, 
indeed, in one of the three lines expression was highest in the thymus. Despite this, 
only plasmacytomas arose in these three transgenic lines. To complicate the picture, 
the fourth transgenic line (y-abl-l) developed pre-B and T lymphomas but no 
plasmacytomas (Harris et al., 1990). Therefore it would appear that the integration 
site altered the target cell, although the possibility that rearrangements of the 
transgene or its regulatory sequences cannot be excluded. In this line 70% of animals 
succumbed to tumour development within the first year of life, 18% of these mice 
developed pre-B cell malignancy and 82% developed T-cell malignancy but the 
susceptibility to these two different tumours was age restricted. Pre-B cell tumours 
were only seen in the first 10 weeks of life, after which only T-cell tumours arose.
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Van Lohuizen et al. (1989b) introduced the Ep-pim-1 construct into mice and 
although the pim-l gene was expressed in both T and B-cells, almost all tumours in 
mice bearing the pim-l gene were of the T-cell lineage. Whether this is due to the 
background strain of mouse used, the regulatory signals incorporated into the 
transgene, which include the Ep enhancer and the MuLV long terminal repeat and 
enhancer, or was intrinsic to the action of pim-l itself is not known.
Further evidence that different tissues respond differently to expression of the 
same oncogene is exemplified by the Jps transgenic mice in which expression was 
observed in a large number of tissues not all of which became transformed (Yee et 
al., 1989). In particular, no myocardial tumours arose despite high levels of 
expression in the heart. Other tissues which expressed the transgene (such as the 
brain, the testes and the lungs) developed either no tumours or only benign tumours. 
This oncogene is a member of a family of genes which code for non-receptor protein 
kinases and these mice showed a high incidence of thyomas and lymphomas causing 
the authors to suggest that these tissues are particularly sensitive to protein-tyrosine 
phosphatases.
Hariharan et al. (1989) have investigated the bcr-abl construct. The majority of 
lines failed to express the transgene suggesting that foetal expression may be lethal. 
Most bcr-abl lines showed a low tumour incidence with pre-B and T-cell lymphomas 
resulting. One mosaic founder gave rise to a subline which was highly tumourigenic, 
moreover, expression of the transgene in this line was subject to the phenomenon of 
imprinting (Adams and Cory, 1991). Transgene imprinting results in differential 
méthylation of the transgene depending on whether it is passed via maternal or 
paternal inheritance (Reik et al., 1987; Sapienza et al., 1987; Hadchouel et al., 
1987). In this line of mice, animals inheriting the transgene through the maternal 
route showed a high rate of tumour incidence mainly in the B-cell lineage whereas in 
animals inheriting through the paternal route expression was not detected and a 
significantly lower rate of tumour onset, mainly in the T-cell lineage, was observed.
Thymic Lymphomas
Compared to B-cell malignancy there are fewer published reports describing the 
action of myc within the T-cell compartment. Spanopoulou et al. (1989) were the 
first group to deliberately target myc expression to T-cells and they achieved this by 
placing the murine myc proto-oncogene within the Thy-1 transcriptional unit. The 
Thy-1 gene is expressed in murine brain and thymus, being one of the earliest T-cell 
markers. Eight out of ten of the resulting founder mice and all of the offspring from 
two founders selected for breeding developed thymic tumours at between eight and
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fourteen weeks of age. These tumours consisted of expanded populations of 
lymphocytes and epithelial cells both of which appeared to be completely transformed 
as defined by their ability to grow autonomously in culture. Cell lines established 
from the two cell types revealed that the lymphoid cells were double positive (CD4+, 
CD 8+) T-cells. Although T-cell lines derived from tumour tissue expressed the 
transgene, the majority of epithelial cell lines did not appear to express the transgene. 
The authors concluded that either the epithelial cells expressed the myc transgene 
transiently inducing transformation independently of the lymphocytes or that the 
altered lymphocytes release signals which transformed the epithelial component 
without the direct involvement of myc.
The pim-l gene is frequently activated in thymic lymphomas induced by 
infection of mice with the slowly transforming Murine Leukaemia Virus (MuLV) 
(Selten et al., 1985). To test directly the oncogenic potential of the pim-l, gene van 
Lohuizen et al. (1989b) produced transgenic mice bearing this gene using the 
immunoglobin enhancer (E/x) and the MuLV long terminal repeat (LTR) to regulate 
expression. The pim-l gene was expressed at high levels in both B and T cells in the 
resulting transgenic mice. Despite this, no general disturbance of the haemopoeitic 
cells was observed. These mice showed a low incidence of tumour formation with 
5%-10% of mice succumbing to lymphoma development at between 3 and 7 months 
of age. All of the tumours, except one, arose from the T-cell lineage and a 
comparison between tumours revealed that different T-cell sub-populations could be 
affected.
Synergy Between Different Oncogenes
In almost all studies describing the action of oncogenes in transgenic mice the 
resultant tumours have proven to be monoclonal or oligoclonal revealing that 
expression of the introduced oncogene is merely the first event in a multistep process 
which ultimately leads to the fully transformed phenotype.
In some of these transgenic mice the tumour cells have been screened for the 
presence of rearranged oncogenes. As mentioned above, Rosenbaum et al. (1990) 
introduced the \-abl gene linked to the E/x enhancer into the mouse germline. Non­
neoplastic haematopoetic tissues expressed the transgene but expression was always 
20-40 fold greater in tumour tissue. This suggests that either enhanced levels of 
transgene expression are necessary for the progression to the fully transformed 
phenotype or that the process of transformation itself up-regulates transgene 
expression. A common secondary event associated with advancement of the tumour 
phenotype appears to be the deregulation of myc expression. 80% of tumours 
screened appeared to harbour a rearrangement of the endogenous myc gene leading the
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authors to conclude that deregulated myc expression could complement y-abl in the 
induction of plasmacytomas. Whether these two steps were sufficient to transform 
cells to the malignant phenotype was unknown.
The complementary action of two oncogenes or putative oncogenes can be better 
understood by breeding two different transgenic lines. This results in a proportion of 
the offspring expressing two different oncogenes in the same tissue. To confirm that 
myc and \-abl were indeed complementary, Rosenbaum et al. (1990) created double 
transgenic mice by crossing transgenic lines carrying Ep-w-abl and Ep-myc. 
Compared to the single Ep-w-abl transgenic lines, plasmacytoma development was 
greatly accelerated in these lines with all of the mice dying by 8 weeks of age. 
However the co-operation between these two oncogenes appears to be stage specific, 
as only plasmacytomas developed with no pre-B and B-cells tumours so characteristic 
of the Ep-myc lines being detected. In the w-abl lines the main pathological finding 
was enlargement of the lymph nodes but the anatomical distribution of affected lymph 
nodes varied although the majority were mesenteric. By comparison, all of the 
tumours in the w-abl/myc lines developed gut associated plasmacytomas. The tumours 
arising from these double transgenic lines were oligoclonal rather than the monoclonal 
phenotype seen in the w-abl lines.
To investigate additional secondary events which transform pre-B and B-cells in 
the Ep-myc mice Harris et al. (1988a) have screened tumour DNA for the presence of 
genes which can transform 3T3 fibroblasts. Analysis of one Ep-myc tumour revealed 
the presence of a mutated ras gene. This mutated gene was cloned and was shown to 
be capable of transforming non-tumourigenic pre-B cells derived from Ep-myc bone 
marrow.
To identify collaborative oncogenes Alexander et al. (1989) utilised a different 
approach. These workers infected cell lines derived from Ep-myc mice with 
retroviruses bearing the w-K-ras, w-raf and the w-abl oncogenes. Both ras and raf 
appeared to transform cell lines to the tumour phenotype as shown by the development 
of tumours after the cells were transferred to nude mice. Infection of normal cells 
with w-raf did not produce tumours in recipient mice and tumours only rarely arose 
with w-ras infection of normal cells.
Independent studies carried out by van Lohuizen et al. (1989b) demonstrated 
that the Ep-pim-1 transgene could also co-operate with myc. Infection of neonatal Ep 
-pim-l mice with MuLV resulted in a dramatic acceleration of tumour incidence and a 
decrease in the latent period. The resulting tumours were analysed and Southern 
blotting revealed that proviruses had integrated into the c-myc proto-oncogene in 21 
out of 26 lymphomas, in the remaining tumours proviral integration involved 
activation of the N-myc oncogene. These authors concluded that there appeared to be 
co-operation between these two oncogenes but could not exclude the possibility that
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expression of pim-\ may make the activation of c-myc more likely, perhaps by 
expanding a population of cells susceptible to transformation by c-myc. This work 
was extended when Verbeek et al. (1991) crossed transgenic mice bearing the Ep-myc 
and Ep-pim-l transgenes to create doubly transgenic mice. The effects of the synergy 
between these two transgenes are the most potent to be described to date. Double- 
transgenic myc/pim-l foetuses died in utero. The single-positive lines Ep-myc and E/x 
-pim-l result in the development of B lymphoid and T lymphoid tumours respectively. 
Foetuses harbouring both oncogenes developed pre-B cell leukaemia at day 17-19 of 
gestation. The severity of disease in these foetuses varied, implying that stochastic 
events were involved in tumour progression. In addition, tumour cells were 
transplanted into nude mice resulting in the outgrowth of monoclonal tumours. 
Together these results suggested, despite the obvious potency of this oncogene 
collaboration, that additional genetic or epigenetic events were necessary for the 
development of truly malignant cells.
The one w-abl line which produced tumours in lymphoid cells also showed 
synergy with Ep-myc (Adams and Cory, 1991). Offspring carrying both transgenes 
became ill at two weeks of age with a disseminated invasive lymphoblastic lymphoma 
and accompanying pre-B cell leukaemia. Despite the potency of this combination 
demonstrated by the age range at which these mice became ill, the tumours were not 
transplantable (Adams and Cory, 1991). Acceleration of tumour development also 
occurred when the Ep-myc transgene was complemented with Ep-N-ras transgene 
(Harris et a l ,  1988a). All mice carrying both oncogenes rapidly developed B 
lymphoid tumours, in this case the tumours consisted of pre-B cells or an even earlier 
cell type defined as pro-B cells (Adams and Cory, 1991).
A common chromosomal translocation found in human follicular B-cell 
lymphomas brings together the bcl-2 gene and the immunoglobin heavy chain 
enhancer resulting in deregulation of bcl-2 expression (Cleary et al., 1986). 
McDonnell et al. (1990) used an immunoglobin-M-2 minigene to express bcl-2 in 
both the B and T-cell lineages of transgenic mice. This appeared to have no effect on 
either T-cell numbers or on the relative proportions of T-cell subsets. However, these 
mice had an expanded population of small resting B-cells, these cells co-expressed 
IgM and IgD, and despite not actively proliferating, were responsive to 
lipopolysaccaride and anti-IgM stimulation. In vitro studies showed that these 
transgenic B-cells displayed extended survival times in culture and it seems likely that 
the expanded population of these cells arose not because of increased proliferation but 
rather due to an extended life span. These mice displayed no obvious increase in 
tumour incidence.
Strasser et al. (1990) bred Ep-myc and Ep-SW-bcl-2 mice together to produce 
doubly transgenic mice. Compared to the c-myc lines', tumour development was
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accelerated with mice becoming ill at 5-6 weeks of age and with a greater degree of 
synchrony than observed in the Ep-myc lines. These results showed that bcl-2 
expression could complement the action of myc. Pre-B and B-cells are the target cell 
in the Ep-myc mice (Adams et al., 1985) and a population of B-cells are expanded in 
the Ep-bcl-2 lines (McDonnel et al., 1990) however, Ep-bcl-2lmyc mice all 
developed tumours which consisted of a novel, previously uncharacterised cell type 
(Strasser et al., 1990). The phenotype of these cells was suggestive of a 
haematolymphoid stem or progenitor cell. These mice also had an expanded 
population of pre-B and B-cells characteristic of the Ep-myc mice, but these cells did 
not appear to be malignant. It is unclear whether bcl-2lmyc was responsible for full 
transformation of these primitive cells or whether a third step was necessary for their 
transformation.
Slowly Transforming Retroviruses Can Be Used To Identify Novel Oncogenes
Nusse and Varmus (1982), showed that slowly transforming retroviruses could 
be used to search for previously unknown proto-oncogenes. Murine retroviruses 
induce tumours by a process known as insertional mutagenesis. When the provirus 
integrates into the chromosomal DNA, enhancer and promoter elements within the 
provirus can cause the transcriptional activation of host proto-oncogenes. It is also 
possible that these mutational events could disrupt the regulatory or coding sequences 
of a tumour suppressor gene rendering the cell in which this happens more susceptible 
to transformation. Whatever mechanism operates, the resulting tumour may carry a 
provirus adjacent to or within a gene which has a role to play in tumourigenesis. The 
presence of the provirus can therefore act as a label with which to isolate and examine 
the surrounding DNA.
A number of groups have utilised this approach in mice (Mucenski et al., 1988), 
rats (Tsichlis et a l ,  1985) and cats (Fulton et al., 1987). In mice the oncogenic 
process has been examined in different cells types by using different exogenous 
retroviruses and activated endogenous retroviral sequences such as Murine Leukaemia 
Virus (Cuypers et al., 1984), Friend Murine Leukaemia virus (Bordereaux et al., 
1987), Mouse Mammary Tumour Viruses (Gallahan and Callahan, 1987), and Mink 
Cell Focus-Forming Viruses (Li et al., 1984). These studies have yielded a large 
number of novel genes or insertion sites (for review see Kung et al., 1991).
An alternative approach, outlined by Bems et al. (1989), is to infect transgenic 
animals already bearing an oncogene with a slowly transforming retrovirus. This 
inevitably shortens the latent period required for tumour development and as a result 
restricts the search to those host genes which complement the action of the transgene.
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There are a number of advantages in adapting this approach to transgenic mice 
which already express a known oncogene. (1) The search for common insertion sites 
is narrowed by the underlying action of the transgene. (2) Transgene expression can 
widen the range of cells normally transformed by a specific virus species. (3) 
Complementation between a known oncogene and a novel one can be established.
Two independent publications (van Lohuizen et al., 1991, Haupt et al., 1991) 
have clearly demonstrated the value of infecting oncogene-bearing transgenic mice 
with slowly transforming retroviruses in order to identify novel host proto-oncogenes.
Both works involved infection of Ep-myc transgenic lines with Moloney Murine 
Leukaemia Virus (Mo-MuLV) and in both cases infection of these lines resulted in a 
dramatic acceleration of tumour development. Van Lohiuzen et al. (1991) found that 
the average age of tumour development decreased from 150 days to 50 days and a 
similar reduction in the latent period was reported by Haupt et al. (1991). MuLV 
development normally results in the development of T-cell lymphomas, whereas, 
expression of the myc proto-oncogene is restricted to the B-cell lineage in Ep-myc 
transgenic lines. Nearly all tumours developing in the MuLV infected myc lines were 
of B lymphoid origin, thus the use of transgenic mice has widened the tissue types that 
can be examined using this approach.
Van Lohuizen et al. (1991) examined proviral insertion patterns and 
immunoglobin heavy chain rearrangements and showed that the developing tumours 
were either monoclonal or oligoclonal. This implied that either only rare insertion 
events led to the advancement of the tumour phenotype or that in addition to 
integration in specific insertion sites additional events, unrelated to MuLV infection, 
were also necessary. Proviral integration sites were screened for the presence of 
known oncogenes or previously identified insertion sites. Van Lohuizen e/ al. (1991) 
found that in 30% of tumours the provirus had activated the pim-l gene, in one 
tumour the provirus was detected within the pim-2 locus and in another within the ahi- 
1 locus. Proviral insertions were not found near c-abl, c-raf, bcl-2, c-myb nor the 
insertion site pvt-l in any of the tumours analysed. Haupt et al. (1991) found no 
rearrangement of N-ray, U-ras, K-ras, cbl, bcl-2, myb, raf or rel proto-oncogenes in 
the tumours arising from their experiments, but the provirus altered the pim-l gene in 
18% of tumours analysed and was found within the pim-2 locus in 6% of tumours.
These groups independently discovered a previously unknown gene, the bmi-l 
gene, which appears to co-operate with the myc gene in B lymphoid tumours. This 
locus was a common insertion site in 35 % of the tumours examined by van Lohuizen 
et al. (1991) and in 47% tumours examined by Haupt et al. (1991). The bmi-l gene 
appears to be expressed in the nucleus and has a sequence consistent with that of a 
transcriptional regulator. Two additional novel common insertion sites, bla-l and
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pal-\, were found by van Lohuizen et al. (1991) and another novel site, emi-\, was 
reported by Haupt et al. (1991).
Both groups reported that complementation existed between some of these 
different integration sites as a number of tumours carried proviral integrants in more 
than one site. This work forms the basis from which to establish groups of 
complementing gene products and examine their corporate role in transforming a 
specific tissue, in this case the B-cell lineage.
The results presented in this chapter describe an oncogene induced model of T- 
cell lymphoma. The human c-myc oncogene was targeted to the T-cell compartment 
using the CD2 locus control region. This has resulted in transgenic lines of mice 
which exclusively develop T-cell tumours. Experiments have been initiated to 
ascertain which host proto-oncogenes can synergise with myc within the T-cell 
lineage.
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A TRANSGENIC MOUSE MODEL OF T-CELL LYMPHOMA 
SECTION 6.2 - MATERIAL AND METHODS
6.2.1. Production Of Transgenic Mice
(see Chapter 1 - General Material and Methods.)
6.2.2. Southern Blotting
Preparation of high molecular weight DNA from mouse tissues was carried out 
as described in Chapter 1. DNA was digested with the appropriate restriction 
endonucleases, separated by agarose gel electrophoresis, transferred to nylon filters 
and hybridised to the appropriate radiolabelled probes at high stringency using the 
protocols described by Sambrook et al. (1989). Random priming (random priming 
kit, Amersham Ltd.) and radiolabelling of these probes was also carried out using 
methods described by Sambrook et al. (1989).
A total of three different probes were used. Transgene sequences were 
identified using a human c-myc exon 3 probe (1.38 Kb, Clal-EcoRI). T-cell receptor 
/3-chain (TCR/3) gene rearrangement patterns were determined using 1.2 Kb EcoRI 
fragment of the clone 86T5 (Hedrick et al., 1984). Moloney Murine Leukaemia 
Virus (Mo-MuLV) proviral sequences were detected using a probe derived from the 
U3 domain of the long terminal repeat (Cuypers et al., 1986). This work was carried 
out by M. Stewart, M. Campbell and R. McFarlane.
6.2.3. Northern Blotting
Cellular RNA was extracted from mouse tissues using the RNAzol B method 
(Biogenesis Ltd.). 20 mg samples were separated by electrophoresis on 1% agarose 
gels containing 2.2M formaldehyde, transferred on to nylon filters and hybridised 
using procedures described by Sambrook et al. (1989). The presence of human c-myc 
RNA was determined by probing with a 339 bp Aval fragment of human c-myc exon 
1 cloned into the Aval site of plasmid pBR322 (the gift of Dr. G. Bimie, Beatson 
Institute for Cancer Research). This work was carried out by M. Stewart.
6.2.4. RNase Protection Assay
Plasmid pSPT-PIP2 was generated by subcloning a 2.54 kb HindlH/Nael 
fragment containing 5' upstream sequences and the first 213 bp of the human c-myc
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exon 1 into the plasmid PSPT18 (Boehringer Mannheim). Transcription of this 
plasmid by T7 polymerase after linearisation with Smal generates a 314 nucleotide 
transcript.
For RNase protection analysis, 5 pg of total RNA and 7.5 x W  - 1 x 1(P cpm 
of labelled RNA antisense probe were prepared according to standard protocols for in 
vitro transcription from bacteriophage promoters (Melton, 1985).
RNA and probe were combined in a single eppendorf tube, dried down and the 
pellet resuspended in 20 pi of hybridisation buffer (80% formamide, 4(X)mM sodium 
chloride, 40mM PIPES pH 6.4, ImM EDTA). The solution was heated to 85°C for 
5 minutes then allowed to cool slowly to 55°C and left at this temperature for 16 
hours. RNase digestion (lOmM Tris, pH 7.6, 5mM EDTA, 0.3 sodium acetate pH 
7.0, 0.8 pg/ml RNase A, 3 units/ml RNase T l) was performed for 60 minutes at 
30°C after which RNA-RNA hybrids were precipitated following addition of carrier 
yeast tRNA (20/xg). The RNA pellets were dissolved in formamide denaturing buffer 
and analysed by electrophoresis on a 6% polyacrylamide 8M urea sequencing gel. 
Gels were fixed in 10% methanol, 10% acetic acid, dried down and exposed 
overnight at -70°C to Kodak XAR-5 film using an intensifying screen. Dr. M. 
Stewart carried out the RNase protection analysis and I am grateful to her for 
providing the above information.
6.2.5. Flow Cytometry
Thymus tissue was mixed with phosphate buffered saline and minced using 
sterile scissors and the dead cells removed by centrifuging the cells through a ficoU- 
hypaque gradient (2000xg for 10 minutes). Cells were directly labelled by 
resuspending them at 2.5 x 10  ^ml with a 1:40 dilution of pre-titrated antibody. Four 
hundred microlitre reaction mixtures were incubated at 4°C for 35 minutes before 
washing and analysis. Rat monoclonals FITC anti-CD8, RD anti-CD4 and FITC anti- 
macrph were obtained from Coulter Ltd. The analysis was carried out on a EPICS 
elite cytometer (Coulter Ltd.) This work was carried out by M Campbell, K Blyth 
and L. Keanie.
6.2.6. Histology And Immunocytochemistry
Material for histological examination was fixed using 10% neutral buffered 
formalin, paraffin embedded and stained with haematoxylin and eosin. 
Immunocytochemistry was carried out on snap frozen material sectioned in a cryostat 
and acetone fixed. Labelling of sections was carried out with monoclonal antibodies 
as described by Mason (1985). The monoclonal antibodies used in this work
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included: Rabbit anti-rat immunoglobins (Dako Z455), Rat APAAP complex (Dako 
D488) and fast red substrate. Primary antibodies included rat monoclonal anti-CD4 
(L3/T4 sera-lab clone YTA3.1.2), anti CD8 (Lyt 2 and Lyt 3 sera-lab clones YTS 
169.4 and YTS 156.7), anti-Thy-1 (clone YTS 154.7) and anti-CD3. This work was 
carried out by D. Onions and S. Toth.
The work described in this chapter was a collaborative project involving a 
number of workers with different areas of responsibility. Dr. M. Stewart constructed 
the CD2-myc transgene and prepared it for microinjection. Southern blotting. 
Northern blotting and RNase protection assays were the primarily the responsibility of 
Dr. J. Neil, Dr. M. Stewart, Dr. M. Campbell and Mr. R. McFarlane. 
Histopathology and immunocytochemistry sections were prepared by Dr. S. Toth, and 
examined by Dr. Toth and Prof. D. Onions. Flow cytometry studies were primarily 
the responsibility of Prof. D. Onions and Dr. M. Campbell the samples usually being 
prepared by Miss L. Keanie and Mrs. K. Blyth.
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A TRANSGENIC MOUSE MODEL OF T-CELL LYMPHOMA
SECTION 6.3 - RESULTS
6.3.1. Generation Of myc Transgenic Mice
In order to explore the pathogenesis of T-cell neoplasia, transgenic mice 
carrying the human proto-oncogene c-myc were produced. The human c-myc locus, a 
Hind III-EcoRl fragment in plasmid pMC41 (Watson et aL, 1983), was fused to a 
5.5kb BamHI-Xba fragment of the CD2 dominant control region (DCR). This 
transgene was designed to direct human c-myc expression to the T-cell compartment 
as the CD2 DCR has previously been shown to confer high level copy number 
dependent expression within the T-cell lineage (Lang et al., 1988). The CD2-myc 
construct is shown in Figure 6.3.1.
Figure 6.3.1. The CD2-myc Transgene Construct.
R1H3P
human c-myc
ex l ex2
PsI I fragment replaced
K1113
CD2-myc
CD2DCR Bam-Xba5.5kb exl ex2 ex3
Figure 6.3.1.
This shows a map of the transgene construct used to generate the 800 and 900 lines. The Pst-1 
fragment 5' to exon 1 of the human c-myc gene was replaced with a 5.5 Kb Bam-Xba fragment 
containing the dominant control region of the human CD2 gene.
A total of 330 embryos were successfully injected with the CD2-myc construct 
and transferred to 15 pseudopregnant recipients. Of these, 6 recipients gave birth to 
58 pups all of which survived to weaning. All 58 were screened for the presence of 
human c-myc sequences and two mice, F022 and F051, were found to harbour the 
transgene. Southern blotting was carried out by M. Stewart. Compared to the 
integration frequencies reported by other workers (Brinster et al. , 1985) and the other
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lines of transgenic mice produced in this study (see Chapter 2), these figures were low 
with only 3.4% of screened mice proving to be transgenic.
Both the transgenic mice and their non-transgenic littermates were C57B1\6 (B6) 
X CBA\Ca F2 mice. In order to maintain this genotype each of the transgenic 
founders, F022 and F051, were bred to non-transgenic littermates to produce the 800 
and 900 lines respectively, the 8(X) line being studied in detail. Therefore, the 
majority of mice in both lines are hybrids originally derived from the C57B1\6 and the 
CBA\Ca inbred lines of mice.
6.3.2. Hum an c-myc Expression In Transgenic Lines
Transgene copy number was ascertained by Southern blotting and densitometry 
analysis after titrating genomic DNA and comparing it against known concentrations 
of plasmid DNA. Mice from the 800 line had approximately 14 copies of the 
transgene whereas mice from the 900 line had only 3 copies. Offspring from both 
transgenic founders were culled and total RNA was prepared from various lymphoid 
organs. A 339 base pair probe homologous to exon 1 of the transgene was used to 
determine if human c-myc transcripts were present in these tissues. However, in none 
of the organs analysed by Northern blot analysis was human c-myc mRNA detected. 
In order to exclude the possibility that the transgene was being expressed at levels 
below that of the sensitivity of Northern blot analysis or in a small sub-population of 
cells, RNase protection assays were carried out. Message specific for the human c- 
myc gene was not detected in any of the tissues analysed using this approach.
6.3.3. Thymic Lymphoma Development In myc Transgenic Mice
Despite the inability to detect transgene expression, a proportion of the 8(X) 
series and 900 series mice developed thymic tumours indictating that the presence of 
the trangene renders these mice susceptible to T-cell transformation. The incidence 
rate varied markedly between the two lines. These experiments are ongoing but at 
present 18 mice in the 800 series have spontaneously developed T-cell lymphoma, an 
incidence rate of 16%. To date, only 2 mice in the 9CX) series have developed 
lymphoma, an incidence rate of 3%. The age at which mice developed thymic 
lymphoma ranged from 10 weeks of age to 23 months. Mice that are less than 2 
months of age have been excluded from the incidence analysis as no mice have 
succumbed to thymic lymphoma below this age. Thymic lymphoma has not been 
detected in non-transgenic mice kept throughout the duration of the study.
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The majority of mice in the 800 series are of the C57B1/6 x CBA/Ca genotype 
(hereafter referred to as B6/CBA), however 22 transgenic mice were derived from 
B6/CBA X Balb\c hybrids. The tumour incidence in mice of this genotype is 21% 
whereas the tumour rate in B6/CBA mice is 14%, although this difference is not 
significant (x^ =  2.2: P >  0.05). As the experiment proceeds and more mice 
succumb, it will be possible to establish if crossing onto the Balb\c background 
renders animals more susceptible to transformation.
At present there is not enough data to determine whether or not homozygote 
animals have an increased risk of developing T-cell neoplasia. Of the 18 animals in 
the 800 series which have developed tumours, 12 are known to be heterozygote. The 
remaining 6 animals which succumbed could be either heterozygote or homozygote 
for the transgene and breeding studies suggest that the ratio of homozygote to 
heterozygote in this group is 40% to 60% respectively. Therefore, with the results 
presently available it does not appear that homozygosity increases the frequency of 
tumour development in these mice. The results of tumour incidence in the 800 series 
within the various groups is summarised in Table 6.3.1.
Table 6.3.1. Tumour Incidence in the 800 Line.
800 Series
(a)
At Risk Developing Tumour
Total Number of Transgenic Animals. 113 18
Number of B6/CBA Animals 85 12
Number of B6/CBA x Balb\c Animals 22 6
Number of Known Heterozygotes 63 12
Number of Homozygotes/Heterozygotes (40/60) 48 6
Number of Known Homozygotes 2 0
Table 6.3.1. Shows the tumour incidence in the 800 series maintained throughout the period of study, 
(a) "At Risk" describes the number of transgenic animals, over two months of age, which have been 
kept under observation through out the duration of this study.
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To assess the incidence and age range at which tumour development occurs, 
groups of mice were monitored over a period of time. The age at which mice 
succumb to T-cell neoplasia ranges from 2 months to 23 months. The majority (88%) 
died between 2 and 9 months and 72% of mice died between 2 and 6 months of age. 
The experiment is still on-going and the results of the age incidence are at present 
preliminary as it is not yet clear how many mice will survive to old age. However, 
the results suggest that there is a broad age-range at which mice are more likely to 
develop T-cell lymphoma.
6.3.4. Tumour Phenotype
Affected mice showed loss of weight, deterioration of coat quality and an 
increased respiratory rate. The gait of ill mice was altered and they were often 
smaller than their litter mates. As soon as clinical signs became apparent, affected 
mice were culled. With the exception of one mouse the pathological changes were 
consistent with an enlarged thymus being found in every case, although the degree to 
which secondary organs were involved varied between mice. Two general pictures 
emerged. Those mice with grossly enlarged spleen and lymph nodes and those mice 
in which spread to secondary organs was not obvious with these organs retaining their 
normal size, shape and colour at post mortem.
The gross pathology of the thymus also varied. In some mice the thorax was 
filled with thymic tissue and obviously attached to the pleura and other thoracic 
organs. Occasionally, cords of thymic tissue extended from the main tumour mass 
giving a very irregular appearance. Other mice showed only an enlarged thymus 
which did not occupy the whole cavity, had a smooth surface and occupied a defined 
space. A large range of phenotypes was observed between these two extremes.
The size of the thymus did not appear to be related to the extent of secondary 
organ involvement. Similarly, the age of the affected animal was not related to the 
extent of thymic change, or the degree to which secondary organs were altered.
One mouse which became ill did not have a thymus that was greatly increased in 
size. This mouse was the founder animal of the 800 series and the oldest of all mice 
to develop T-cell lymphoma to date. The only obvious gross pathological feature 
found being a large abdominal mass which was of a similar colour, consistency and 
had a similar surface texture to that of the thymic tumours.
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6.3.5. Histopathology
The pathology of all affected animals was similar. In most cases the normal 
thymic architecture was almost completely replaced by lymphoblasts. These cells 
showed some variation in size with ovoid or indented nuclei containing either single 
or multiple nucleoli. The cytoplasmic border of the lymphoblasts was fairly 
indistinct, eosinophilic and cells showed a high mitotic rate with many abnormal 
mitotic figures. In addition, marked lymphocytolysis and phagocytic activity resulted 
in "starry sky" appearance. In one mouse the cortex appeared to be the site of origin, 
the medulla being invaded from this site.
Other organs were altered to varying degrees. In every animal examined 
neoplastic changes were present in the spleen and extensive alteration of the spleen 
and lymph nodes was common, these organs being largely replaced with lymphoblasts 
again giving a "starry sky" appearance. In some cases areas of splenic red pulp were 
still recognisable. The bone marrow was diffusely infiltrated with lymphoblasts with 
only small numbers of residual haemopoetic cells present.
In the majority of cases, non-lymphoid organs were also heavily infiltrated with 
lymphoblasts. Changes were seen in the liver, the lungs, the kidneys and in one case 
the ovaries of affected animals. The degree of involvement in these organs varied.
The large abdominal mass recovered from the founder mouse consisted of 
lymphoblasts.
As most of the lymphoid organs were replaced by tumour cells the pathway of 
spread could not be established. However, with non-lymphoid organs a 
haematogenous route of spread was evident, indicating leukaemia. The histological 
examination of these tissues led to a diagnosis of lymphoblastic thymic lymphoma 
with associated lymphoblastic leukaemia.
6.3.6. RNA And DNA Analysis Of Tumour Tissue
In all tumour samples examined a moderate to high level of human c-myc 
expression was detected. Therefore, c-myc expression did not appear to be discernible 
in transgenic lymphoid cells until after they became transformed.
Transformed cells were also analysed to determine T-cell receptor beta (TCRjS) 
gene rearrangement. The presence of only one or two rearranged bands indicates that 
these tumours were either monoclonal or oligoclonal. The analysis may be 
complicated by the presence of non-transformed cells within the sample or 
rearrangement of the second allele, both of which would give an additional series of 
bands.
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6.3.7. Phenotype Of Transformed Cells
Immunofluoresence staining revealed that transformed cells carried Thy-1, CD3, 
CD4 and CDS cell surface markers, in none of the tumours examined was the B-cell 
specific marker evident, indicating that these tumours were of the T-cell lineage.
Cells were prepared from tumour tissue for analysis by flow cytometry on an 
EPICS Elite cytometer (Coulter Ltd.). Although only a small number of tumours 
have currently been analysed these results show that each tumour had a largely 
homogenous cell population. However, in different tumours the cell populations 
pathologically expanded differed. In two out of four thymic tumours analysed the 
major cell population was CD 4+/CD8+ whereas in the other two tumours the cells 
were CD4-/CD8+. In the four tumours analysed there appeared to be a correlation 
between the cell type involved and the gross pathological picture. In the two CD8+ 
single positive tumours there was obvious metastasis with marked enlargement of 
secondary organs such as the spleen and lymph nodes whereas in the CD4-H/CD8+ 
tumours the gross changes were confined to the thymus. Flow cytometry of healthy 
transgenic mice revealed that no abnormalities could be discerned when compared 
against control mice.
6.3.8. Induction Of Thymic Lymphomas Using MuLV And MuLV-supF
To determine if the presence of the transgene rendered these mice more 
susceptible to Murine Leukaemia Virus (MuLV) induced tumourigenesis animals, 
heterozygote for the transgene, were bred with Balb\c females and the resulting 
offspring infected with Moloney Murine Leukaemia Virus (Mo-MuLV) within the 
first 24 hours of life. Neonates were infected by injecting approximately 0.1ml of 
Mo-MuLV or Mo-MuLV-supF directly into the abdomen. These experiments were 
designed so that transgenic positive and transgenic negative littermates were infected 
with the same batch of virus on the same day. Animals were sacrificed when they 
were first noticed to be ill and samples taken at post mortem.
In total, three separate experiments were performed. In the initial preliminary 
experiment 9 offspring from the 800 line and 10 offspring from the 900 line were 
infected with Mo-MuLV. In the 800 series, 4 of the 9 infected mice carried the 
transgene and these mice succumbed on average 63 days after infection (range 53-70 
days). The non-transgenic litter-mates survived significantly longer, dying on average 
144 days after infection (range 103-203). A similar result was obtained with mice 
from the 900 series. Of the 10 infected mice, 4 proved to be transgenic and these 4 
had an average lifespan of 67 days (range 61-72 days) whereas the control mice died 
on average 132 days post-infection (range 107-146 days).
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The second experiment concentrated on the 800 series and on this occasion the 
Murine Leukaemia Virus carried the supF gene (Mo-MuLV-supF), this recombinant 
virus being used to facilitate the cloning of subsequent insertion sites (Reik et a l ,  
1985). Twenty-four mice were infected, subsequent analysis revealing that 12 of 
these mice were transgenic. The average lifespan for the transgenic group was 75 
days (range 63-84). In the control group only 7 out of 12 mice developed lymphoma 
by 250 days at which point the experiment was concluded. The average lifespan of 
the control mice which succumbed before the end of the experiment was 191 days 
(range 135-250).
In the third experiment, all 8 of the Mo-MuLV-supF infected mice were 
transgenic as they were the offspring from an animal homozygote for the transgene 
and a Balb\c female. These mice died on average 70 days after infection (range 66- 
70) with 7 out of 8 mice being found ill on the same day. These results are 
summarised in Table 6.3.2 and Figure 6.3.2.
The results show that infection with MuLV increases tumour incidence and 
results in a dramatic acceleration of tumour development. Infection of CD2-myc mice 
changes the pattern of tumour development in three ways. 1) The incidence rate of 
spontaneous tumours is only 16% but all of the infected mice die. 2) Infected mice 
succumb to lymphoma development much earlier in life than the uninfected mice and 
3) tumour development in the infected mice is much more synchronous than in the 
uninfected mice. Altogether 24 transgenic mice were infected in these experiments 
and only 31 days separated the ages of mice succumbing to thymic lymphoma.
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Table 6.3.2. Lifespan of Infected Transgenic Mice and Infected Control
Littermates.
Group Group
Size
Average
Lifespan
fdavsl
Range
(days)
Standard Deviation
MuLV
800 series 4 63 53-70 7.1
900 series 4 67 61-72 5.6
Controls 11 137 103-177 33.8
M uLV-sudF
800 Series 20 73 63-84 5.1
Controls 7 191 135-250 42.6
A summary of three experiments in which CYyi~myc transgenic mice were infected with wild type 
MuLV or the recombinant MuLV-supF showing the average lifespan, range and standard deviation of 
affected animals.
There is no significant difference between the age at which transgenic mice 
develop lymphoma when infected with MuLV as opposed to those infected with 
MuLV-supF, although those infected with wild type MuLV died on average 10 days 
earlier than those infected with the recombinant virus. The recombinant retrovirus 
may be slightly less potent than the wild type or this may just reflect a difference in 
titre between the two virus batches.
The large difference in the latent period between transgenic and control mice 
clearly shows that the transgene collaborates with MuLV in the development of T-cell 
lymphoma. Although the numbers involved in Experiment 1 were small, these results 
indicate that the 800 and 900 lines are equally susceptible to MuLV induced 
tumourigenesis.
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Figure 6.3.2. Survival Curves for Infected Transgenic Mice and Infected
Control Littermates.
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Figure 6.3.2. Compares the survival times for (a) infected CDl-myc mice, (b) infected non-transgenic 
mice and (c) uninfected CT>2-myc mice.
6.3.9. Pathology Of MuLV Induced Tumours
There were no obvious differences in the profile of pathological changes 
between those mice spontaneously developing thymic lymphoma and those mice 
developing it after infection. In MuLV induced tumours the thymus was always 
markedly enlarged, often filling the entire thoracic cavity. Evidence of metastasis on 
gross pathology was variable but the spleen was frequently involved.
Histopathological findings were indistinguishable from those already described 
for spontaneous tumours. On histopathological examination evidence of tumour 
infiltration was found in all spleens examined.
6.3.10. Immunocytochemistry Of MuLV Induced Tumours
Tumour tissue recovered from CD2-myc animals infected with MuLV was tested 
for the presence of cell surface markers. The staining pattern observed was very
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similar to that described for spontaneous tumours. All tumours examined were 
positive for Thy-1, CD3, CD4 and CDS whereas none proved to be positive for the 
B-cell specific Ig marker. Therefore, in all tumours examined only cells displaying 
the T-cell phenotype were found.
6.3.11. Flow Cytometry Analysis O f Tum our CeUs From Infected Mice
The cell types found in tumours arising from infected transgenic mice are 
similar to those seen in the spontaneous myc mice. To date, four tumours from this 
group have been analysed, in two of these tumours the major cell type was the 
CD 4+/C D 8+ cell whereas the other tumours showed a CD8+ singly positive 
phenotype.
6.3.12. Transgene Expression In The MuLV Induced Tumours
Southern blotting of T-cell receptor chain (TCR/?) genes with a 1.2 Kb probe, 
derived from clone 86T5 (Hedrick et al., 1984), revealed that the MuLV induced 
tumours were monoclonal or oligoclonal with only one or two TCRjS chain 
rearrangements being detected within each tumour.
The induced tumours were also clonal with respect to proviral integration, this 
was confirmed by the relatively simple proviral integration pattern observed after 
hybridisation with a probe specific for the U3 region of the viral LTR.
Total RNA was isolated from tumour tissue of MuLV infected CD2-myc strains 
and hybridised with a 339 bp probe recognising the transcript encoded by the human 
c-myc. As with spontaneous tumours, virally induced tumours in CD2-myc all 
showed high levels of transgene expression.
Although high levels of expression were found in both spontaneous and MuLV 
induced tumours, no expression was found in young, healthy animals when thy mi 
were examined by either Northern blotting or RNase protection assays. To investigate 
the possibility that proviral integration occurred within the transgene tandem arrays, 
thereby causing activation of the transgene, the tumours were analysed for the 
presence of the transgene rearrangements using the human c-myc exon 3 probe. 
Southern blotting was used to compare the integrated transgene within the tumour 
cells with the germline pattern. Tumours from 6 mice were analysed but no obvious 
rearrangement of the transgene was evident in any of these tissues.
Therefore, there is no evidence of insertional mutagenesis occurring within any 
of the multiple transgene copies in any of the tumours analysed. These results do not, 
however, exclude the possibility that proviral sequences integrated at some distance 
either 5 ' or 3' to the transgene insertion site.
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A TRANSGENIC MOUSE MODEL OF T-CELL LYMPHOMA 
SECTION 6.4 - DISCUSSION
To explore the effects of the myc oncogene within the T-cell compartment, the 
human c-myc gene, coupled to the regulatory sequences of the CD2 dominant control 
region (CDR), was introduced into the mouse germline. This resulted in two 
transgenic lines being created both of which developed thymic lymphomas, albeit at 
markedly different rates. In the most intensively studied line (CD2-/wyc-800), 16% of 
mice succumbed, whereas in the CD2-myc-900 line only 3% of mice developed 
tumours.
The pathology and histopathology were indicative of T-cell tumours with the 
primary site of tumour involvement almost always being the thymus. The T-cell 
origin of these tumours was confirmed by examination of cell surface markers. The 
presence of the T-cell markers; Thy-1, CD3, CD4, and CD8 and the absence of Ig 
antigens shows that in every tumour examined thymocytes were the target cell. No 
tumours have arisen from any other tissue compartment.
These results show that the presence of the myc transgene predisposes these mice 
to tumour formation and that this is restricted to the T-cell phenotype by the CD2 
dominant control region. This is the first work to directly target the oncogenic effects 
of the myc transgene exclusively to the T-cell compartment and we believe that the 
CD2-myc mice described here will be a valuable model with which to study the 
biology of T-cell lymphoma and leukaemia.
Examination of T-cell receptor (TCR) gene rearrangements revealed that these 
tumours were either monoclonal or oligoclonal. This, together with the variable 
latency and the relatively small proportion of mice affected, indicates that rare genetic 
events are probably responsible for the progression to the tumour phenotype.
The hypothesis that tumourigenesis is a multistep process has become well 
established in recent years and the use of transgenic mice to pursue the study of 
oncogenesis has played a major role in lending credence to this theory (Adams and 
Cory, 1991). The results in this study add weight to this hypothesis as they suggest 
that one or more additional genetic or epigenetic events are contributing to the tumour 
phenotype.
High levels of human c-myc expression were found in every tumour analysed 
but despite the increased incidence of thymic lymphoma in these mice, it has not been 
possible to detect transgene expression in the tissues of healthy CD2-myc mice using 
both Northern blotting and RNase protection assays. That the transgene does not 
appear to be expressed within preneoplastic T-cells is somewhat surprising as all
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previous reports of transgene constructs employing the CD2 regulatory sequences 
describe high level, copy number dependent expression in the T-cell lineage. The low 
frequency of transgenic founders and the finding that the CT^l-myc transgene was not 
expressed in the only two founder mice which resulted from this work, raises the 
possibility that foetuses expressing the transgene died in utero during early thymic 
development. Therefore, it is possible that over expression of myc in the T-cell 
compartment of the developing foetuses is lethal. Alternatively, the presence of 
plasmid sequences in the CD2-wyc construct may have suppressed expression as it has 
previously been shown that the inclusion of plasmid sequences can inhibit transgene 
expression (Townes et a l ,  1985).
There are a number of possibilities which could explain the role of the 
apparently quiescent transgene in the development of thymic lymphomas. Any rare 
genetic event leading to activation of the transgene may be the first step in 
tumourigenesis, that this event ultimately leads only to T-cell tumours is probably due 
to the presence of the CD2 regulatory sequences. This implies that either the CD2 
element is functional, but cannot overcome the repression of the down-regulated myc 
gene, or that the action of the CD2 unit is itself compromised and that activation of 
the transgene involves a process which returns function to this regulatory unit. None 
of these putative activation events have resulted in expression being detected in a 
tissue other than the T-cell lineage and similarly, no tumours have been found outside 
this tissue type.
At present it is not possible to say whether activation of the transgene is the only 
event necessary for tumour development or whether subsequent random events are 
also required after transgene expression is initiated. A considerable amount of 
evidence supports the latter hypothesis, as expression of oncogenes (Hariharan et al. , 
1989; Yee et al., 1989; Me Donnell et al., 1990; van Lohuizen et al., 1989b) 
including c-myc (Adams et al., 1985) within transgenic animals does not appear to be 
sufficient to induce tumour formation in the majority of cases. Even in transgenic 
mice expressing two complementary oncogenes, additional events appear to be 
necessary for transformation to the fully malignant phenotype (Rosenbaum et al., 
1990; Verbeek et al., 1991).
Alternatively, it is possible that the transgene is being expressed in a small sub­
population of cells, with the total level of messenger RNA being below the sensitivity 
of our assays. Expression within these cells would render them more vulnerable to 
additional transforming events, which in turn could allow this population to become 
dominant. However, this hypothesis still fails to explain why only a very small group 
of T-cells should express the transgene given the reported dominance of the CD2 
regulatory region. In addition, the phenotypic features of the transformed cells do not 
suggest that these cells are a specialised or unusual sub-population of T-cells.
172
Another possibility which cannot formally be excluded is that a small number of 
mice do express the transgene. The mice in this experiment are a genetically 
heterogeneous group of individuals and it is possible that inheriting a specific 
combination of alleles permits transgene expression rendering individual mice much 
more susceptible to neoplastic disease. Such a hypothesis might be investigated by 
repeatedly crossing transgenic mice into a variety of different genetic backgrounds, or 
alternatively, it may be possible, with long term breeding studies, to identify sub-lines 
of mice which are either susceptible or resistant to T-cell neoplasm.
There is a precedent for the situation described here. Hariharan et al. (1989) 
introduced the bcr-y-abl gene into the germline of mice and despite being unable to 
detect transgene expression in tissues of healthy mice, these animals showed an 
increased incidence of lymphoma development. Two constructs were used, in one the 
transgene was coupled to the immunoglobin enhancer (Ep) and in the other, part of 
the long terminal repeat (LTR) of the Myeloproliferative Sarcoma Virus (MPSY) was 
used. The Ep enhancer has been reported to produce expression in both B and T- 
cells, whereas, the LTR produces expression in myeloid as well as lymphoid cells 
(Bowtell et al., 1988). It is interesting to note that 75% of tumours in the Ep-6cr-v- 
abl mice were of T-cell origin and all of the tumours arising in UTR-bcr-v-abl mice 
were of T-cell origin. This may suggest that events which activate non-expressing 
transgenes are more likely to occur in the T-cell lineage than in the B-cell 
compartment.
Preneoplastic Changes
Consistent with the apparent lack of transgene expression, the haematopoietic 
populations in healthy transgenic mice did not appear to be perturbed. It is not known 
whether obvious preneoplastic changes would be expected if  the myc transgene was 
being expressed. Constitutive expression of the myc proto-oncogene within the B-cell 
lineage causes disturbances in the B-cell population with expansion of pre-B cells and 
a subsequent reduction in the proportion of mature B-cells (Langdon et al., 1986). 
Changes in B-cell populations in myc bearing transgenic mice have also been reported 
by Yukawa et al. (1989). These workers compared the action of the Ep-wyc 
transgene on two different genetic backgrounds and found that B6 mice developed 
mainly B-cell tumours, whereas C3H/HeJ mice developed mainly T-cell tumours. 
However, the transgene was expressed in both T-cells and B-cells in both strains of 
mice. Expression within the B-cell compartment produced changes in the 
preneoplastic B-cell population but no change in the characteristics of the T-cell 
population could be detected - even in the mouse strain which developed mainly T-cell
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tumours. Therefore, in the C3H/HeJ strain, expression of the myc gene in the T-cell 
compartment was associated with the development of T-cell tumours but not with an 
obvious alteration to the preneoplastic T-cell population.
Further evidence for the action of myc on T-cells was reported by Spanopoulou 
et al. (1989). In this case, thymic expression of myc was achieved using the Thy-1 
regulatory unit. These transgenic mice developed tumours in the thymus which 
consisted of lymphoid and epithelial cells, thymic expression of the myc gene in 
healthy tissue was comparable to that found in tumour tissue but expression of CD3, 
CD4, CD8 and heat stable antigen (HSA) in the thymocytes of young healthy mice 
was normal.
However, the 'L-myc gene does appear to affect T-cell populations. Moroy et 
al. (1990) found that the L-myc gene is preferentially expressed in T-cells when under 
the regulation of the immunoglobin enhancer. Expression of this gene caused 
disturbances in T-cell development with expanded thymic cortices, enlargement of 
cortical lymphocytes and spleens which contained enlarged and irregular follicles. 
The relative populations of T-cell subsets were, however, unaltered.
The Incidence Of Tumour Formation In CD2-myc Transgenic Mice
In this present study the two transgenic lines showed markedly different rates of 
tumour formation with the incidence rate in the 8(X) and 900 lines being 16% and 3% 
respectively. Transgene integration being essentially a random process means that the 
integration sites in the two transgenic lines differ. The two lines also differ with 
respect to transgene copy number with the 800 line carrying approximately 14 copies 
and the 900 line carrying only 3 copies. Although the great majority of transgene 
constructs are heavily influenced by their integration site, the CD2 dominant control 
region has been reported to confer on the transgene independence from the integration 
site influence and allow high levels of transgene expression (Lang et al., 1988). If 
expression were present it would be expected to be directly correlated with the 
number of integrated copies. It is possible, therefore, that if expression is occurring 
in a sub-population of T-cells that the transgene copy number and resultant level of 
expression is directly influencing the tumour incidence.
If the transgene is being repressed and activation events are required to induce 
expression, then it may be that the transgene in the 800 line occupies a position within 
the host chromatin which is more likely to be activated than in the 900 line. In this 
case tumour incidence would be independent of transgene copy number. Copy 
number may influence the rate of tumour formation indirectly, the larger size of the
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transgene integration site in the 800 line making random activation events much more 
likely to influence transgene expression as a consequence of target size.
Alternatively, some combination of these may be possible. The initial rate 
limiting event may be activation of the quiescent transgene. After this has occurred 
the next limiting event may be the level of expression which in turn is copy number 
dependent.
Genetic Background
Preliminary results suggest that the offspring of B6\CBA x Balb\c CDl-myc 
mice may have an increased tumour incidence. That genetic background can 
influence the incidence and pattern of tumour formation in transgenic mice bearing 
oncogenes has previously been reported by Sidman et al. (1988). These workers 
found that the oncogene potential of the E/x-wyc transgene varied on different genetic 
backgrounds. Tumours developed relatively slowly in B6 mice in sharp contrast to 
SJL mice which developed lymphomas rapidly. Balb\c mice represented an 
intermediate situation with lymphomas developing at an early age but the subsequent 
incidence rate flattening off. To investigate the effect of genetic background on the 
CDl-myc mice further would require moving the transgene onto different genetic 
backgrounds, including the Balb\c strain, and then assessing the tumour incidence.
MuLV Infection O f CDl-myc Mice
The presence of the transgene greatly accelerated MuLV induced 
tumourigenesis. CDl-myc mice all develop thymic lymphoma at between 9-12 weeks 
of age when infected with MuLV, whereas infected control mice had an average 
lifespan of 23 weeks. Further, infection of CDl-myc neonates increases the incidence 
and synchrony of tumour development when compared with spontaneous tumours 
arising in non-infected transgenic animals. Infection increases the incidence from 16 
to 100% and whereas mice developed spontaneous tumours over a wide age range (2- 
23 months), all MuLV infected mice died at around 3 months. Taken together, these 
results suggest that MuLV infection and the CDl-myc transgene collaborate in the 
development of thymic lymphoma. That the infective oncogenesis does synergise 
with the CDl-myc transgene is confirmed by finding that all tumours examined in 
these mice strongly express the transgene.
The pathological and histopathological features of the MuLV induced tumours 
are very similar to those found in non-infected CDl-myc mice. Again, there is 
primary involvement of the thymus, with metastasis to other organs, both lymphoid
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and non-lymphoid. In addition, a similar cell population is affected, the main target 
cell appearing to be either the CD 4+/CD8+ double positive or the CD8+ single 
positive cell. That virally induced tumours are also clonal is shown by T-cell receptor 
(TCR) gene rearrangement patterns and the relatively simple pattern of proviral 
integration sites in individual tumours. In conclusion, it appears that although viral 
induction affects the kinetics of tumour development it does not appear to alter the 
characteristics of the resultant tumours.
Preliminary results suggest that although the incidence rate of spontaneous 
tumours is markedly different between the two transgenic lines, these lines are equally 
susceptible to MuLV induced tumourigenesis. This finding does not support the 
suggestion that the target size of the transgene integration site is an important factor in 
influencing the likelihood of spontaneous activation events.
Tumour tissue from infected mice was examined for transgene rearrangements 
in order to better understand the mechanism of tumour formation in infected mice and 
the nature of the interaction between the integrating proviral sequences and the 
transgene. No obvious rearrangement of the transgene was detected, indicating that 
integration had not occurred within the tandem arrays of the transgene. Despite this 
result, the simplest and most attractive explanation is that integrating proviral 
sequences activate the quiescent transgene with the responsible proviral sequences 
being situated 5' or 3' of the transgene insertion site. In this hypothesis, the 
integrating proviral sequences would substitute for the unknown initial event which 
induces activation of the transgene - the possible first step in the development of 
thyomas in the non-infected transgenic mice.
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Future Prospects
The CD2-myc mice represent a powerful model with which to extend our 
understanding of the mechanism underlying T-cell lymphoma development. The 
CD2-myc lines are unique as they are the only mice in which the c-myc oncogene is 
exclusively targeted to the T-cell lineage and as such they will allow an investigation 
into those events which can collaborate with myc in the development of T-cell 
tumours.
Future research will attempt to identify those genes and those events that 
together with myc contribute to the induction of T-cell tumours. Infecting the CD2- 
myc mice with MuLV should identify those genes which can co-operate with myc in 
T-cell transformation and these studies may also result in the identification of 
previously uncharacterised genes and loci. This approach has been successfully used 
to identify those genes which complement one another in transforming B-cells (Haupt 
et a l ,  1991; van Lohuizen et al., 1991). These studies revealed that different 
oncogenes (or putative oncogenes) can be grouped on the basis of mutual 
complementation.
Parallel studies will investigate those functional characteristics, specific to T- 
cells, which render them vulnerable to transformation. T-cell function is based on the 
ability of these cells to interact with antigens via the T-cell receptor. This process 
involves recognition, activation and proliferation. In tlie case of self antigen, 
activation appears to be followed by programmed cell death - apoptosis.
We intend to investigate the relationship between antigen recognition and 
tumour development by deliberately stimulating the immune system with both 
endogenous and exogenous antigens. The attraction of this approach is that any 
transformed population which subsequently arises can be screened for its specificity to 
the original antigen.
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